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1. Summary 
 
The increasing use of appliances, which generate electromagnetic fields (EMFs), has 
provoked public concern about their safety. Scientific research into possible health effects 
however produced conflicting results. One of the open questions is whether or not EMF 
exposure has genotoxic effects. Therefore, the main objective of my thesis was to 
investigate DNA damage formation and repair, cell cycle progression, apoptosis and DNA 
damage signalling in cultured human cells under EMF exposure. In particular, the nature of 
possible genotoxic effects and the mechanisms underlying the cellular responses were to be 
addressed.  
As in the past, genotoxic effects of EMF exposure often could not be reproduced in 
independent studies, I first aimed at the validation of results of previous studies [1-3].  In 
these studies, different genotoxicity tests revealed increased DNA damage after exposure of 
human fibroblast cells to EMFs in the low frequency range, as used in power lines, as well as 
in the radiofrequency range, as applied by mobile phones and wireless technologies. I could 
show that genotoxic effects of 50Hz EMFs can be reproduced independently. Effects of 
radiofrequency EMF exposure, however, were detectable only in one particular cell line (HR-
1d), but not in the cell line used in the original study (ES-1). Because the visual scoring 
method of DNA fragmentation analysis (comet assay) used in the previous studies was 
criticized in the scientific community, I compared this method with an automated 
computerized comet analysis. This established that increases of DNA fragmentation 
following EMF exposure are detectable in both types of analyses.  
Expanding the study to other cell lines, I was able to show, that 50Hz EMF exposure in two 
different fibroblast cell lines but not in the cancer cell line HeLa lead to comet assay effects. 
Furthermore, I showed that DNA fragmentation is not found in G1 blocked cells, suggesting 
replicating cells to be involved in EMF directed effects. This indicated, that the DNA 
fragmentation detected following EMF exposure might not reflect direct induction of DNA 
damage but rather an EMF dependent alteration of the S-phase population. Furthermore 
apoptosis was suggested as confounder for comet assay effects before. Addressing this 
question, I found decreased replication efficiency and an increased apoptotic fraction after 
50Hz EMF exposure in the fibroblast cell line showing the higher comet assay effect. 
Therefore, I conclude that these cells encounter problems in entering S-phase or progression 
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through S-phase, which could lead to apoptosis and, hence, apoptotic DNA fragmentation, in 
a subpopulation. These effects, however, cannot entirely explain the genotoxicity observed, 
as the fraction of cells with increased DNA fragmentation was higher than the proportion of 
apoptotic cells. 
I then addressed the type of possible DNA damage generated by EMF exposure. An inhibitor 
of the DNA single strand break (SSB) sensor poly-ADP-ribosylation polymerase was used to 
examine an engagement of DNA single strand break repair following EMF exposure. The 
results showed that the increase of DNA fragmentation did not change further by applying 
both inhibitor and EMF exposure compared to inhibitor or EMF exposure alone. Therefore 
the effects appear to be epistatic, indicating that EMF exposure may affect DNA SSB repair 
rather than inducing DNA damage itself. To address the occurrence of DNA double strand 
breaks or stalled replication forks, I made use of phosphorylated H2AX (γH2AX) as a marker 
in EMF exposed cells. This revealed no difference between non-exposed and exposed cells, 
suggesting that the increase in DNA fragmentation is unlikely due to such lesions. 
Biological effects of EMF exposure were hypothesized to reflect an influence on the free 
radical pool of cells and, thus oxidative stress. I examined the steady state levels of oxidative 
DNA damage after EMF exposure and found no indications for increased generation of 
indicator lesions. This result fails to support the hypothesis of EMF induced oxidative stress, 
although I cannot completely rule out small changes of a sub-detectable level. DNA base 
excision repair (BER) is the system specifically repairing small lesions including oxidative DNA 
base damage. To examine, if this pathway is activated during EMF exposure, I examined the 
formation and levels of nuclear XRCC1 foci. XRCC1 is a central component of the BER system 
and can be seen to localize to sites of DNA damage and repair. However, immunostaining of 
XRCC1 revealed no difference in numbers and distribution of foci following EMF exposure. 
Adding a DNA Polymerase β (the BER polymerase) inhibitor, however, the subG1 fraction of 
cells increased synergistically with ELF-EMF exposure. This could indicate, that either BER 
protects cells from entering apoptosis following EMF exposure or that the DNA damage 
generated by inhibiting DNA Polymerase β is less efficiently processed under EMF exposure. 
Taken together, these results suggest, that the small increase in DNA fragmentation 
observed in human fibroblasts exposed to 50Hz EMFs can be accounted for by a combination 
of effects including impaired repair of endogenously arising DNA damage, disturbance of S-
phase progression and apoptosis in a small fraction of cells, rather than by directly induced 
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DNA damage. 
In a second part of my thesis, I used the highly sensitive comet assay, cell cycle analysis and 
immunofluorescence staining technologies established for the EMF studies to contribute to 
different projects addressing regulatory aspects of DNA BER. In a first study, we showed that 
Thymine DNA Glycosylase (TDG) levels were cell cycle regulated and TDG is absent in S-
phase in biochemical assays. Regulation occurs at the protein level, as mRNA levels remain 
constant throughout the cell cycle. The protein is ubiquitinated and degraded by the 
proteasome. To provide biological evidence for such a regulation in vivo, I stained cells with 
antibodies for TDG and the S-phase marker PCNA by immunofluorescence and counted cell 
numbers of double and single stained cells. PCNA positive cells did not stain for TDG and vice 
versa. As PCNA is a marker for S-phase, this shows, that TDG is absent in S-phase cells. 
In a second study we provided evidence for a regulation of DNA Polymerase β (DNA Pol β) by 
protein arginine methylation. This methylation has impact on its in vitro performance like 
DNA binding and processivity, but an in vivo relevance of this modification remained to be 
shown. I showed that DNA Pol β knock out cells complemented with a mutated form of DNA 
Pol β, not able to be methylated, showed a higher level of DNA fragmentation upon induced 
DNA damage than cell complemented with wild type DNA Pol β. Together with reduced 
survival rates and an increased subG1 fraction in cells challenged with a DNA damaging 
agent, this established the in vivo relevance of DNA Pol β methylation. Arginine methylation 
therefore might represent a novel regulatory protein modification in DNA BER.  
In a third study, I contributed to the investigation of the toxicity mechanism of the 
chemotherapeutic drug 5-fluorouracil (5-FU), which is not fully understood so far. An 
involvement of the BER enzyme TDG was suggested by biochemical evidence, leading to the 
question, if TDG wild type and knock out cells respond differently to 5-FU. TDG knock out 
cells displayed hypersensitivity to 5-FU, which suggested a deleterious repair mechanism 
through TDG, probably leading to the induction of DNA SSBs. I indeed found increased DNA 
strand breaks in TDG wild type cells compared to knock out cells, while XRCC1, a marker for 
BER, was more activated in knock out cells. In cell cycle analyses 5-FU induced accumulation 
on S-phase of TDG deficient cells was less pronounced than in wild type cells. This suggests 
that TDG contributes to 5-FU mediated cytotoxicity, probably by inducing DNA SSBs due to 
its slow turnover rate and the resulting saturation of BER, leading then to checkpoint 
activation and S-phase accumulation.  
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2. Introduction 
 
Damage to DNA occurs frequently in cells and has to be fixed with high accuracy in order to 
avoid cell death or transformation. There are different sources of DNA damage and different 
possibilities of repair (Figure 1).  
 
     
Figure 1. DNA damage and consequences. 
A) Common DNA damaging agents (top), examples of DNA lesions (middle) and relevant repair mechanisms for 
removal of the lesion (bottom). B) Consequences of DNA damage: cell cycle arrest in G1, S, G2 or M phase 
(top), effects on DNA metabolism (middle) and long-term effects of DNA injury (bottom). Adapted from 
Hoeijmakers et al., 2001 [4]. 
 
Sources for DNA damage can be exogenous (e.g. chemicals, UV light, X-rays) or endogenous 
(reaction products of normal cellular metabolism). Of the latter, oxidation, alkylation and 
hydrolytic deamination are responsible for the majority of lesions which, if not repaired, may 
lead to mispairing during DNA replication. Mispairing, deletions or insertions can also occur 
because DNA polymerases make errors. DNA strand breaks can be the consequence of many 
of these DNA damaging agents and either affect only one or both DNA strands. 
Electromagnetic fields are discussed as a possible source of DNA damage, but conclusive 
evidence has not been presented so far.  
A B 
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DNA damage may give rise to genomic instability and/or trigger cellular responses such as 
cell cycle checkpoint activation, cell cycle arrest, apoptosis, gene activation and DNA repair. 
Depending on the type of lesion and the cellular context of its occurrence cells make use of 
different and specific repair pathways for the restoration of intact DNA (for review see[4]). 
Failure of one of these mechanisms can lead to mutations and eventually to transformation 
of the cell and to cancer of the organism.  
 
2.1. Biologic effects of electromagnetic fields 
There is an ongoing debate about the biological effects of electromagnetic fields. Effects on 
human health and well being including sleep disturbance, headaches and interference with 
cognitive abilities are discussed. Alteration of immune responses or calcium homeostasis of 
cells have been reported. Even DNA damage induction and increased risk of cancer are being 
considered as possible outcomes of daily EMF exposure. The same way the exposure to 
electromagnetic fields increases within the recent years, public safety concerns have 
become a political and scientific issue.  Many of the open questions have been addressed 
scientifically, but the currently available data is not conclusive. 
 
2.1.1. Basic physical background 
An electromagnetic field (EMF) can be seen as a wave with a certain wavelength λ and a 
frequency in Hertz (Hz). It is composed of an electric field (Volts per meter: V/m) and a 
magnetic field that can be expressed as magnetic field strength in Ampere per meter (A/m) 
or as magnetic flux density in Tesla (T). Both fields are perpendicular to each other. A 
magnetic field induces an electric field and, vice versa, moving electric charges induce a 
magnetic field. In the low frequency range (0-300kHz) magnetic and electric field can be 
distinguished, but with higher frequencies the alteration between the two is so fast that the 
resulting field is seen as one and is referred to as an electromagnetic field.  
The electromagnetic spectrum ranges from extremely low frequencies (ELF, 0Hz-300Hz) such 
as that emitted by  traction power and power lines, through radiofrequencies (RF, 100kHz-
10GHz), including for example TV and mobile phone radiation and visible light, to X- and γ-
rays (Figure 2). The latter two are also known as ionizing radiation, because their energy is 
high enough to ionize atoms and molecules (the energy of the field is directly proportional to 
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its frequency), thereby affecting chemical bonds. By contrast, the lower ranges of the 
spectrum are termed the non-ionizing radiation.  
 
           
Figure 2. The electromagnetic spectrum. 
Frequency-wavelength relationship of electromagnetic fields and application examples of different frequency 
ranges (top). Additionally shown are known consequences of the different electromagnetic fields (bottom). 
Adapted from Moulder, 2004. 
 
Known consequences of non-ionizing radiation are on one hand thermal effects, which play 
a more important role in the RF range and on the other hand induction of electric currents in 
the body and therefore electric effects on nerves and muscles in the ELF range. To protect 
people from the consequences of such effects, an international commission (ICNIRP) has 
defined official EMF exposure threshold values for the population [5]. The threshold for the 
50Hz magnetic field (ELF range), e.g. that produced by power lines and household 
appliances, is set to 100µT for the general population. For the mobile phone radiation the 
threshold is expressed as specific absorption rate (SAR), which is a measure for the 
electronic heating of the tissue through the RF field in Watt per kilogram. The whole body 
threshold is 0,08W/kg and the threshold for specific body parts is set to 2W/kg (e.g. a mobile 
phone is only affecting a part of the head).  Whether or not there are non-thermal effects 
below these threshold values is still not definitely solved. Both power line radiation (50Hz in 
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Europe) and mobile phone radiation (1950MHz for GSM) is widespread and the question of 
adverse health effects is of great public interest. 
 
2.1.2. Effects of extremely low frequency electromagnetic fields (ELF-EMFs) 
For ELF-EMFs, epidemiologic studies have associated exposure near power lines with an 
increased incidence of childhood leukaemia [6-8]. An association with other types of cancer 
including breast cancer, acoustic neuroma or cancers of the nervous system however was 
not found [9, 10]. Experimental laboratory studies addressing possible genotoxic effects 
produced conflicting results. Genotoxicity tests like comet assay, sister chromatid exchange 
(SCE) analysis and micronucleus formation were applied to investigate the formation of DNA 
strand breaks and the occurrence of chromosomal aberrations (Review: [11]).  
In the comet assay, a number of cells are embedded in agarose and, following in-gel lysis the 
nuclei are electrophoresed for a short time. Damaged and unwound DNA is thereby able to 
migrate out of the nucleus and the length of the tail and percentage of migrated DNA are 
therefore a measure for DNA strand breaks. Results are either expressed as tail moment 
(computerized measurement of tail length x % DNA in tail) or tailfactor (visual staging of 
events into 5 categories of damaged cells, which then are multiplied with a damage-related 
factor) [2, 12]. For the micronucleus test metaphase cells are stained after spindle inhibition 
and scored for the occurrence of micronuclei, small “nuclei” that contain acentric fragments 
of chromosomes or whole chromosomes. For sister chromatid exchange analysis cells are 
grown in BrdU containing medium to incorporate it during two rounds of replication 
followed by spindle inhibition and photodegradation. Metaphase cells are stained with 
Giemsa and scored for sister chromatid exchanges (reciprocal exchanges of DNA between 
two sister chromatids of a duplicating chromosome). About half of the studies applying 
these methods in studies about EMF effects reported genotoxicity, others did not find any 
effect. 
Rats acutely (2 hr) exposed to a 60Hz magnetic field at intensities of 0.1-0.5mT showed dose 
dependent increases in DNA single- and double-strand breaks (detected by comet assay) in 
their brain cells from 1.1fold at 0.1mT to 1.6fold at 0.5mT [13]. In another study, mice 
exposed to a 0.5mT 50Hz field for 2h, 5d or 14d were found to have a significantly higher 
amount of tail migration in their brain cells after 14d of exposure [14]. In vitro studies with 
primary fibroblasts exposed to a 50Hz ELF field (100µT magnetic field) showed increased 
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comet assay tailfactors in a dose and time dependent manner peaking after 15h of exposure 
with an about 3.5fold increased tailfactor [2]. From the same group also 3fold increased 
micronuclei formation and 2-4fold increases of various chromosomal aberrations were 
reported [3]. Confirmation of a part of these results by another group, however, was not 
successful [15]. Elevated SCE was found to occur in human peripheral blood lymphocytes 
after 50Hz ELF exposure for 72h with 1µT and 1mT ELF-EMFs [16]. The changes were very 
small (1.04fold increase) but statistically significant. In human amniotic cells 2 fold increased 
numbers of chromosomal aberrations were found after exposure to a 30µT 50Hz ELF EMF 
[17]. 
A prominent cellular response to DNA strand breaks is the phosphorylation of the histone 
variant H2AX (γH2AX). Increased γH2AX foci formation was reported in response to a 50Hz 
field (0.3-0.5mT for 24 or 48h) in mouse preimplantation embryos [18].  
Most robust seem to be effects caused by a combination of ELF-EMF exposure with the 
treatment with a known carcinogen. Reported were increases of the effects of the 
carcinogen after co-exposure with ELF-EMFs (for review see [19]). The carcinogens UV light 
and ionizing radiation and the mitogen TPA (12-tetracanoylphorbol-13-acetate) are 
examples of used substances. 
Other experimental settings, however, (regarding magnetic field strength, exposure time, 
cell type or animals), failed to produce evidence for differences between exposed and non-
exposed cultures. E.g. human blood cells exposed to a 1mT 50Hz field for 2h showed no 
increase in both comet assay tail moment, micronucleus formation and SCE [20]. Results 
from studies on human lymphocytes with 50 Hz exposure of varying magnetic field strengths 
(0.6-1.4mT) showed no increase of chromosomal aberrations in exposed cells [21]. Other cell 
types that did not show differences between sham and exposed cells in genotoxicity tests 
include the human tumor cell line K562 (50Hz, 0.2-200µT, DNA strand breaks) and Chinese 
hamster ovary cells (50Hz, 0.2mT, DNA double strand breaks) [22, 23].  
Cell cycle and proliferation behavior were studied after exposure to ELF EMF´s. In some 
cases stimulation of proliferation and/or 3H-thymidine incorporation [24-26] was observed. 
In chicken embryonic fibroblasts exposed to a 60Hz 0.7mT ELF-EMF for instance, colorimetric 
and 3H-thymidine incorporation assays revealed 26-31% increase of cell proliferation [26].  
Other studies showed proliferation inhibition or decrease of DNA synthesis. In growth 
stimulated lymphocytes 10-30% inhibition of proliferation after exposure to 3-200Hz ELF-
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EMF for 6-48h was shown by 3H-thymidine incorporation rates [27]. In human amniotic cells 
BrdU incorporation rate was reduced after 50Hz, 1mT exposure for 24 and 30h and 
expression levels of cyclin D, p16INK4a and p21CIP1 decreased [28]. There are, however also 
studies that report an absence of any effect on cell proliferation. So did exposure of HL-60, 
K-562, MCF-7, A-375, and H4 cancer cells to 50 and 60Hz ELF-EMFs at 500, 100, 20 and 2µT 
for 3d not lead to any differences in cell number counts and 3H-thymidine incorporation 
[29]. Synergistic effects have been observed regarding cell cycle progression, as in γ-
irradiated HeLa cells the G2 checkpoint appears to be attenuated upon co-treatment with an 
ELF EMF [30].  
Affects on apoptosis of cells were also investigated. There have been reports about an 
inhibitory effect of ELF-EMF´s on UV-induced apoptosis [31, 32], while others found 
increased apoptosis after ELF-EMF exposure [33-35]. Thereby HL-60 cells exposed to a 45mT 
ELF-EMF showed increased apoptosis by microscopic analysis after 1h exposure, rat 
fibroblasts exhibited increased apoptosis upon exposure to 60Hz up to 0.25mT for up to 13d 
and human lymphoblastoid cells showed 2fold increased apoptosis after exposure to a 50Hz, 
60µT ELF-EMF for 72h. 
Altered expression of apoptosis-related genes like bcl-2, bax an c-myc have also been 
reported after exposure to a 50Hz ELF-EMF at 0.1mT, 1.0mT or 2.3mT [36, 37] [38]. 
Furthermore synergistic effects with apoptosis-triggering substances were shown: When 
using vinblastine, a known aneugen, to treat primary human lymphocytes and coexposing 
the cultures with 50Hz ELF-EMFs at 80 and 800µT, the vinblastine effect on micronucleus 
formation and apoptosis was increased by twofold [39]. All in all, the literature seems to 
suggest that magnetic fields alter aspects of apoptosis in cells (for review see [40]). 
Possible EMF induced alterations in gene expression have also been investigated both at the 
mRNA and the protein level. Among the targets identified, heat shock proteins (mainly 
HSP25 and HSP70) seem to be predominant [41-44]. There have even been reports 
proposing the existence of an “electromagnetic field response element” (EMRE), 
represented by a CTCT-sequence in one or several copies. Such sequences can, for instance, 
be found in the promoter region of c-myc and HSP70 [45]. 
Intracellular signaling also seems to be affected by the exposure of cells to ELF-EMF´s. There 
are numerous reports about EMF-induced increases of intracellular calcium concentrations 
and altered calcium-dependent signaling [46-50]. This could be either due to calcium release 
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from intracellular stores or to increased influx trough calcium channels on the outer 
membrane. EMF induced changes on ion-channel opening times and rates have been 
reported [51], and these could be responsible for the altered calcium content of the cells. 
Modulation of intracellular calcium concentrations was reported in lymphocytes, where 
increased calcium influx was shown [49, 52, 53]. This goes in line with reports of stimulation 
of protein kinase C (PKC), an enzyme that needs calcium for activation and regulates 
differentiation and proliferation processes in cells. Also Lyn kinase and its downstream 
targets were shown to be activated by exposure to 50Hz ELF EMFs [54-56]. A possible reason 
for changes in calcium influx could be the change of membrane potential, which was also 
shown [57].  
 
2.1.3. Effects of radiofrequency electromagnetic fields 
Regarding radiofrequency (RF) EMFs in the range of mobile phones there is so far no 
evidence for adverse health effects from epidemiological studies, but the quantity and 
quality of the data available does not allow safe conclusions to be drawn (for review 
see[58]).  
Laboratory studies again produced conflicting results. Rats exposed to a 836MHz field with 
SAR values between 0.0077 and 0.4 W/kg showed no altered tumorigenesis of the central 
nervous system [59] and there was also no effect on benzo(α)pyrene induced tumorigenesis 
after exposure of rats to a GSM modulated 900MHz RF field at 75 and 270mW/kg [60]. 
Another study reported increased DNA strand breaks in brain cells of rats exposed to 
2.45GHz RF fields at SAR values of 0.6 and 1.2W/kg [61, 62], but these findings could not be 
reproduced independently [63]. Exposure of lymphoma-prone Pim1 mice lead to a slightly 
(but significant) higher tumor incidence in one study (900MHz, 0.003-0.32W/kg) but not in 
another (898.4MHz, 0.25-4W/kg) [64, 65]. 
In vitro studies on genotoxic effects of RF-EMFs also produced conflicting results. Human 
lymphocytes showed no significant differences of comet tail moments after exposure to a 
2.45GHz RF field at 2.1W/kg [66]. In another study, comet assays, micronucleus tests, SCE 
and chromosomal aberrations analysis showed no difference between sham and exposed 
lymphocytes after exposure to a 935MHz RF field at 1 and 2 W/kg for 24h. [67]. DNA strand 
breaks however, could be detected after exposure of human fibroblasts and rat granulosa 
cells to an unmodulated and to a modulated 1.8GHz RF field (1.2 or 2W/kg) [68]. An attempt 
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to replicate this study with an identical cell line but unmodulated signal only however was 
not successful [69].  
In conclusion in vivo and in vitro studies related to genotoxicity and tumor promotion led to 
different and sometimes conflicting outcomes. From 21 studies on exposed rats or mice 
reviewed in [70] only 4 reported differences between exposed and non-exposed animals. In 
the same review from 24 in vitro studies genotoxic effects were reported in only 3. In a 
recent review [71] 10 out of 12 studies did not find indications for tumor promotion in 
different rat and mouse models. From the in vitro genotoxicity studies reviewed in this 
report 10 out of 13 were negative. Hence the majority of the genotoxicity and cancer 
promotion studies in the RF range yielded negative results.  
Changes of global gene expression were reported for human endothelial cells after exposure 
to a 900MHz RF field at 2.8W/kg [72]. A heat shock response resulting from RF exposure is 
discussed in [73]. In the 13 studies reviewed, HSP70 induction was shown in 4 cases and 
HSP27 induction in 2.             
 
2.1.4. Quality and reproducibility aspects 
A major problem of the research about biological effects of ELF- and RF-EMF exposure is the 
low magnitudes of effects reported and, hence, the lack of reproducibility. There is very little 
consistency in experimental approaches, including exposure conditions (time and field 
strength) and setup as well as biological systems (cell lines, animals), making direct 
comparisons difficult. But even when identical biologic systems and experimental conditions 
were applied, results were not always reproducible. Allegations of data fabrication in the 
case of a recent study [74] did not help clarify the situation either. So, to get conclusive 
answers in this field, well controlled and coordinated independent research will have to be 
done in the future. 
 
2.1.5. Possible mechanism of DNA directed EMF effects 
There is so far no established biophysical mechanism by which weak ELF-EMFs could impact 
DNA, although numerous hypotheses have been put forward.  
Increased intracellular radical formation may be due to an influence of the field on the iron 
pool of the cell [75, 76] and via the Fenton reaction: Fe
2+
 + H2O2  Fe
3+ 
+ ·OH + 
-
OH. These 
radicals then could lead to increased oxidative damage. 
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Another hypothesis is that a temporary electric current is induced in DNA leading to a 
movement of electrons and therefore to the formation of temporary guanine radicals that, 
upon reactions with water, can be converted to oxidative damage. The possibility of an 
induction of electric currents in DNA was already shown in vitro on short double stranded 
DNA pieces [77, 78] and over long distances in DNA oligomers with guanine as 
thermodynamic sink for a positive charge [79].  
Another popular hypothesis is an influence of the EMF on the structure and function of 
proteins that contribute to DNA metabolism. An impact of electromagnetic fields on 
enzymatic turnover has already been shown [80-82]. The activity of the transmembrane 
proteins Na,K-ATPase and cytochrome oxidase, for instance, is increased upon ELF exposure 
with 10µT fields between 1-2500Hz and the effect varies with the frequency applied [82]. 
Resonance as a mechanism of an influence on enzymes with turnover rates close to the 
applied frequency is therefore a possible scenario. It was also shown that chemical reactions 
can be influenced directly by electromagnetic fields. The Belousov-Zhabotinski (BZ) reaction 
(the oxidation of malonic acid in the presence of bromide, bromate, and an inorganic redox 
catalyst such as the Fe
+2
/Fe
+3
 couple) was found to be accelerated upon exposure to ELF 
fields [83]. Moreover chromatin condensation in response to ELF and RF exposure was 
revealed in blood cells from healthy and EMF hypersensitive persons [84]. About half of the 
tested samples were positive, regardless of their hypersensitivity status. 
It is so far not known, to what extent the mechanisms proposed for ELF-EMF effects on DNA 
also apply to possible RF-EMF effects. The frequency in the RF range is by far too high, for 
instance, to interfere with enzyme turnover. However in todays applications of RF-EMFs 
these waves are modulated to carry information (Figure 3a), e.g. in amplitude or frequency. 
In mobile phone communication for example different modulations are applied, which add 
2, 8, and 217Hz ELF components to the GHz field. Hence, these modulations add low 
frequency components to the RF-EMF, which then could be responsible for biological effects.  
Radiofrequency fields do not penetrate tissues as deep as ELF fields do. The higher the 
frequency, the lower is the penetration of the field. There is, however, still penetration, 
which is illustrated for a phone hand set in Figure 3b. For mobile phone radiation, it is clear 
that 70% of the energy is absorbed by the first 1-2cm of tissue. Hence, only cells on the 
surface of the human body are really exposed to the field and the exposure decreases the 
further away a cell is from the surface. As for an in vitro study one would like to assess the 
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“worst case scenario”, the highest environmental exposure value for a surface cell is taken 
as a reference.   
 
               
Figure 3. Radio frequency electromagnetic fields. 
A) Schematic presentation of an amplitude modulated carrier wave (top) and a frequency modulated carrier 
wave (bottom). B) Computer simulation of a typical mobile phone radiation within the head of a person. Colour 
range from yellow (highest energy absorption) to blue (lowest energy absorption). Adapted from www.it 
is.ethz.ch. 
 
2.2. DNA damage and repair 
Omnipresent chemical and physical agents generate various types of damage to the DNA of 
living cells. To deal with this damage nature has evolved diverse and specific repair 
mechanisms. If repair fails or the amount of DNA lesions exceeds allover repair capacity, 
there are further possibilities to rescue the cell or the body like cell cycle arrest and 
apoptosis. Numerous signaling pathways are involved in decisions for cell cycle arrest, repair 
and/or apoptosis. 
 
2.2.1. DNA damage 
 
2.2.1.1. Endogenous sources 
DNA damage of endogenous origin represents a major challenge to cells. Experimental 
evidence suggests that the number of lesions is about 30 000 per human cell in a day. Such 
lesions occur spontaneously through reactions of the DNA with oxygen, water or cellular 
metabolites [85]. This can involve the sugar-phosphate backbone of the DNA or DNA bases.  
Hydrolytic DNA damage: A frequent form of damage is hydrolytic base loss (depurination/-
pyrimidination) resulting in abasic sites (AP-sites), whereby depurination is 20x more 
B 
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frequent than depyrimidination. These lesions are potentially both cytotoxic and mutagenic, 
especially when not repaired until DNA replication. 
Deamination damage: Another frequent form of DNA damage is the spontaneous 
deamination of the exocyclic amino group in cytosine, adenine, guanine and 5-
methylcytosine resulting in uracil, hypoxanthine, xanthine and thymine, respectively. 
Cytosine and 5-methylcytosine deamination are biologically important as these are relatively 
frequent events that can even occur enzymatically, e.g. during antibody gene hypermutation 
[86]. Deamination products have the potential to be mutagenic, as uracil and thymine would 
pair with adenine during DNA replication, hypoxanthine with cytosine. Xanthine does not 
pair efficiently with any of the bases and would therefore lead to a replication block.  
Oxidative damage: Many metabolic processes produce potentially harmful intermediates 
that are able to react with DNA. Reactive oxygen species (ROS) are thereby the most 
abundant products and do not only react with DNA but also with lipids and proteins [87]. 
ROS are constantly generated as by-products of aerobic metabolism, such as in the electron 
transport chain and cells use multiple systems of antioxidant defense and damage removal 
to protect themselves against potential harmful consequences of these agents. The hydroxyl 
radical (·OH) is the most reactive of the primary ROS, but due to its high reactivity it never 
diffuses more than one or two molecules in diameter before reacting with a cellular 
component. So to damage DNA, it has to be produced directly next to it. However, diffusion 
through the cell can occur through H2O2, which is mainly generated as a side product of the 
respiratory chain in mitochondria and is able to react with a metal ion in the so called Fenton 
reaction (Fe
2+
 + H2O2  Fe
3+ 
+ ·OH + 
-
OH [88]) in the vicinity of DNA. Another ROS, the 
superoxide radical (·O2
-
) is not very reactive with DNA but has the potential to be converted 
into H2O2 too, or to reduce Fe
3+
 (which would be needed for Fenton reactions). It also reacts 
with NO· (produced by nitric oxide synthase) to produce ONOO
-
, a diffusible anion that leads 
to a complex pattern of DNA damage involving mainly guanine oxidations [89]. Another 
mechanism for the action of ROS is through lipid peroxidation, where ROS can abstract 
electrons from residues of organic macromolecules and therefore initiate chain reactions 
that result in damage at considerable distances from the original event, which could also be 
DNA [90]. In general, the two main modes of DNA attack by ROS are addition to the double 
bonds of DNA bases (resulting e.g. in thymine glycol or 2,6-diamino-4-hydroxy-5-
formamidopyrimidine (FaPy)) and hydrogen abstraction from the deoxyribose sugar units 
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(producing carbon-centered radicals on the sugar which can be transformed into strand 
breaks) [91]. The biologically most relevant oxidative lesion in DNA is guanine with a 
saturated imidazole ring, 7, 8,-dihydro-8-oxoguanine (8-oxoG). 8-oxoG is potentially 
mutagenic by pairing with adenine during replication.  
Alkylation damage: A second group of metabolically derived DNA damaging agents are 
alkylating agents like S-adenosylmethionine (SAM) or reactive alkyl radicals as products of 
lipid peroxidation. The resulting lesions are described in the exogenous damage section (see 
2.2.1.2.). 
Polymerase errors: Another source of DNA alterations are replication errors occurring by 
incorporation of incorrect bases and resulting in mismatches. The rate depends on the 
fidelity of the polymerase involved and although replicative polymerases have a 
proofreading ability, there is a low amount of errors that escape proofreading. 
 
2.2.1.2. Exogenous/environmental sources 
Ionizing radiation: A constant exogenous source of DNA damage is ionizing radiation (IR). 
Cosmic radiation and radionuclides occur naturally in our environment and body internal 
decay of radionuclides (mainly potassium-40) is also occurring.  Artificial sources of IR like 
the X-rays used in medical diagnostics and radiopharmaceuticals can increase the effective 
dose a person is exposed to. Ionizing radiation causes damage to all cellular components and 
induces a variety of DNA lesions by both direct and indirect ionization [92]. Ionization of 
water molecules is the most relevant reaction (as water is the most abundant molecule) and 
leads to the formation of hydroxyl (·OH), superoxide (·O2
-
) and H· radicals and H2O2, which 
then lead to oxidative DNA damage as discussed in 2.2.1.1. In addition to simple radical 
damage, ionizing radiation can also induce ring-saturated derivatives of bases (like thymine 
glycol), base-dimerisation, protein-DNA cross-linking as well as DNA single- and double 
strand breaks resulting from direct and indirect attacks to the sugars in the DNA backbone. 
Ultraviolet (UV) light: the ultraviolet component of sun light is another important source of 
DNA damage. The UV spectrum is subdivided into three parts according to wavelength: UV-A 
(320-400nm), UV-B (295-320nm) and UV-C (100-295nm). Solar UV radiation is mainly 
composed of UV-A and UV-B, because the ozone layer in the stratosphere prevents 
penetration of wavelengths below 300nm. The most frequent lesion of DNA exposed to UV 
is the cyclobutane pyrimidine dimer (CPD), a covalent linkage between adjacent pyrimidines, 
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predominantly involving thymidines [93]. CPDs are very stable and lead to bending of the 
DNA. They also interfere with base pairing during DNA replication, because correct hydrogen 
bonding cannot be established.  To a lesser extent, UV radiation leads to the generation of 
(6-4)-photoproducts (6-4PPs), a lesion that also involves pyrimidine dimerisation (mainly TC 
and CC pairs). 6-4PPs  are chemically less stable than CPDs, but have more helix distorting 
effects [94]. Other pyrimidine lesions can be 5,6,-dihydroxydihydrothymine (thymine glycol) 
or pyrimidine hydrates. Purine lesions (e.g. 8,8-dihydro-di-adenine or 8-(2-hydroxy-2-
poropyl)guanine) have also been identified [95], but they are less well characterized and 
seem to play a minor role in the damage spectrum of UV light. To a minor extent UV-
irradiation induces DNA-DNA interstrand and DNA-protein cross-links as well as DNA single-
strand breaks. Finally, UV generates oxidative damage such as 8-oxoG via the action of 
cellular photosensitizers like thymine or riboflavin. 
Alkylating agents: Many different chemicals damage DNA, a property frequently used in 
cancer therapy. An important group are the alkylating agents, such as methyl methane 
sulfonate (MMS), N-methyl-N´-nitro-N- nitrosoguanidine (MNNG), Mitomycin C and 
Cisplatin, the latter two being in use as anticancer drugs [96]. Environmentally occurring 
alkylating agents include methyl chloride and streptozotocin. Some substances have to 
undergo metabolic activation to become reactive, e.g. benzo[a]pyrene or aflatoxins, which 
are activated by the action of the cytochrome P-450 system [97, 98]. Alkylating agents react 
with nucleophilic centers in macromolecules. Numerous reaction sites were identified in all 
DNA bases with the N7 position of guanine and the N3 position of adenine being the most 
reactive [99]. Alkylated bases can be mutagenic and/or cytotoxic. Bifunctional alkylating 
agents like cisplatin can react with two nucleophilic centers and, if these are in opposite DNA 
strands, may generate inter-strand cross-links (ICLs). ICLs are a biologically important class of 
damage, because they result in complete block of DNA replication and transcription. 
Psoralens, a group of DNA intercalating substances, can react with two pyrimidines upon UV-
A radiation and therefore also cross-link both DNA strands [100]. Alkylating agents can also 
cross-link DNA with proteins. Topoisomerase inhibitors like camptothecin and etoposide also 
produce DNA-protein (in this case the topoisomerase) cross-links as well as DNA strand 
breaks [101]. Some other chemicals also act by causing strand breaks in DNA through a free-
radical based mechanism, e.g. the anticancer drug bleomycin or a group of antibiotics called 
enediynes [102]. 
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2.2.1.3. 5-fluorouracil 
5-fluorouracil (5-FU) is a drug widely used for treatment of cancers, including colorectal and 
breast cancer, but also head and neck cancers and cancers of the aerodigestive tract [103]. It 
was developed in the late fifties as an antimetabolite that inhibits DNA synthesis [104]. 
Today it is mostly used in combination with other chemotherapeutics or radiotherapy to 
improve tumor response rates. 5-fluorouracil is an analog of uracil with a fluorine atom at its 
C-5 position.  
 
                                         
Figure 4. 5-fluorouracil (5-FU) metabolism. 
80% of 5-FU are catabolized in the liver by dihydropyrimidine dehydrogenase (DPD). The remaining 20% are 
converted into three main active metabolites: 1. fluorodeoxyuridine monophosphate (FdUMP) by thymidine 
phosphorylase (TP) and thymidine kinase (TK), which leads to thymidilate synthase (TS) inhibition; 2. 
fluorouridine mono (-di, and –tri) phosphate (FUMP) by the action of orotate phosphoribosyltransferase 
(OPRT), this can become incorporated into RNA, disrupting normal RNA function and processing. 3. 
fluorodeoxyuridine triphosphate (FdUTP) by ribonucleotide reductase, this can (like dUTP) be incorporated into 
DNA, leading to DNA damage and mispairing during replication. Adapted from Longley et al., 2003 [105]. 
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Intracellularly 5-FU is converted to several different metabolites (Figure 4) [105]. Orginally, 
5-FU was thought to act only as an inhibitor of thymidilate synthase (TS) after conversion to 
fluorodeoxyuridine monophosphate (FdUMP) by thymidine phosphorylase (TP) and 
thymidine kinase (TK). Since TS catalyzes the conversion of deoxyuridine monophosphate 
(dUMP) to deoxythymine monophosphate (dTMP), TS inhibition leads to cellular depletion of 
dTTP that is used in DNA replication and repair, accumulation of dUMP and through 
feedback mechanisms to an imbalance of the whole nucleotide pool. This imbalance is 
thought to severely disturb DNA synthesis resulting in cell lethality.  
These DNA directed effects are not the only consequences of 5-FU anabolism. The drug is 
also converted to fluorouridine mono (-di, and –tri) phosphate (FUMP) by the action of 
orotate phosphoribosyltransferase (OPRT) and eventually becomes incorporated into RNA, 
affecting normal RNA function and processing [105]. But FUDP can also be converted to 
fluorodeoxyuridine triphosphate (FdUTP) by ribonucleotide reductase and can (like dUTP) be 
incorporated into DNA [105].   
When used as anticancer drug, response to 5-FU varies. Increased sensitivity or resistance to 
5-FU can be due to different mechanisms, involving either altered expression of targets like 
TS or catabolizing enzymes like DPD or altered expression of processing proteins like TP and 
TK. Also changes in repair pathways that process DNA aberrations induced by 5-FU can 
contribute. 
Different repair pathways seem to be involved in the repair of 5-FU mediated DNA damage 
depending on the kind of lesion and the cell cycle status. Base excision repair (BER, see 
2.2.2.4.) involving the uracil removing glycosylases uracil-DNA-glycosylase (UNG), thymine-
DNA-glycosylase (TDG) and single-strand selective monofunctional uracil-DNA glycosylase 1 
(SMUG1) as well as the mismatch repair system (MMR, see 2.2.2.2.) seem to play a role.  
 
2.2.2. DNA repair  
Depending on the type of DNA damage, cells employ different ways of repair. Single strand 
excision of the damage and resynthesis from the undamaged strand is used when the 
damage affects only one of the complementary strands, homology dependent or 
independent sealing is used when double strand breaks (DSB) occur, and in some cases 
damage tolerance pathways are engaged. 
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2.2.2.1. DNA Double strand break repair 
A rare but dangerous lesion for the cell is a DNA double strand break (DSB). DSBs can cause 
from ionizing radiation, the impact of DNA reactive chemicals (including cancer drugs like 
Bleomycin) or can arise during DNA replication of single strand breaks. There are two 
different ways to repair such lesions: Homologous recombination (HR) and non-homologous 
end-joining (NHEJ) (Figure 5) [106].  
 
                                    
Figure 5. Double strand break repair pathways. 
Double strand breaks arising from ionizing radiation, chemicals, V(D)J recombination and/or single strand break 
replication result in activation of the homologous recombination (left) or the non-homologous end-joining 
(right) pathway. In HR, DSBs are recognized by ATM and the MRN complex, which exposes the 3´ends for 
RPA/Rad52 facilitated Rad51 binding. Strand invasion into homologous regions and DNA synthesis follows to 
produce D-loops. Holliday junctions form and are then resolved by resolvases. NHEJ (mainly used in G1) starts 
with binding of the Ku70/Ku80 heterodimer, DNA-PK then associates to build the active kinase, one target is 
the XRCC4/ligase 4 complex, which ligates the break. Adapted from Hoeijmakers et al., 2001 [4]. 
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In late S and G2, when an identical copy of each DNA duplex is available, the error free HR 
pathway is preferred, but in G0/G1 the more error prone NHEJ pathway prevails. The two 
Phosphatidyl-inositol-3-OH-kinase-like kinases ATM (Ataxia teleangiectasia mutated) and 
ATR (ATM related) and DNA-dependent protein kinase (DNA-PK) are critical for the proper 
cellular response to DSBs. They transduce DNA damage signals and phosphorylate numerous 
substrates like histone H2AX and the MRN complex (consisting of the three proteins MRE11, 
RAD50 and NBS1), altogether coordinating the repair process and/or cell cycle responses. 
In HR, the MRN complex first resects one strand of both ends in 5´-3´ direction and the 
resulting 3´ overhang is covered by several Rad51 units building a nucleoprotein filament. 
This step is mediated by RPA (replication protein A) and Rad52. Rad51 then promotes ATP-
dependent and RPA-stimulated interaction with the undamaged homologous DNA duplex 
and catalyses strand invasion to form a D-loop structure. The homologous region is used as a 
template for DNA synthesis and the resulting Holliday-junctions are cleaved by resolvases. 
HR also seems to be involved in the repair of another very toxic lesion, the interstrand cross-
link (see 2.2.1.2). The damage sensors of this lesion are not known so far, but seem to 
require factors from other DNA repair pathways like nucleotide excision repair and 
mismatch repair [107]. 
NHEJ is initiated by binding of the Ku70/Ku80 heterodimer to the end of the DNA break, 
followed by recruitment of the catalytic subunit of DNA-PK to form the active holoenzyme. 
One of the targets of the kinase is XRCC4, which together with DNA ligase IV links duplex 
DNA molecules with non-complementary ends. To facilitate ligation, most DSB have to be 
processed. This is done by either of the nucleases provided by the MRN complex (3´flaps), 
FEN1 (5´flaps) or Artemis (5´ and 3´ overhangs). Occasionally, a few nucleotides are gained 
ore lost during NHEJ, which also implies the involvement of DNA polymerases and/or 
nucleases. 
There are several human diseases known to be caused by defects of proteins involved in DSB 
repair, e.g. Ataxia telangiectasia (defects of ATM), Nijmegen breakage syndrome (mutations 
in NBS1) or Bloom Syndrome (defects of Bloom helicase). All of them display hypersensitivity 
to DNA damaging agents and tumor susceptibility, but there can be also neurodegenerative 
and immunological diseases [108], the latter caused by defects in V(D)J recombination or 
immunoglobulin class switch recombination. 
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2.2.2.2. Repair of DNA polymerase errors and DNA damage tolerance  
The postreplicative mismatch repair (MMR) system is responsible for the removal of 
mispairing bases resulting from DNA polymerase errors during DNA replication. It may also 
contribute to the removal of oxidized, methylated and deaminated bases and of chemically 
induced DNA lesions such as photoproducts or intrastrand cross-links [106]. Recognition of 
the mismatched base is thereby carried out by the MutSα complex, that consists mainly of 
MSH2 (MSH stands for MutS Homolog, MutS was first described in bacteria) and MSH6 or 
MSH3. The two complexes have different substrate spectra. Upon binding to the mismatch, 
this complex binds ATP and interacts with the MutLα heterodimer, consisting of MLH1 (MutL 
homolog) and PMS2. Excision of the mispaired base is performed by an exonuclease, such as 
Exonuclease I followed by DNA synthesis by a replicative DNA polymerase, e.g. Polymerase 
δ. Recruitment and specific binding of the complexes is facilitated by PCNA (proliferating cell 
nuclear antigen) [109], a homotrimer which is also involved in the other steps of MMR by 
interacting with Exonuclease I and Pol δ. How the discrimination between parental and 
newly synthesized DNA strand is achieved is not entirely clear. A generally accepted 
hypothesis involves recognition of unligated single strand breaks (SSB) arising during 
replication through interaction with nick-associated proteins [110]. As these can be 
separated from the mismatch, either sliding of the protein complex or DNA bending could be 
involved in identification of the strand to be excised. Regulation of MMR is thought to 
involve transcriptional as well as post-translational mechanisms, e.g. MSH2 has a p53 
binding site in the promoter region and is inducible upon co-transfection with p53 and 
transcription factors Fos/Jun [111]. A syndrome resulting from defects in mismatch repair is 
the well known genetic predisposition to colorectal (and other) cancers called Hereditary 
Nonpolyposis Colorectal Cancer (HNPCC) syndrome, which is responsible for 2-7% of all 
diagnosed colorectal cancers [112].  
If a bulky lesion is not repaired before S-phase, there are two possibilities for the cell to 
overcome the resulting replication block. In normal replication, proliferating cell nuclear 
antigen (PCNA) builds a homotrimeric sliding clamp around DNA and interacts with and 
coordinates many essential replication proteins including pol δ/ε, Ligase I, Helicase E1 and 
the clamp loader replication factor C (RFC). If replication is blocked, the chromatin-bound 
protein Rad17 gets phosphorylated by ATR and recruits the 9-1-1 heterotrimeric sliding 
clamp to replace PCNA. This complex then targets repair proteins to the site of the lesion 
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[113]. Another possibility is mono-ubiquitination of PCNA, which then can interact with the 
so called “error-prone” DNA polymerases (e.g. pol η, κ, μ), that are able to replicate across a 
lesion but with high probability of creating a mutation. This pathway is called translesion 
synthesis. The different polymerases have different lesion-specificities and are therefore 
able to replicate across different kinds of lesions [114].  
 
2.2.2.3. Repair of bulky DNA damage 
The nucleotide excision repair (NER) pathway enables cells to eliminate bulky DNA adducts 
like UV-light induced 6-4PPs and CPDs or chemically induced adducts such as those 
generated by aflatoxine or benzopyrene, as well as intrastrand cross links. There are two 
different NER subpathways: global genome repair (GGR), which acts independently of 
transcription and removes larger adducts like 6-4PPs effectively, but less DNA distorting 
adducts like CPDs only slowly. These lesions are removed more effectively by the other 
subpathway, which is called transcription coupled repair (TCR). TCR removes RNA-
polymerase-blocking lesions from the transcribed strand of active genes [115].  
In GGR the lesion is detected by the XPC-HR23B complex (XP from Xeroderma Pigmentosum) 
or by the RPA-XPA complex facilitated by DDB1/2 (DNA damage binding), but the question 
who comes when is still a matter of debate [116]. The transcription factor complex TFIIH, 
which consists of seven different proteins, including the helicases XPB and XPD, is then 
recruited to the site of DNA damage and mediates unwinding. This makes the DNA 
accessible for the two exonucleases XPF-ERCC1 (5´) and XPG (3´), which cleave ~28nt around 
the lesion. Resynthesis is carried out by pol δ or pol ε and ligation by ligase I. Some of the 
genes are inducible upon UV radiation (mediated by p53) like DDB2 and XPC. A human 
syndrome based on a defect in GGR is Xeroderma pigemtosum (XP). XP is characterized by 
severe UV sensitivity with a high incidence of skin tumors. It can occur in several of the 
proteins involved [117].  
In TCR the two factors CSA and CSB (CS: Cockayne´s Syndrome) detect a stalled transcription 
elongation complex and induce ubiquitination of RNA polymerase (II) which leads to release 
of the complex [118] from DNA. As in the case of GGR incision is performed by the 
exonucleases XPG and XPF-ERCC1, synthesis by pol δ or pol ε and ligation by ligase I, after 
which restart of transcription can follow. CS patients suffer from growth retardation, UV 
sensitivity and accelerated aging but not from elevated tumor incidences, possibly because 
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affected cells are effectively removed by apoptosis [119]. Because of the coupling to active 
genes and the reduced transcription upon UV irradiation TCR deficiency is also referred to as 
a “transcription syndrome”. Another syndrome based on TCR deficiency is the so-called UV-
sensitive syndrome, which does not belong to the CS complementation groups and does not 
show the developmental defects of CS, but only sensitivity to UV [120].  
 
2.2.2.4. Repair of small DNA lesions and single-strand breaks 
For smaller lesions affecting one nucleotide only there are different possibilities of repair: 
the simplest process is direct damage reversal. It takes place e.g. for O6-methylguanine by 
transfer of the methyl group from the O6-position of guanine to an active site cysteine 
residue in the O6-methylguanine-DNA methyltransferase (MGMT) in a one-step reaction. 
This transfer leads to irreversible inactivation and targeting of MGMT to ubiquitination and 
proteasomal degradation [121]. Other alkylation-removing proteins belong to the AlkB 
homologue group and have been shown to repair 1-methyladenine, 3-methylcytosine and 1-
ethyladenine [122].  
Small DNA base lesions, however, are generally fixed by the base excision repair (BER) 
pathway (Figure 6) [123]. This pathway repairs abasic sites, DNA single-strand breaks and a 
wide spectrum of oxidized, deaminated and alkylated DNA bases. Recognition of base 
damage is carried out by DNA glycosylases. These enzymes are specialized for certain kinds 
of damage, e.g. OGG1 for 8-oxoG, MPG for different alkylated guanines and UNG for Uracil 
[124]. There are two classes of glycosylases. Monofunctional DNA glycosylases (e.g. UNG, 
MPG) remove the modified base leaving an abasic site (AP site), while the bifunctional 
enzymes (e.g. OGG1) also cleave 3´ to the AP site after base removal. The resulting 3´ 
overhang is then trimmed by AP endonuclease (APE1) and the gap is filled by DNA 
Polymerase β (DNA Pol β) [125]. For the monofunctional glycosylases cleavage of the 
phosphodiester-bond is carried out by APE1 resulting in a 3´OH and a 5´deoxyribose-
phosphate (5´dRP) end. This overhang can be removed by the lyase activity of DNA Pol β 
after incorporation of the missing single nucleotide [126]. The nick is then sealed by DNA 
Ligase III, which interacts with DNA Pol β through the XRCC1 protein. This subpathway 
generated short repair patches. If DNA Pol β is not able to remove the 5` overhang, because 
it is distorted (e.g. 5'-oxidized AP sites induced by ROS), it dissociates from the lesion and 
DNA synthesis of 2-10nt is accomplished by DNA Pol δ or Pol ε together with PCNA, PARP 
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and RFC [127]. The resulting oligonucleotide overhang is then excised by the structure 
specific flap endonuclease FEN1 and the nick is sealed by DNA Ligase I (long patch BER). 
 
                           
Figure 6. Base excision repair pathways. 
In short patch BER (center), which is the predominant pathway, excision of the lesion by a glycosylase or 
spontaneous base loss generates an abasic site, which is processed to a single strand break by AP 
endonuclease. Polymerase β adds one nucleotide and removes the 5´ overhang by its β-lyase activity and the 
XRCC1/ligase III complex seals the nick. If a bifunctional glycosylase initiates BER (right), it cleaves 3´ to the AP 
site after base removal and the 3´ overhang is processed by AP endonuclease. 
Gap filling and ligation are carried out by pol β and XRCC1/lig III as before, but there is no trimming by pol β. In 
long patch BER (left) pol δ/ε synthesizes 2-10nt supported by RCF, PCNA and PARP, the overhang is excised by 
FEN1 and the nick is sealed by DNA Ligase I. Adapted from Schärer and Jiricny, 2001 [124].  
 
Mouse knock outs of the key base excision repair proteins downstream of the DNA 
glycosylases are all embryonic lethal, as described for Apex1, Pol β, Xrcc1 and Lig1 [128], 
while glycosylase knock out animals show no or mild phenotypes in hypersensitivity to DNA 
damaging agents. There seems to be some redundancy among these enzymes or overlap 
with other pathways like TCR. 
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2.2.2.5. Regulation of base excision repair 
Repair pathways are regulated in numerous ways at levels of gene or protein expression or 
activity and localization of enzymes. In base excision repair for example, p53 stimulates the 
pathway through its interaction with APE1 and DNA Pol β [129]. AP endonuclease activity at 
AP sites is furthermore enhanced by its physical interaction with heat shock protein 70 
(HSP70) [130]. Other examples of proteins interacting with and modulating BER enzymes 
are: the MMR complex MSH2/6 interacts with and stimulates the adenine DNA glycosylase 
MYH [131]; the NER endonuclease XPG promotes binding of thymine glycol DNA glycosylase 
to its substrate [132]; the NER recognition factor XPC stimulates thymine DNA glycosylase 
(TDG) activity [133]. The latter are also examples for an interplay between repair pathways.   
Regulation can also occur by protein modification. The SUMOs (small ubiquitin-like 
modifiers) seem to play an important role in this pathway, as some of its proteins are 
modified by them, e.g. PCNA [134], TDG [135], XRCC1 and PARP [136]. Others interact non-
covalently with SUMO/SUMO-modified proteins like Uracil DNA glycosylase (UNG), TDG and 
XRCC1. But there are also other types of posttranslational protein modification that play a 
role in this pathway, namely phosphorylation, acetylation, ubiquitination, nitrosylation and 
methylation. For example  nitrosylation of OGG1 inhibits its glycosylase activity [137] and 
acetylation of FEN1 reduces its substrate binding and nuclease activities [138].  
 
2.2.2.6. Thymine DNA Glycosylase  
The products of cytosine- and 5-methylcytosine- deamination, uracil and thymine, have to 
be repaired correctly to avoid mutation during DNA replication. While uracil can be 
recognized as a foreign base in DNA, thymine represents a normal DNA base and, thus, has 
to be recognized by virtue of its mispairing with guanine. The BER enzyme that is able to do 
this was isolated in the early 1990s from HeLa cells and named thymine DNA glycosylase 
(TDG) [139]. Later it was shown that this enzyme can also recognize uracil opposite guanine 
(like three other known glycosylases UNG, MBD4 and SMUG1) and process this lesion with 
even higher efficiency. TDG also processes modified uracils including 5-hydroxymethyluracil 
or 5-fluorouracil (5-FU) as well as ethenoadducts (a product of lipid peroxidation) and 
thymine glycol. Although TDG prefers guanine as opposite base, some of these lesions (like 
uracil, 5-FU and ethenoadducts) are also recognized and processed when they are opposite 
adenine, albeit with lower efficiency [140].  
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Orthologs of TDG were found in bacteria, yeast, drosophila, xenopus and mouse [140, 141]. 
Their common domain structure consists of a conserved core domain harboring the active 
site and non-conserved N- and C-terminal extensions of variable length, which are 
responsible for differences between the orthologs in substrate specificity, enzymatic activity 
and interaction partners (Figure 7) [142].  
 
                       
Figure 7. Domain structure protein interaction map of human thymine DNA glycosylase (TDG). 
Conserved sequences, protein motifs and known interactions with other proteins are indicated. The sequence 
motifs G(I/L)NPG(L/I) and VMPSSSAR (hsTDG) contain critical residues of TDGs active site. Similarities in the N-
and C-terminal parts of the mammalian TDGs are restricted to the SUMO-interaction motifs and the 
SUMOylation consensus motif VKEE. Bars on top show the minimal sequence requirement for G·U or G·T 
processing. The predicted AT-hook motif present in the N-terminus may provide non-specific DNA binding 
capacity. Bars at the bottom TDG indicate identified protein interaction domains. NR: nuclear receptors 
(androgen receptor, glucocorticoid receptor, progesterone receptor, peroxisome proliferator-activated 
receptor a, thyroid hormone receptor a, Vitamin D3 receptor). Adapted from Cortazar et al., 2007 [142]. 
 
TDG is a monofunctional DNA glycosylase which, like all DNA glycosylases, acts by flipping 
out the substrate base from the DNA double helix for processing. Additionally, it interacts 
with the guanine (adenine) opposite the target base through hydrogen bonds mimicking 
Watson-Crick base pairing [143, 144]. Furthermore, the N-terminal domain makes unspecific 
DNA contacts. Together, these interactions seem to be quite strong and prevent TDG from 
turning over following base excision [144]. So, there is need for a factor releasing TDG from 
the AP-site, which could be APE1, the enzyme catalyzing the downstream step in the BER 
process. Indeed, APE1 was shown to be able to release TDG in vitro, but only when provided 
in a high molar excess over TDG [145], suggesting this to be passive rather than active. As 
already mentioned, TDG is modified by SUMO in the C-terminal domain and it was shown, 
that this interaction induces a conformational change, which allows the enzyme to dissociate 
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from the AP-site [146]. These findings lead to the concept that after base hydrolysis, SUMO 
modification is responsible for TDG release from the AP-site. As this modification is 
reversible, deSUMOylation by specific isopepdidases can recycle the enzyme for another 
round of repair [147].  
Surprisingly for a glycosylase, TDG also seems to play a role in regulation of gene expression. 
Various physical and functional interactions of TDG with transcription factors and nuclear 
receptors were reported, e.g. retinoic acid receptors, c-Jun, estrogen receptor α or CREB 
binding protein [148-151]. It has also been hypothesized that TDG is involved in epigenetic 
changes of the genome, as the chicken homolog seems to be able to actively demethylate 5-
methyl-cytosines (5-meC) in CpG islands [152, 153]. This function is not entirely clear though, 
as the recombinant protein has no or only poor activity on 5-meC and there seems to be no 
global demethylation through overexpression. Specific auxiliary factors (e.g. the 
transcription factors?) might be needed to target the protein to specific sites in the genome. 
Furthermore  an interaction of TDG with de-novo-methyltransferase Dnmt3a was recently 
reported [154], which could implicate a role of this glycosylase in DNA methylation.  
 
2.2.2.7. DNA Polymerase β 
One of the differentially modified enzymes of the BER pathway is DNA Pol β, a small, one 
subunit DNA polymerase [155]. It belongs to the X-family of polymerases [156] and has two 
different enzymatic activities: it synthesizes short patches of DNA (up to 6 nt) and removes 
5´dRP residues through its β-lyase activity. This lyase activity resides in the 8kDa 
aminoterminal domain of the protein (Figure 8) and is connected to the 31 kDa polymerase 
domain by a protease sensitive hinge region [157].  
In contrast to the large replicative polymerases of the B-family, Pol β has no inherent 
proofreading and exonuclease activity and is therefore less accurate in DNA synthesis. 
Knock-out mice deficient in Pol β are not viable, they die at embryonic day 10.5, and 
fibroblast cell lines derived from these embryos show hypersensitivity towards DNA 
alkylating agents, but not towards UV, γ-radiation, H2O2 or Cisplatin [125]. Regulation of the 
polymerase activity was shown to occur through phosphorylation [158] and the β-lyase 
activity is modulated by acetylation of the active lysine residue by the transcriptional 
coactivator p300 [159].  
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Figure 8. DNA polymerase β. Crystallographic structure for DNA polymerase β complexed with a gapped DNA 
substrate. Image prepared using GRASP software (Graphical Representation and Analysis of Structural 
Properties) [160]. Lyase domain in white and polymerase domain in blue. Adapted from Idriss et al., 2002 [157]. 
 
 
2.3. Cell cycle  
The life of a cell begins with division from a mother cell and ends with the subsequent 
division into daughter cells or with its death. The phases through which the cell passes from 
one cell division to the next is called the cell cycle. In general, the cell cycle can be divided 
into four main phases (Karp, 2002) (Figure 9). In G1, cells grow and carry out normal 
metabolism, they harbor an unreplicated copy of each chromosome. In S-phase, cells 
duplicate their genome (Replication). In G2, cells grow and duplicate organelles and control 
DNA integrity. Sister chromatids of each chromosome exist, which are distributed equally to 
the two daughter cells in Mitosis (M). Mitosis is again divided into four different phases: In 
Prophase, the chromosomes condense, the cytoskeleton, golgi and endoplasmatic reticulum 
(ER) disassemble, the nuclear envelope disperses and the mitotic spindle is assembled. In 
Metaphase, the microtubules attach to the kinetochores of the chromosomes and position 
them at the spindle equator. In Anaphase, centromeres split and chromatids separate and 
move to opposite spindle poles. In Telophase, the nuclear envelope, golgi and endoplasmatic 
reticulum of the daughter cells form and chromosomes become dispersed again.  
At the so called restriction point in G1, cells are committed to go through another round of 
the cell cycle. If the conditions for another cell division are not given (e.g. lack of nutrients), 
the cell enters G0, a nonproliferative phase during which growth, differentiation or 
apoptosis may occur.  
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Figure 9. Cell cycle and checkpoints.  
Different cell cycle phases (G1, S, G2, M) and related cyclin/cdk complexes. Additionally shown are the 
respective cell cycle checkpoints with the proteins involved. Adapted from Lodish, 2006. 
 
The cell cycle is tightly regulated, as any error (e.g. unbalanced distribution of chromosomes) 
could lead to major problems for the organism. Regulation occurs by a family of cyclin 
proteins that act as regulatory subunits of the cyclin-dependent kinases (cdk). The activity of 
the cyclin/cdk complexes is controlled by the expression of the appropriate cyclins during a 
specific phase of the cell cycle (Figure 9). The cyclin/cdk complex is then activated by 
sequential phosphorylation/dephosphorylation steps mainly affecting the cdk subunits. The 
complex of early G1 is either cdk2, cdk4, or cdk6 bound to a cyclin D isoform. There are 
several proteins that can inhibit the cell cycle in G1. For example, if DNA damage occurs, p53 
accumulates in the cell and induces a p21-mediated inhibition of cyclin D/cdk. Mdm2, by 
facilitating the nuclear export and inactivation of p53, becomes part of an inhibitory 
feedback loop that inactivates p21-mediated G1 arrest [161]. If the cyclin D/cdk complex is 
inhibited, the retinoblastoma protein (Rb) is in a state of low phosphorylation and is tightly 
bound to the transcription factor E2F, inhibiting its activity. E2F transcription factors regulate 
the expression of a number of genes important in cell proliferation, particularly those 
involved in progression through G1 and into the S-phase of the cell cycle. Passage through 
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the restriction point and transition to S phase is triggered by cyclin D/cdk dependent 
phosphorylation of Rb [162]. Phosphorylated Rb dissociates from E2F, which is then free to 
promote expression of DNA replication initiating proteins. Cyclin E/cdk2 accumulates during 
late G1 phase and triggers the passage into S phase [163]. The synthesis and accumulation of 
cyclin B/cdc2 begins during S-phase, but the complex is phosphorylated at Thr14 -Tyr15 and 
kept inactive [164]. Cyclin A/cdk2 accumulates during S phase and its activation triggers the 
transition to G2, a phase characterized by the accumulation of cyclin B/cdc2. When the cell 
reaches a critical size, the phosphatase cdc25 is activated and removes the inhibitory 
phosphate residues at the cdc2 subunit, while the kinase CAK transfers an activating 
phosphate to residue Thr 161. The resulting activation of the cdc2 kinase drives the cell into 
mitosis. Cyclin B/cdc2 catalyzes the phosphorylation of lamins and histone 1, and is involved 
in the regulation of cell division events. The metaphase to anaphase transition is triggered by 
its inactivation and the proteasomic degradation of cyclin B through the action of the protein 
ubiquitin ligase APC (anaphase promoting complex). APC is also responsible for the 
ubiquitination of securin, the inhibitory protein of the protease separin. Separin is then able 
to cleave the cohesin complex, that holds sister chromatids together from S-Phase until 
Metaphase. This induces the separation of chromatids and their movement to the poles of 
the mitotic spindle, after which the mitotic apparatus disappears, the nuclear membranes 
reform and the nucleoli reappear. During cytokinesis, the cytoplasm divides and the resulting 
daughter cells enter G1 again.  
2.3.1. DNA damage checkpoints 
Different DNA damage checkpoints in mammalian cells control the cell cycle at different 
points (Figure 9) (for review see [165]). If DNA damage is sensed, there is slow down or even 
arrest of the cell cycle until the damage is repaired. In general, there are damage sensor 
proteins, which phosphorylate their substrates upon sensing DNA damage, the signal is then 
transduced by these adaptor and mediator proteins to effector proteins, that can initiate cell 
cycle arrest, activation of repair proteins or apoptosis. 
DNA damage is signaled mainly by the two Phosphatidyl-inositol-3-OH-kinase-like kinases 
ATM (Ataxia teleangiectasia mutated) and ATR (ATM related). ATM is thought to be engaged 
predominantly in signaling DNA strand breaks, while ATR is largely responsible for stalled 
replication forks, although it seems also to compensate partly for ATM function in cells 
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lacking this kinase [166]. There are other proteins recruited to sites of damage 
independently of ATM like MDC1, 53BP1, BRCA1 and the MRN complex, which therefore 
also could serve as damage sensors [167]. But their accumulation into microscopically visible 
foci then depends on ATM-mediated phosphorylation of the histone H2AX [168]. Also, in the 
case of stalled replication forks there are additional proteins and complexes recruited, 
namely the Rad9-Rad1-Hus1 (9-1-1) sliding clamp, ATRIP, RPA and Claspin.  
There are two other DNA damage signaling proteins besides the ATM/ATR kinases, which 
both act throughout the cell cycle: the DNA-PK (DNA-dependent protein kinase) [169] 
together with the Ku70/Ku80 heterodimer, which are involved in non-homologous end-
joining, and the PARPs (poly(ADP-ribose) polymerase), proteins, that catalyse 
poly(ADP)ribosylation (PAR) from the donor NAD+ at sites of DNA damage. They are able to 
detect single strand breaks (SSB) as well as double strand breaks (DSB) and contribute to 
multiple repair pathways [170]. Targets for poly(ADP)ribosylation by PARP are for example 
XRCC1, p53, XPA, MSH6, DNA-PK and Ku70 [171]. 
After damage recognition the signal is forwarded by the mediator proteins mentioned above 
(MDC1, 53BP1, BRCA1, MRN complex) and by transducers like the CHK1 and CHK2 kinases, 
leading to degradation or inhibition of cell cycle promoting cyclins (e.g. CDC25 
phosphorylation by CHK1) to give repair systems time to act before sensitive phases of cell 
division like replication or mitosis are executed. In addition, DNA repair systems become 
activated and there is upregulation of different genes through transcription factors like p53, 
which is stabilized through phosphorylation by ATM and ATR.  
Prominent checkpoints throughout the cycle are the G1 checkpoint, mainly mediated by 
ATM/CHK2 and the G1/S checkpoint, where ATR/CHK1 is more involved and which prevents 
cells from entering S-phase. The important intra-S checkpoint is able to slow down 
replication transiently, while the G2/M checkpoint prevents cells from initiating mitosis. 
Besides DNA damage checkpoints there are checkpoints that assess correct spindle assembly 
and position during mitosis.  
 
2.3.2. Apoptosis 
If the amount of DNA damage is high, repair systems may become saturated and the risk for 
mutations and, hence, neoplastic transformation of cells increases. Under such conditions 
cells can enter the so-called programmed cell death or apoptosis pathway, thereby 
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committing suicide and sparing the organism from the potentially devastating consequences 
of genetic mutations. Apoptosis is also a normal event during development, e.g. in limb 
development and during maturation of immune cells, where cells which react to the 
organism´s own proteins have to be destroyed.  
Apoptosis is initiated if survival signals (trophic factors) are absent or if destruction signals 
are arriving from another cell or are generated within the cell. An important apoptosis 
activator after DNA damage is p53, whose (normally) rapid proteasomal degradation is 
inhibited by ATM/ATR-mediated phosphorylation. p53 activates expression of genes that 
control apoptosis like FAS and the Bcl-2-family members BAX, Noxa and PUMA [172-174], 
and it is able to repress gene expression of survival factors (e.g. survivin [175]). p53 also 
translocates to the mitochondria to bind to the antiapoptotic proteins Bcl-2 and Bcl-XL [176], 
and mediates the release of histone 1 variant H1.2 from DNA, which then induces 
cytochrome c release from mitochondria [177]. p53-independent pathways of apoptosis also 
exist and involve proteins such as CHK2, PML (promyelocytic leukaemia), Nurr77 or the 9-1-1 
complex [178-180].   
Increase of permeability of the mitochondrial membrane and cytochrome c release, 
upregulation of proapoptotic and inhibition of antiapoptotic proteins lead to the activation 
of a cascade of different caspases, through which the signal is amplified. Effector caspases 
cleave short amino acid sequences in different target proteins, e.g. of the nuclear lamina and 
the cytoskeleton. Dying cells shrink and condense, DNA is fragmented and membrane 
vesicles are released which are eventually engulfed by phagocytotic cells. One important 
marker recognized by these cells is phosphatidylserine, a phospholipid that is translocated to 
the outer membrane in apoptotic cells [181]. Importantly, the content of the cell is never 
released to the surrounding medium. This distinguishes apoptosis from necrosis, whereby 
cells swell and burst and release their intracellular contents, which can damage surrounding 
cells and cause inflammation.  
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3. Aims of the thesis 
 
Conflicting results have been published with regard to the genotoxic effects of extremely low 
frequency (ELF) and radiofrequency (RF) electromagnetic fields (EMFs) [2, 3, 13, 15-17, 20, 
21, 61, 63, 66, 68, 69]. This has raised considerable public concern, which led the Swiss 
National Science Foundation to initiate a national research program (“Nationales 
Forschungsprogramm NFP 57”) with the aim to provide scientific arguments for the 
assessment of the risk associated with electromagnetic fields. This PhD thesis was initiated 
as a project of the Forschungsstiftung Mobilfunk (Zürich), supporting independent research, 
and continued and finalized as part of the NFP57 program. 
 
The objectives of this PhD thesis were: 
- to re-examine and validate genotoxic effects of ELF- and RF- EMFs observed, but not 
reproduced, in previous studies [1, 2, 68], 
- to address conceptual and technical shortcomings of previous studies regarding the 
mode of comet assay scoring and evaluation, 
- to explore the molecular events underlying EMF dependent genotoxic effects (oxidative 
damage or other resulting DNA lesions, cell cycle effects, apoptosis) 
For this purpose, I established techniques to assess genotoxicity, DNA damage signaling, cell 
cycle distribution and apoptosis and applied them to different ELF- and RF- exposed cell 
lines. Furthermore a set of fluorophore-tagged proteins was constructed as tools to facilitate 
live cell imaging and therefore real time assessment of ELF-EMF effects. 
 
In addition to the EMF studies, I used the established techniques in collaboration projects to 
address and/or establish:  
- the biological significance of cell cycle regulation of Thymine DNA Glycosylase (TDG),  
- the mechanism of DNA directed cytotoxicity of the anticancer drug 5-fluorouracil,  
- the role of arginine methylation in the regulation of the base excision repair associated 
DNA Polymerase β 
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4. Results 
 
4.1. Biologic effects of electromagnetic fields 
 
4.1.1. Molecular mechanisms that lead to DNA fragmentation under extremely low 
frequency electromagnetic field exposure (Appendix I) 
Electromagnetic fields in the extremely low frequency range were previously found to cause 
genotoxicity in some studies, but not in others. Because of the considerable public concern 
about the safety of ELF-EMFs, this study was designed to re-examine the issue and to clarify 
some of the discrepancies. For this purpose, I performed comet assays analyses applying the 
same exposure conditions and cell line as in a previous study. I showed genotoxic effects 
when cells were exposed to an intermittent 50Hz, 1mT ELF-EMF for 15h. These effects were 
less pronounced than previously published, but nevertheless statistically significant. I then 
expanded the analyses to other cell lines. Human primary fibroblasts but not HeLa cells were 
found to have increased comet tailfactors/tail moments when exposed under the same 
conditions. By blocking the fibroblast cells in G1, I showed that this effect depends on cycling 
of the cells. Since the effect was not further increased by using an 8-oxoG glycosylase (Fpg) 
in the comet assay, there seems to be no increase of unrepaired oxidative purine damage 
after exposure. As the DNA of apoptotic and S-phase cells is also migrating into the tail of the 
nucleus in the comet assay, I analyzed cell cycle distribution, replication and apoptosis in the 
fibroblast cell lines. This revealed an about 1% decrease of replicating cells and about 1.5% 
more apoptotic cells in the fibroblast cell line, which showed the highest comet assay 
effects. These cells can account for a part but not all of the comet assay effect I measured. 
There, about 8% of cells were found to shift into the higher fragmentation fraction. Although 
the possibility of a direct damage of DNA due to ELF-EMF exposure cannot be ruled out, our 
data suggests that cells entering S-phase under ELF-EMF exposure may encounter replication 
problems, which eventually leads to the induction of apoptosis and, hence, contributes to 
highly fragmented nuclear DNA observed by comet assays.  
 
4.1.2. Genotoxic Effects From Radiofrequency Electromagnetic Fields: Revisiting a 
Controversial Issue (Appendix II) 
Two recent scientific publications regarding in vitro effects of RF-EMFs received considerable 
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public attention and concern, because they reported enhanced DNA fragmentation in 
different human cell lines (ES-1, IH-9 and HW-2 fibroblasts) following exposure to 
unmodulated and talk-modulated RF-EMF signals [68, 182]. These studies came under 
massive criticism on the ground of a statistical considerations, culminating in allegations of 
data fabrication and scientific misconduct [74]. Indeed, a first partial replication study failed 
to reproduce genotoxic effects in human ES-1 fibroblasts, although these analyses focused 
on the 1.8 GHz carrier wave only, and did not systematically address effects of modulated 
signals [69]. Therefore, it remains unclear whether or not RF-EMFs have a genotoxic 
potential.  I re-examined these effects using the same exposure conditions and cell line (ES-
1) as in the previously published studies.  
Both studies made use of the comet assay to analyze DNA fragmentation, the first 
performed a visual analysis of the comet effects, the replica study a computerized analysis.  
In this study, I performed both types of analyses, to allow for direct comparison. Cells were 
exposed to a GSM modulated RF-EMF at SAR values of 1 and 2W/kg and to the carrier wave 
(1950MHz) without modulation at 1W/kg. Exposure was intermittent (5´field on/10´field off) 
for a total of 16h. In the ES-1 cell line, I did not find any significant differences by applying 
both the visual and the fully automated computerized analysis of the comet assay. I also 
used a second human primary fibroblast cell line, HR-1d, which under ELF-EMF exposure 
conditions proved to be more sensitive than ES-1. I found a slight but significant increase of 
the visually scored comet tailfactor for both SAR values in the GSM modulated field, which 
was a bit more pronounced at 1W/kg. When applying the automated computerized analysis, 
the tail moment change was only significant for the 1W/kg GSM modulated RF-EMF. Hence, 
these result support the visually scored data partially, i.e. for the condition that produced a 
slightly more robust tail factor differences (1 W/kg GSM talk modulated RF-EMFs). Applying 
the stringent requirement that a genotoxic effect is genuine only if both comet scoring 
techniques produce statistically significant differences, we conclude the RF-EMF exposure at 
1W/kg slightly increases the steady-state level of DNA strand breaks in the HR1-d cell line. 
The results do not support the genotoxic effects reported in the first study with the ES-1 cell 
line, but nevertheless show, that increased DNA fragmentation is detectable under RF-EMF 
exposure. 
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4.1.3. Additional data: ELF-EMF exposure 
In addition to the data summarized in 4.1.1. and 4.1.2., I performed experiments to explore 
the type of DNA damage generated and the biological pathways involved in electromagnetic 
field effects. For this purpose, I chose to use the ELF-EMF exposure conditions, as effects 
there are more robust and established. Materials and methods covering this part are 
described in Focke et. al. (Appendix I) and in section 4.1.4. 
 
4.1.3.1. No detectible genotoxic effect of induced electric fields 
For in vitro ELF-EMF exposure, induction of the magnetic field is constant throughout the 
whole cell culture dish. Therefore all cells are exposed to the same field strength. However, 
the induced electric field is different, as there is no induction in the central part of the Petri 
dish and increasing induction towards the peripheral areas of the dish. Thus, I examined to 
what extent the induced electric field contributes to the genotoxic effects found before. 
 
                                
Figure 1. Contributions from the induced electric field. 
ES-1 cells exposed to 50Hz, 1mT intermittent (5/10) ELF-EMF for 15h were harvested separately at the central 
and peripheral petri dish area, analysed with the alkaline comet assay and visually scored into five defined 
stages (A-E) by increasing amount of DNA in tail and tail length. Shown are mean percentages of cells in comet 
stages A-E for sham and exposed cells with standard errors as obtained from 4 independent experiments. Stage 
A represents cells without DNA migration and stages B-E cells with increasing amounts of migration (see 
Appendix I). The box contains mean comet tailfactor values for sham and exposed cells. Individual stages and 
tailfactors were compared by Student´s t-test.  
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To this end, I harvested ES-1 fibroblast cells in a 10cm Petri dish from the central and 
peripheral area separately after 50Hz, 1mT intermittent ELF-EMF exposure for 15h and 
compared them by comet analysis. The results show no significant difference between cells 
exposed in the central and in the peripheral area of the dish (Figure 1), but significant 
differences between sham and exposed cells. This indicates that the comet effects measured 
upon ELF-EMF exposure result from the magnetic field with negligible contributions from the 
induced electric field. 
 
4.1.3.2. No adaptaion of cells under continuous ELF-EMF exposure 
In Focke et. al. (Appendix I), I show that continuous ELF-EMF exposure, in contrast to 
intermittent exposure, has no effect on comet tailfactors in all cell lines. We reasoned that 
this might reflect a potential of cells to adapt under continuous exposure conditions, e.g. 
through induction, stabilization or degradation of proteins involved in DNA repair, cell cycle 
or apoptosis. To address this, I applied exposure protocols, where fibroblast cells were first 
exposed to a continuous ELF-EMF at 50Hz, 1mT for 4h followed by 24h recovery and 15h 
intermittent exposure (Figure 2) to see if the EMF effect is still detectable in the comet 
assay.  
                                 
Figure 2. Potential of cells to adapt to ELF-EMF under continuous exposure. 
HR-1d fibroblast cells were exposed to a continuous ELF-EMF (4h) at 50Hz, 1mT, then  left to recover for 24h 
and then exposed to 50Hz, 1mT intermittent (5/10) ELF-EMF for 15h. They were analysed with the alkaline 
comet assay and visually scored as described in Appendix I. Shown are mean percentages of cells in comet 
stages A-E for sham and exposed cells with SEMs as obtained from 4 independent experiments. The box 
contains mean comet tailfactor values for sham and exposed cells. Individual stages and tailfactors were 
compared by Student´s t-test.  
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I found no statistically significant differences between cells that were exposed intermittently 
only and cells that had continuous exposure before intermittent exposure. This would argue 
against adaptation of cells under continuous exposure conditions. However, it could be that 
adaptation takes place in another time window, which was not addressed in this experiment. 
This question should be addressed more systematically in experiments allowing monitoring 
of cellular responses under “real time” exposure conditions (see 4.1.3.5.). 
 
4.1.3.3. DNA Damage recognition after ELF-EMF exposure 
Comet assay effects indicate an increase in the steady state levels of DNA strand breaks. To 
address whether these breaks are detected by DNA damage recognition proteins, I analysed 
two different factors, which are known to detect different spectra of DNA damages. 
PARP recognizes DNA single strand breaks and is mainly involved in DNA BER and DNA SSB 
repair. Phosphorylated H2AX (γH2AX) is a prominent marker for double strand breaks and 
stalled replication forks.  
In the case of PARP, I used the inhibitor 3-aminobenzamide (3ABA) to examine the effect of 
PARP (and therefore SSB repair) inhibition on the comet assay affects of ELF-EMF exposure. 
For this purpose, ES-1 fibroblast cells were intermittently exposed to a 50Hz, 1mT ELF-EMF 
for 15h in the presence of 3ABA and visual comet assay analysis was done. 3ABA increased 
background damage levels by 1.4 fold regarding the comet tailfactor, but there was almost 
no difference between cells treated with the inhibitor only and cells exposed to both ELF-
EMF and inhibitor (Figure 3).  
It is conceivable that the higher background damage level caused by 3ABA masked the effect 
of the magnetic field. However, I was not able to find an experimental condition, where no 
background effect of 3ABA treatment was present. Both treatments might be epistatic, 
indicating that PARP inhibition and ELF-EMF exposure affect the same processes. Hence, the 
result might suggest that ELF-EMF exposure might affect SSB repair efficiency rather than 
inducing DNA damage itself. Another possibility to assess the role of SSB repair in this 
context would be to measure poly(ADP)ribose formation directly in ELF-EMF exposed cells. 
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Figure 3. Inhibition of single strand break repair does not lead to increased DNA damage levels . 
ES-1 cells were exposed to 50Hz, 1mT intermittent (5/10) ELF-EMF for 15h including the PARP inhibitor 3-
aminobenzamide. They were analysed with the alkaline comet assay and visually scored as described in 
Appendix I. Shown are percentages of cells in comet stages A-E for sham and exposed cells with SEMs as 
obtained from 2 independent experiments. The box contains mean tailfactor values for sham and exposed 
cells. Individual stages and tailfactors were compared with Student´s t-test.  
 
As a DNA damage marker, γH2AX can be visualised by immunofluorescence with phosphor-
specific antibodies. To address the question, if DSBs and stalled replication forks are present 
in ELF-EMF exposed cells, I exposed ES-1, HR-1d, MCR-5 and HeLa cells to an intermittent 
50Hz, 1mT ELF-EMF for 15h, fixed them and stained for γH2AX. I evaluated foci formation by 
counting γH2AX foci numbers and assigning cells to three classes: 0, 1-10 and >10 foci. As 
shown in Figure 4, there was no significant difference between sham and exposed cells in all 
four tested cell lines. As γH2AX does localize mainly to DSBs and stalled replication forks, the 
results suggest that the comet tailfactor increase is unlikely accounted for by such lesions.  
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Figure 4. No detection of increased numbers of DSBs and stalled replication forks. 
HR-1d, ES-1, MRC-5 and HeLa cells exposed to 50Hz, 1mT intermittent (5/10) ELF-EMF for 15h were stained 
with γH2AX antibody and microscopically scored for number of foci. Shown are percentages of cells in the 
three categories 0, 1-10 and >10 foci with SEMs as obtained from at least 3 independent experiments. 
Categories of sham and exposed cells were compared with Student´s t-test.  
 
4.1.3.4. Addressing the role of DNA BER in ELF-EMF induced comet effects 
ELF-EMF exposure has been associated with increased ROS formation, which, through fenton 
reactions, could generate oxidative DNA lesions. Oxidized bases and other small DNA lesions 
are recognized and repaired by the DNA BER system, key components of which are XRCC1 
and DNA Pol β. Therefore, I addressed the role of BER in ELF-EMF induced genotoxicity by 
examining XRCC1 and Pol β function. First, I measured XRCC1 foci formation in two primary 
fibroblast cell lines and HeLa after 50Hz, 1mT intermittent ELF-EMF exposure for 15h by 
immunofluorescence. (Figure 5).  
I found no significant difference between sham and exposed cells in all cell lines tested. 
Thus, ELF-EMF exposure does not affect steady state levels of XRCC1 foci in cells, although it 
does increase comet tailfactors, which appears to be inconsistent. The effect on foci 
formation, however, may be transient and dynamic, which could only be addressed in real 
time analyses. 
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Figure 5. XRCC1 foci formation after ELF exposure. 
HR-1d, ES-1 and HeLa cells exposed to 50Hz, 1mT intermittent (5/10) ELF-EMF for 15h were stained with XRCC1 
antibody and microscopically scored for numbers of foci. Shown are percentages of cells in the three categories  
0, 1-4 and >4 with standard errors, as obtained from 2 independent experiments. Categories of sham and 
exposed cells were compared with Student´s t-test.  
 
To address the role of DNA Pol β, I made use of the nucleoside analogue AZT (3´-azido-3´-
deoxythymidine), which is preferentially incorporated by DNA Pol β (and reverse 
transcriptase), but not by replicative DNA polymerases. It then blocks further processing of 
the lesion and, therefore, inhibits BER. To examine, if inhibition of BER affects the comet 
assay effect, I exposed the cells in the presence and in the absence of AZT to 50Hz, 1mT 
intermittent ELF-EMF for 15h and performed comet and cell cycle analysis afterwards. To 
find the appropriate AZT concentration, I first performed MTT survival assays for all cell lines 
and choose a concentration, which showed (almost) no impact on 48h survival (Figure 6A).  
This was 100µM in the case of HR-1d, 200µM for ES-1 and 10µM for the HeLa cell line. 
Addition of AZT increased background of DNA damage levels in comet analyses in all cell 
lines tested (Figure 6B-D): 2.4fold in HR-1d, 2.1fold in ES-1 and 1.2fold in HeLa. Despite the 
increased background, however, the ELF-EMF exposure effects are still discernible in the 
presence of the inhibitor (difference between AZT sham and AZT exposed), but the relative 
tailfactor increase is not enhanced compared to AZT free conditions.  
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Figure 6. ELF-EMF induced comet effects under Pol β inhibition. 
A) HR-1d, ES-1 and HeLa cells were treated with increasing amounts of AZT and survival was tested after 48h of 
incubation. B, C, D) HR-1d, ES-1 and HeLa cells treated with 200, 100 and 10µM AZT, respectively were exposed 
to 50Hz, 1mT intermittent (5/10) ELF-EMF for 15h, analysed with the alkaline comet assay and visually scored 
into five different stages as described in Appendix I. Shown are mean percentages of cells in comet stages A-E 
for sham and exposed conditions with standard errors, as obtained from 2 independent experiments (1 
experiment for HeLa). The box contains mean tailfactor values for sham and exposed cells without and with 
inhibitor. Individual stages and tailfactors were compared with student´s t-test.  
 
Cell cycle analysis by FACS then revealed a significant 2-fold increase of S-phase cells after 
AZT treatment in the fibroblast cultures (Figure 7), indicating S-phase accumulation and 
therefore problems with replication due to unrepaired DNA damage.  
Besides incompletely repaired DNA damage, an accumulation of cells in S-phase could 
account for the increased comet tail factors observed following AZT treatment. S-phase cells 
naturally contain DNA fragments and therefore are scored as comet stage B-E events. 
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Figure 7. Cell cycle analysis after ELF-EMF exposure under Pol β inhibition. 
HR-1d, ES-1 and HeLa cells treated with 200, 100 and 10µM AZT respectively were exposed to 50Hz, 1mT 
intermittent (5/10) ELF-EMF for 15h, stained with propidium iodid (PI) and analyzed by FACS for cell cycle 
distribution. Shown are percentages of cells in the different cell cycle stages according to their PI content with 
standard errors. Differences between single stages in sham, ELF-EMF exposed and AZT treated cells were 
compared with Student´s t-test: * p<0.05; ** p<0.01; *** p <0.005.  
 
Also, the G2 population increased slightly in all three cell lines tested. Both S- and G2- 
effects, however, were not further increased by ELF-EMF exposure. On the other hand, the 
subG1 population, which might include apoptotic cells, was increased in all cell lines, but 
only after combining AZT with ELF-EMF treatment. This is statistically significant for HR-1d 
with about 7% more cells in subG1 compared to AZT alone. This could indicate, that DNA BER 
protects cells from entering apoptosis following ELF-EMF exposure.  
This leaves us with two possible interpretations. (I) The putative DNA damage generated by 
ELF-EMF exposure is substrate for the BER pathway, or (II) the damage generated by AZT, i.e. 
unligatable DNA single strand breaks are less efficiently processed and recovered under ELF-
EMF exposure. 
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4.1.3.5. Establishment of fluorophore-tagged proteins for live cell imaging under ELF-EMF 
exposure 
To be able to address transient effects during ELF-EMF exposure, we started to establish 
tools for real time examination of cells during exposure. For this purpose, a small ELF-EMF 
exposure chamber is in development in collaboration with IT´IS foundation (ETH Zurich), 
which can be used for live cell microscopy. For real time analysis of cellular EMF responses, 
we started to establish constructs for expression of fluorophore tagged proteins of interest. 
These included: XRCC1, a BER protein known to be recruited immediately after DNA damage 
induction; OGG1, a DNA glycosylase recognizing the major oxidative DNA lesion 8-oxoG; 
TDG, a DNA glycosylase with a wide substrate spectrum including oxidative lesions; XPC, a 
component of NER also interacting with BER enzymes; PARP, a sensor of DNA strand breaks; 
APE1, a component of BER; RPA2, a ssDNA binding protein; PCNA, a replication and repair 
protein usable as cell cycle marker; H2B, a nucleosome component and MBD1, a methyl-CpG 
binding protein.  
Constructs for XRCC1, PARP, APE1, TDG, XPC and MBD were already available, so I 
established fluorophore tagged RPA2, PCNA, H2B and OGG1. For this purpose, I reverse 
transcribed cDNA from total RNA of HeLa cells and PCR-amplified the four genes from this 
cDNA. I cloned these fragments into a pEGFP-C1 vector (Clontech, Palo Alto, CA, USA). 
Construction details are shown in Figure 8. Selected clones were then validated by 
sequencing. In the case of H2B all clones represented an in-frame H2Bj variant, which seems 
to be prominent in HeLa. I then subcloned H2B and OGG1 into a pEYFP-N1 vector (Clontech) 
to provide an alternative for combined analyses of two different proteins.  
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Figure 8. Vector constructs for EGFP-RPA2, EGFP-PCNA, H2B-YFP and OGG1-YFP. 
A) pEGFP-C1 vector (Clontech) includes an optimized GFP variant gene with a CMV promoter, an SV40 origin of 
replication in mammalian cells, a pUC origin of replication for E.coli, a neomycin/ kanamycin resistance cassette 
and a multiple cloning site after the EGFP. The gene of interest (GOI) was cloned by using Xho I and Hind III 
restriction sites in the MCS to insert the gene in frame directly behind the EGFP ORF. Arrows represent ORFs, in 
blue are the used restriction sites. B) pEYFP-N1 vector (Clontech) is based on the same features as pEGFP-C1. 
The GOI was cloned in front of the EYFP ORF by using Xho I and BamH I restriction sites in the MCS. 
OGG1: 1073bp 
H2B: 413bp 
B 
OGG1: 1073bp 
RPA2: 848bp 
PCNA: 822bp 
H2B: 413bp 
A 
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Thereafter, I transiently transfected Cos7 cells (African Green Monkey SV40-transformed 
kidney fibroblast cell line) with the EGFP-RPA2, EGFP-PCNA, H2B-YFP or OGG1-YFP 
constructs. Following incubation for 48h, I harvested cells, prepared SDS extracts and 
examined expression of fusion proteins by Western blotting with anti-GFP antibody. I was 
able to identify all of the tagged proteins (Figure 9). In all cases, a small amount of 
degradation products (probably truncated versions or GFP only) was apparent. Expression 
levels of PCNA and RPA2 were low, but still detectable. 
 
                     
Figure 9. GFP western blot of transiently transfected Cos7 cells. 
Transiently transfected Cos7 cells from a 80% confluent 3cm petri dish were harvested 48h after transfection 
with 100µl 2xSDS buffer and incubated at 95°C for 5min. 20µl were loaded onto a 10% SDS-polyacrylamide gel, 
transferred to a microcellulose membrane and stained with anti-GFP antibody. Fluorescence detection was 
done with the Li-COR Odyssey Infrared Imaging System. Predicted sizes: EGFP: 27kDa, MBD-nls-GFP: 50kDa, 
OGG1-EYFP: 65kDa, EGFP-PCNA: 56kDa, H2B-EYFP: 47kDa, EGFP-RPA2: 59kDa 
 
Examination under live cell microscopy showed the expected localization patterns for all of 
the proteins (Figure 10). GFP protein alone was distributed throughout the whole cell (Figure 
10A), OGG1 shows mainly nuclear staining with some spots outside (Figure 10B), probably 
representing mitochondria as observed before [183]. The nuclear staining pattern for OGG1 
is not homogenous, there appear to be more and less condensed regions. RPA2 shows a 
diffuse nuclear staining (Figure 10C). MBD shows nuclear localization with condensed 
regions as published before [184] (Figure 10D), probably representing heterochromatin 
areas. APE1 has a diffuse nuclear staining pattern (Figure 10E).  
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Figure 10. Localization of target genes in Cos7 cells. 
Cells were analysed 24h after transfection with a Leica DMI6000B live cell imaging microscope using a Ludin 
chamber (Life Imaging Services) and GFP or YFP filters with a 100x magnification. A) EGFP alone localized 
throughout the whole cells B) OGG1-EYFP, localization mainly within the nucleus, but also mitochondrial C) 
EGFP-RPA2, nuclear localization D) EGFP-MBD, nuclear localization with a foci-like pattern E) EGFP-APE1, 
nuclear localization F) H2B-EYFP, nuclear localization with a foci-like pattern G) XRCC1, nuclear localization, foci 
in a subset of cells. H) EGFP-PCNA, nuclear localization, different patterns throughout the cell cycle: the first 
cell is outside S-phase, the others in different stages of S-phase: early, mid and late S  
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H2B has a nuclear staining pattern with condensed regions [185] (Figure 10F). XRCC1 has a 
diffuse nuclear staining pattern with foci in a subset of cells, probably representing DNA 
repair foci (Figure 10G). PCNA shows nuclear staining, which is diffuse from G2 to G1 and 
becomes condensed during S-phase [186] (Figure 10H).  
To analyse, if recruitment of DNA repair proteins takes place after laser-induced DNA 
damage, I tested XRCC1 transfected cells by inducing DNA damage with micro-laser 
irradiation (355nm, 100ms per point). XRCC1 is immediately recruited to the site of 
irradiation and accumulates over time.  
 
 
Figure 11. Recruitment dynamics of XRCC1 after laser induced DNA damage. 
XRCC1 transfected Cos7 cells were laser irradiated with 100ms per FRAP point on one line through the nucleus. 
XRCC1 localization was monitored over time. A) before irradiation, B) directly after irradiation, C) 10s, D) 30s, E) 
60s, F) 10min, G) 30min, H) 60min 
 
4.1.4. Additional experimental procedures 
 
4.1.4.1. Comet assay 
For discrimination between central and peripheral cells, ES-1 human primary fibroblasts 
were seeded 24h before ELF-EMF exposure in DMEM onto 10cm Petri dishes containing 
24x26mm cover slips in the center and at the periphery. After 15h intermittent (5min 
on/10min off) exposure with 50Hz, 1mT ELF-EMF cells from the different cover slips of sham 
and exposed cultures were harvested for comet analysis as described in the Appendix 7.1. 
A 
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For the continuous pre-exposure experiments, cells were exposed for 4h continuously at 
50Hz, 1mT and then left to recover/adapt for 24h. Then they were subjected to 50Hz, 1mT 
intermittent (5min on/10min off) ELF-EMF exposure for 15h h. This is the only exposure 
protocol, where we could not use blinded conditions. After the second exposure period 
comet assay was performed as described in Appendix 7.1. 
In the PARP inhibition experiments 10mM 3ABA (Sigma) was added directly before ELF-EMF 
exposure. In the case of AZT survival assays were performed to adjust the appropriate 
concentration by seeding 1500 cells per well in triplicates into a 96well plate 16h before AZT 
addition. Cells were incubated 48h with the indicated concentrations of AZT (Sigma). 10µl of 
WST-8 [2-(2-methoxy-4-nitrophenyl)-3-(4-nitrophenyl)-5-(2,4-disulfophenyl)-2H-tetrazolium, 
monosodium salt] (“Cell Counting Kit 8”, Dojindo Laboratories, Kumamoto, Japan) was 
added. The converted product was measured at 450nm in an ELISA plate reader after 2-4h. 
In the ELF-EMF exposure experiments, appropriate concentrations of AZT were added to the 
cultures immediately before exposure.  
 
4.1.4.2. Immunofluorescence 
Cells were seeded in DMEM and grown on cover slips for 24h. Cells were then exposed to a 
50Hz, 1mT intermittent (5/10) ELF-EMF for 15h, then washed twice in PBS and fixed for 15 
min with PF-buffer (PBS, 2% paraformaldehyde) at RT. After four washing steps of 10 min in 
PBS at RT, cells were permeabilized in ice cold P-buffer (PBS, 0.2% TritonX100) for 5 min. To 
reduce autofluorescence, the coverslips were incubated for another 5 min in ice-cold P-
buffer containing 0.2% NaBH4. After blocking twice in H-buffer for 10 min (PBS, 1% BSA) and 
once in D-buffer for 10 min (PBS, 1:20 donkey serum), samples were hybridized with anti-
XRCC1 antibody (#ab1838, Abcam, Cambridge, UK, dilution 1:50 in H-buffer) or anti γH2AX 
antibody (#05-636, Upstate, NY, USA, dilution 1:500 in H-buffer) for 1h at RT. Following four 
washing steps of 10 min in H-buffer, the samples were hybridized with secondary antibody 
(anti-mouse IgG Cy2, dilution 1:500 in H-buffer) for 1 h at RT. After four washing steps of 10 
min in PBS, the coverslips were dried and embedded in Mowiol (Mowiol 4.88, Calbiochem 
#475904). XRCC1 signals were visualized on an Axiovert 200M microscope (Zeiss, Germany) 
using a FITC filter (exitation 492 nm, emission 520 nm). 
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4.1.4.3. Construction and validation of expression vectors 
 
Table 1: Primers for amplification of target genes from cDNA 
 
 
5µg of total RNA from HeLa cells was reverse transcribed using the “RevertAid™ H Minus 
First Strand cDNA Synthesis Kit” (#K1631, Fermentas, St. Leon-Rot, Germany) according to 
the manufacturer´s instructions. cDNA was PCR amplified with Phusion polymerase 
(Finnzymes, Finland) and primers P1 (forward) and P2 (reverse) for the four genes RPA2, 
H2B, PCNA and OGG1 respectively (see Table 1), thereby introducing XhoI, HindIII and BamHI 
restriction sites at the ends (see Figure 8). PCR conditions were as follows: 98°C, 30s (1x), 
98°C, 10s – 62°C, 10s – 72°C, 10s (35x), 72°C, 30s (1x). PCR fragments were purified with 
“peq gold Cycle-Pure Kit” (peqlab, Erlangen, Germany) according to the manufacturers 
instructions. Restriction digest was carried out using HindIII and XhoI (New England Biolabs, 
USA) enzymes followed by ligation using 1U Ligase T4 and transfection of DH5α competent 
bacteria by electroporation. MiniPreps were carried out with “peqgold Plasmid Mini Prep 
Kit” (peqlab) according to the given instructions. After a test digest positive clones were used 
for sequencing with the BigDye Terminator sequencing kit according to the manufacturer´s 
instructions using primer PC or PC1. Reaction program was as follows: 96°C, 10s – 50°C, 5s – 
60°C, 4min (35x). For subcloning into pEYFP-N1 vector (clontech), targets and vector were 
restriction digested with XhoI and BamHI and ligated into the new vector as before. 
RPA2 P1   5´-CGGACTCGAGGGGCCGCCATGTGGAACAGTGGATTCGAAAG-3´ 
P2   5´-TACCAAGCTTACGGATCCGA TTCTGCATCTGTGGATTTAAAATGG-3´ 
H2B P1   5´- TTATCTCGAGGCGCCGCCATGCCAGAGCCAGCGAAGTC-3´ 
P2   5´- TGCAAAGCTTACGGATCCGACTTAGCGCTGGTGTACTTGG-3´ 
PCNA P1   5´- TGTTCTCGAGGCGCCACCATGTTCGAGGCGCGCCTGG-3´ 
P2   5´- CTTGAAAGCTTACGGATCCGAAGATCCTTCTTCATCCTCG-3´ 
OGG1 P1   5´- GCGGCTCGAGGTGCCGCCATGCCTGCCCGCGCGCTTCTGC-3´ 
P2   5´- TGTCAAGCTTACGGATCCGAGCCTTCCGGCCCTTTGGAACC-3´ 
seqPN  5´- CGCCGTCCAGCTCGACCAG-3´ 
seqPN1  5´- CGTGTACGGTGGGAGGTC -3´ 
seqPC 5´- CATGGTCCTGCTGGAGTTCG-3´ 
seqPC1  5´- TCTACAAATGTGGTATGGCTGA-3´ 
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Transfection-grade DNA was obtained by extraction with “QIAfilter endofree plasmid Midi 
Kit” (Qiagen) according to the instructions. 
For transient transfection Cos7 (SV40 immortalized African green monkey kidney fibroblasts) 
cells were grown in DMEM (dulbeccos modified eagle´s medium, Sigma) supplemented with 
10% FCS and 1% L-Glutamine. 50% confluent cultures in 6well plates were transfected with 
0.5µg DNA using 1µl Transfectin (BioRad). Cells were harvested after 48h for GFP western 
blot analysis. For microscopic analysis cells were seeded in 12well plates onto cover slips and 
transfected with corresponding amounts of DNA and transfectin. Analysis was done after 
24h with a Leica DMI6000B life cell imaging microscope using a Ludin chamber (Life Imaging 
Services). For FRAP analysis cells were irradiated partially with a laser at 355nm to induce 
DNA damage and followed over time to analyse recruitment and dynamics of proteins. 
For Western blot cells were lysed directly on the plate by adding 100µl 2xSDS buffer (100mM 
NaCl, 500mM Tris [ph=8], 10% wt/vol SDS). After 5min at 95°C, 20µl of the lysates were 
separated in a 10% SDS-polyacrylamide gel and transferred to a nitrocellulose membrane 
(Millipore, USA). After blocking membranes with TBS buffer (100 mM Tris/HCl, 150 mM NaCl, 
pH 8.0) with 5% dry milk for 1h at RT, they were incubated with the first antibody (mouse 
anti-GFP # 11-814-460-001, Roche, Switzerland, 1:1000) in the blocking buffer for 1h at RT, 
followed by three 10min washing steps with TBS at RT. Secondary antibody (#926-32220, 
goat anti-mouse IRDye 680, LI-COR, Lincoln, USA) was diluted 1:10 000 in blocking buffer and 
hybridized to the membranes for 1h at RT. After three washing steps of 10 min at RT 
detection of the signals was carried out using the Odyssey Infrared Imaging system (LI-COR).  
 
4.2. Involvement of Thymine DNA Glycosylase in DNA based cytotoxicity of 5-
fluorouracil (Appendix III) 
 
5-fluorouracil (5-FU) has been in use as chemotherapeutic substance since decades, but its 
exact mode of action is still poorly understood. Inhibition of the thymidilate synthase by 5-
FU increases the dUMP (or FdUMP) level on the expense of dTMP, which, upon conversion 
to dUTP (or dFdUTP) can get incorporated into genomic DNA. This DNA directed action of 5-
FU has been proposed to generate toxic DNA damage through excision repair processes. The 
pathway generating this lethal DNA damage has not been defined yet. In biochemical assays, 
uracil and 5-FU in DNA represent substrates for the Thymine DNA Glycosylase (TDG). The 
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aim of this study was to evaluate a possible role of TDG dependent BER in the response to 5-
FU treatment. In a genetic approach we discovered that mouse embryonic fibroblast cells 
with a targeted disruption of the TDG gene show significantly reduced sensitivity towards 5-
FU treatment compared to wild type cells. This phenotype could be complemented by 
expression of a catalytically active TDG. 
Therefore I addressed the question, if TDG dependent DNA strand breaks can be seen in 5-
FU treated cells making use of the highly sensitive comet assay I established in the 
laboratory. Thereby I saw increased levels of DNA fragmentation in wild type cells compared 
to knock out cells. Analysing the cell cycle of these cells, I found that wild type cells 
accumulate more in S-phase than knock out cells upon 5-FU treatment. This correlated with 
the loss of activation of an intra S-phase DNA damage checkpoint. Altogether, these findings 
suggest a rate limiting role for TDG in mediating the DNA directed cytotoxicity of 5-FU. 
 
4.3. Cell cycle regulation of the uracil DNA glycosylases TDG and UNG 
(Appendix IV) 
 
TDG is a member of the uracil DNA glycosylase (UDG) superfamily of proteins, which all 
excise uracil from DNA. Hence, the uracil processing activity of TDG is not unique, at least 
three additional proteins (UNG, SMUG and MBD4) with such properties are present in 
mammalian cells. The co-evolution of these apparently redundant enzymes implies the 
existence of non-redundant biological functions that must be coordinated. In this study, we 
addressed the role of gene regulation in the functional separation of the DNA glycosylases 
UNG and TDG. We found that UNG is present mainly in S-phase, while TDG is detectable 
from G2 to the next G1 phase and absent in S-phase. As part of this study I provided 
cytological support for counter-regulation of these two DNA glycosylases. For this purpose, I 
stainied HeLa cells with antibodies against TDG and the S-phase marker PCNA to do 
immunofluorescence. I counted cells for single and double staining and showed, that PCNA 
positive (and therefore S-phase) cells do not stain for TDG and vice versa. We also showed, 
that regulation of TDG occurs at the protein level, as mRNA levels are constant throughout 
the cell cycle and that the protein is ubiquitinated and degraded by the proteasome.  
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4.4. Arginine Methylation Regulates DNA Polymerase β (Appendix V) 
 
In this study, we addressed the function of a newly discovered arginine methylation in DNA 
Polymerase β, the DNA polymerase involved in DNA BER. Pol β was found to form a complex 
with the protein arginine methyltransferase 6 (PRMT6) and to be specifically methylated at 
arginine in vitro and in vivo. In biochemical assays, methylation of Pol β by PRMT6 strongly 
stimulated DNA polymerase activity by enhancing DNA binding and processivity, while single 
nucleotide insertion and dRP-lyase activity were not affected. Two residues, R83 and R152, 
were identified in DNA Pol β as the sites of methylation by PRMT6. I contributed to the 
genetic complementation experiments of this study, which confirmed, that the amino acid 
residues targeted by PRMT6 in vitro are indeed important for the cellular resistance to DNA 
alkylating agents. Making use of differentially complemented mouse embryonic fibroblast 
cell lines with a genomic DNA Pol β knock out, I investigated DNA fragmentation levels 
following MMS (methyl methanesulfonate) treatment. This showed, that DNA Pol β knock 
out cells complemented with a mutated form of DNA Pol β, not able to be methylated, 
exhibit a higher level of DNA fragmentation upon induced DNA damage than cell 
complemented with wild type DNA Pol β. Together with reduced survival rates and an 
increased subG1 fraction in cells challenged with a DNA damaging agent, this established the 
in vivo relevance of DNA Pol β methylation.  
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5. Discussion and Outlook 
 
5.1. Biologic effects of electromagnetic fields 
 
Genotoxicity of 50Hz electromagnetic fields 
Genotoxicity studies with 50Hz electromagnetic fields in the past produced conflicting 
conclusions. Independent confirmation of results was not possible in some cases. This study 
was aimed at the validation of previous work reporting ELF-EMF derived genotoxicity, and at 
the clarification of discrepancies between different studies. Using identical exposure 
equipment and conditions (50Hz, 1mT, 15h) and the same cell line (ES-1) and comet analysis 
method as published previously [1], I could reproduce evidence for increased DNA 
fragmentation in comet analysis following ELF-EMF exposure. This comet effect was less 
pronounced than previously published, but nevertheless statistically significant. I observed 
increased levels of comet tail DNA under intermittent but not under continuous exposure 
conditions. This excludes thermal effects as a cause. I tested, if cells are able to adapt under 
continuous exposure conditions, but did not find evidence in support of such a scenario. 
Hence, the reason for the difference between intermittent and continuous exposure remains 
unclear. As the visual method of comet scoring used in the original study was criticized, I 
compared side by side visual and automated computerized analysis and showed, that the 
observed DNA fragmentation was in the same range, irrespective of the scoring method. I 
then expanded the study to other cell lines. ELF-EMF induced DNA fragmentation was more 
pronounced in a fibroblast cell line from an older donor and absent in the cancer cell line 
HeLa. This could be due to altered DNA repair, cell cycle control or apoptosis capacities in 
the cancer cell line. 
I addressed whether cells in different stages of the cell cycle are affected differently by ELF-
EMF exposure. Cells blocked in G1 phase did not show a significant comet tailfactor increase, 
suggesting, that cells undergoing DNA replication show the ELF-EMF effect more readily than 
non-replicating cells. This could have influenced outcomes of other studies, as the fraction of 
S-phase cells varies with different cell lines and culture conditions. For instance, the 
previously reported influence of EMFs on the iron pool of the cell [75], which I did not find in 
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my experiments, might be due to the use of iron-chelators, which are known to induce G1 
arrest. 
 
Effects of ELF-EMF exposure on cell cycle and apoptosis 
Results with G1 blocked cells suggested, that ELF-EMF directed effects are detectible mainly 
in S-phase cells. DNA of S-phase cells is known to migrate into the comet tail and therefore 
contributes to the outcome of the assay [187, 188]. It was therefore not clear from the 
previous studies, if the observed comet tailfactor differences upon ELF-EMF exposure were 
due to direct DNA damage or due to an increase of the fraction of S-phase cells. Interference 
of electromagnetic fields with cell cycle progression was shown before, whereby inhibition 
of proliferation was observed [27, 28] as well as acceleration [24, 26]. However, cell cycle 
analyses in my study after intermittent 50Hz, 1mT exposure for 15h revealed no significant 
differences between exposed and non-exposed cells, indicating that an accumulation of cells 
in S-phase is not responsible for the increased comet tailfactor. The number of replicating 
cells however, was slightly but significantly reduced in the cell line showing higher DNA 
fragmentation in the comet assay. This suggests that ELF-EMF exposure disturbed DNA 
replication or entering of S-phase in a subpopulation of cells.         
Apoptotic cells were also suggested to account for the comet tailfactor increase after ELF-
EMF exposure [188, 189]. In this study the cell line, that showed the higher comet tailfactor 
increase, also had increased levels of apoptotic cells after ELF-EMF exposure (4.5% versus 
3%), suggesting that apoptotic cells might contribute to the comet effects. Cells entering S-
phase, which, as shown before, encounter replication problems, might be driven into 
apoptosis. But as about 2.4% more cells are found in comet stage E, the stage, that would 
contain apoptotic cells, after ELF-EMF exposure and the increase of apoptosis was measured 
to be 1.5%, apoptosis can only partially account for the comet effect.  
 
Type of possible DNA lesions induced by ELF-EMF exposure 
The comet tailfactor increase seems to be partially due to increased apoptosis, but the 
remaining part must be of other origin. The hypothesis of an influence of EMFs on the free 
radical pool [190-193] and the generation of oxidative DNA damage due to Fenton reactions 
was not supported by monitoring unrepaired oxidative damage in ELF-EMF exposed cells. 
The data cannot definitely rule out the generation of a small amount of oxidative DNA 
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damage upon ELF-EMF exposure, but they argue against a major contribution of such 
damage. The apparent discrepancy to previous studies might be due to cell line specific 
responses. 
γH2AX is a widely used marker for the visualization of DSBs, but also highlights stalled 
replication forks. As I found no change in γH2AX foci numbers and distribution after 
intermittent 50Hz, 1mT exposure for 15h, the generation of significant levels of DSBs can be 
excluded. There is a report of increased γH2AX foci formation in mouse preimplantation 
embryos [18] after ELF-EMF exposure with 0.3-0.5mT for 24h. These developing cells could 
respond more sensitively to ELF-EMF exposure, possibly due to high proliferation rates and, 
hence, the presence of a large fraction of replicating cells.  
I also studied the influence of inhibition of the DNA SSB sensor PARP on ELF-EMF effects. 
Usage of the inhibitor increased background DNA fragmentation, possibly because of 
increased steady state levels of DNA repair intermediates. When applying both inhibitor and 
EMF, the comet tailfactor did not increase further, indicating no direct SSBs as a result from 
ELF-EMF exposure. Both treatments might be epistatic, indicating that PARP inhibition and 
ELF-EMF exposure affect the same processes. Hence, the result might suggest that ELF-EMF 
exposure might affect SSB repair efficiency rather than inducing DNA damage itself. 
The pathway responsible for the removal of small lesions is DNA BER, critical components of 
which are XRCC1 and DNA Pol β. I could not find evidence for an engagement of XRCC1 
following ELF-EMF exposure. When inhibiting DNA Pol β, cells exhibited increased comet 
assay tailfactors, which is probably due to an accumulation of cells in S-phase, as confirmed 
by cell cycle analysis. The subG1 fraction, which was not increased with ELF-EMF or inhibitor 
treatment alone, was significantly increased upon application of both treatments. As subG1 
might represent apoptotic cells, this finding indicates an involvement of BER. It thus appears 
that, if repair synthesis is inhibited, some cells start to execute apoptosis.  This could either 
be due to the generation of BER relevant DNA lesions induced by ELF-EMF exposure, or to 
inhibition of BER of endogenous DNA damage upon ELF-EMF exposure. 
 
Radiofrequency electromagnetic fields 
Whether or not RF fields also have an influence on biological systems is unclear. The 
majority of studies do not support adverse health effects like cancer promotion. 
Nevertheless there is in vivo and in vitro evidence suggesting genotoxic effects on biological 
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systems. Using the same exposure setup and conditions (intermittent exposure, GSM talk 
modulated field, SAR 1 or 2W/kg, 16h), applied to the same cell line (ES-1), I could not 
reproduce the genotoxic effects obtained in a former study. I did find a small comet 
tailfactor increase in another fibroblast cell line (HR-1d), when applying the same exposure 
conditions. This effect was significant within a SAR range below the official threshold for RF 
exposure of the population (2W/kg). Importantly, differences in comet tail DNA were only 
seen when applying a modulated RF field, which, as described in the introduction, has 
different low frequency components. Therefore, as carrier wave exposure did not lead to a 
significant increase of the comet tailfactor, thermal effects can be excluded and low 
frequency components might be responsible for the described effects.  
 
Possible mechanisms 
Comet tail DNA changes are generally related to changes in steady-state levels of DNA strand 
breaks. This can be due to DNA damage, to an increased S-phase population, or to apoptosis. 
I showed that S-phase-differences and apoptosis indeed play a role, but they cannot explain 
the full extent of the comet assay effects. As DNA BER inhibition led to increased apoptosis 
upon ELF-EMF exposure, small DNA base lesions or single strand breaks appear to occur, 
either directly or indirectly. But what are the events that lead to S-phase-alterations and 
apoptosis and what lesions could be resulting from exposure to electromagnetic fields?  
A well established consequence of electromagnetic field exposure is alteration of calcium 
homeostasis of the cells. As calcium is an important regulator of cellular processes including 
proliferation, gene expression and apoptosis, it might be that the effects on DNA replication 
and apoptosis and the proposed impairment of DNA repair capacity are based on changes in 
calcium distribution within the cell. A recent report showed that calcium levels influence 
DNA replication by enhancing the binding of negative regulators to Cdc6 (cell division control 
protein 6), an essential component of the pre-replication complex [194]. Calcium also plays a 
role in apoptosis [40] and is an important component of many signalling pathways that 
induce changes in gene expression, cell cycle or apoptosis. It has also been shown that the 
functions of membrane channels can be altered due to ELF-EMF exposure, which could 
affect signalling cascades [195]. Hence, changes in intracellular calcium concentration and 
distribution may play a role in the effects observed in this study. 
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Small amounts of oxidative DNA damage might arise due to alteration of the redox status of 
the cell. My results, however, indicate that these effects cannot be significant. Another 
possibility is that cells are affected in repairing endogenous DNA damage or in cellular 
processes like DNA replication due to an influence of the field on the enzymes involved. 
Alterations of enzyme turnover rates upon ELF-EMF exposure have been shown (e.g. [82]), 
although not yet with regard to DNA metabolism. It was suggested that EMFs interact with 
moving electrons in enzymes [196], which could also affect DNA repair enzymes, that often 
contain metal ions. Along the same lines, it is possible that EMFs interact with electrons in 
DNA and either directly cause oxidative damage or, as shown by others, alter specific gene 
expression [197]. Moreover, interactions of EMFs with membrane bound proteins could lead 
to signalling cascades that influence gene expression. The gene expression changes reported 
after EMF exposure comprise heat shock proteins, pointing to a stress response of the cell. 
There are also cell cycle regulating genes like cyclin D, p21CIP1 and p16INK4a [28] and 
proliferation related genes like c-myc [37]. Altered regulation of the cell cycle could be 
responsible for the decreased replication efficiency rates observed here. Furthermore it was 
shown that there can be altered expression of apoptosis-related genes like bcl-2, bax and c-
myc [36]. So, besides the decreased replication efficiency, a direct influence on apoptosis-
related genes could be responsible for the increased fraction of apoptotic cells induced by 
ELF-EMF exposure. 
Taken together these results suggest an indirect influence of the ELF-EMF on essential 
cellular processes like DNA repair, replication or gene expression, rather than the induction 
of DNA damage.  
 
Future directions 
The current evidence suggests that DNA transactions rather than the DNA itself are affected 
by EMF exposure. Hence, the activity of enzymes processing DNA might be altered. 
Therefore, a future approach could be to use in vitro reconstituted enzymatic systems to 
address, if EMF exposure affects DNA repair and replication processes in a quantitative or 
qualitative manner.  
Another approach will be the monitoring of cells during exposure. The current analyses are 
limited in that they only monitor endpoints after exposure, but the cellular responses might 
well be transient. Therefore, we already started to develop a small ELF-EMF exposure 
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chamber, which can be placed under a live cell imaging microscope to allow real time 
assessment of possible ELF-EMF effects. For this purpose, I started to establish fluorophore 
tagged proteins of interest. Important proteins to study are components of the DNA BER 
pathway like XRCC1 and APE1, which can give further hints with regard to the engagement 
of DNA repair following EMF exposure. Additionally, the human 8-oxoG glycosylase OGG1 
will provide further insights into whether oxidative damage is involved, and the damage 
sensing protein PARP will identify putative DNA SSB repair processes. The inclusion of RPA2, 
a damage sensor, will allow the monitoring of ssDNA regions. With this set of diagnostic 
proteins, it will be interesting to assess repair dynamics of induced DNA damage. The 
damage in this context can be induced e.g. by H2O2 or by a micro-laser and differences in 
recruitment dynamics of DNA repair proteins can be measured. As a cell cycle marker, I 
established GFP-tagged PCNA, which is also involved in DNA repair. Another question to be 
addressed is, if electromagnetic fields also have an influence on the epigenome of the cell. 
There is preliminary evidence, suggesting that low dose ionozing radiation may induce DNA 
methylation changes. To answer this question, the methyl-binding protein domain of MBD1 
was chosen to reveal DNA methylation pattern differences as a consequence of EMF 
exposure. 
 
5.2. Involvement of TDG in the toxicity mechanism of 5-FU (Appendix III) 
 
5-fluorouracil (5-FU) is a widely used anti-cancer drug, but its mode of action has not been 
solved. We show in this work, that TDG knock out cells display hyperresistance to 5-FU and 
this phenotype can be reverted by complementation. This suggests an involvement of TDG, 
but not other uracil DNA glycosylases, in 5-FU mediated cytotoxicity. Importantly, this 
establishes for the first time a functional separation between uracil DNA glycosylases. 
Whereas TDG mediates toxicity of 5-FU, SMUG, was reported to protect cells from the 
cytotoxic effects of 5-FU, and UNG does not seem to contribute significantly to the 
processing of 5-FU derived DNA lesions. 
Interestingly, it has been shown that there can be a correlation between reduced BER 
capacity and better survival rates of patients upon combination therapy with 5-FU [198].  
Therefore it will be of great interest, to examine, if TDG levels in tumor cells of patients 
correlate with response of the cancers to the 5-FU treatment.  
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5.3. Cell cycle regulation of Thymine DNA Glycosylase (TDG) (Appendix IV) 
 
This study established the temporal separation of function of the otherwise redundant uracil 
DNA glycosylases TDG and UNG. The two enzymes are present in different cell cycle phases, 
UNG in S-phase and TDG in all other phases of the cell cycle. TDG and UNG have different 
substrate affinity spectra. While UNG processes uracil opposite adenine with high efficiency, 
TDG has a low affinity to this substrate. During DNA replication, misincorporation of uracil 
mostly happens opposite adenine, making UNG the more suitable enzyme for repair. TDG, 
however, could interfere with DNA replication processes following base excision, as it binds 
to AP sites with high affinity. TDG might also interfere with the postreplicative mismatch 
repair system, because it also binds to and processes G:T mismatches, a relatively frequent 
product of base misincorporation of replicative DNA polymerases. In non-replicating cells, 
G:U and G:T mismatches mainly occur by deamination of cytosine and 5-methyl-cytosine, 
respectively, and therefore require a mismatch specific damage directed DNA glycosylase for 
non-mutagenic repair. Hence, the cell cycle regulation of TDG makes perfect biological 
sense. 
This work establishes a novel regulatory mechanism for DNA repair. The fact that the 
ubiquitin-proteasome system is involved in cell cycle controlled degradation of TDG suggests 
this pathway as an important coordinator of BER, especially of uracil repair. It will therefore 
be of interest, if other repair processes are also regulated in this way. 
 
5.4. A new regulatory mechanism for  DNA Polymerase β (Appendix V) 
 
This work established protein arginine methylation as a novel regulatory modification of 
DNA Pol β. The data shows a functional interaction of DNA Pol β with the protein arginine 
methyltransferase PRMT6 and an influence of the methylation on DNA binding and 
processivity of DNA Pol β in vitro, and on the DNA repair capacity of cells in vivo. Hence, 
methylation of DNA Pol β seems to be a biologically significant regulatory mechanism of DNA 
BER. Methylated DNA Pol β could more efficiently protect cells from DNA damage due to the 
higher affinity of the enzyme to DNA repair intermediates generated in BER. Furthermore, 
DNA Pol β-specific protein complexes could be stabilized or weakened due to methylation. 
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Another interesting question to be resolved will be, if PRMT6 interacts also with other BER 
proteins and if protein arginine methylation is more general regulatory mechanism in DNA 
repair.  
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ABSTRACT 
Electromagnetic fields in the extremely low frequency range (ELF-EMF) were reported to 
cause DNA fragmentation as inferred from “comet” analyses of human cell lines. These 
findings were heavily debated on the grounds of theoretical considerations but also because of 
the lack of reproducibility in replication studies. We revisited this issue with the aim to clarify 
some of the discrepancies and uncertainties associated with previous studies. We analysed 
DNA fragmentation using ELF-EMF exposure and comet assay conditions as well as human 
cell lines identical to those used in a previous study. We then expanded the study to include 
additional cell lines and to address possible confounder effects; i.e. cell proliferation and 
apoptosis as well as mode of comet analyses. We found that human primary fibroblasts but not 
HeLa cells show slightly but significantly increased DNA fragmentation in comet assays 
following 15 hours intermittent (but not continuous) exposure to 50 Hz EFL-EMF. This effect 
was apparent in proliferating cells but not in starvation-induced G1-arrested cultures, 
suggesting that processes in DNA replication may be targeted by the exposure. We did not 
find evidence for an ELF-EMF dependent induction of oxidative DNA base damage. In the cell 
line showing the highest ELF-EMF induced DNA fragmentation, however, ELF-EMF exposure 
slightly reduced the fraction of actively replicating cells while increasing the apoptotic fraction, 
and this effect contributed mildly to the comet tailfactor increase. Hence, our data confirm that 
ELF-EMF exposure can induce comet tailfactor increases in primary human fibroblasts, and 
these implicate increased steady-state levels of DNA strand-breaks. The data further suggest 
that these DNA breaks are unlikely due to ELF-EMF induced oxidative DNA damage but can 
be accounted for by the disturbance of S-phase processes and, marginally, by inductions of 
apoptosis. 
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INTRODUCTION 
During the past decades, the exposure of humans to extremely low frequency electromagnetic 
fields (ELF-EMFs) has grown considerably, mainly because of an ever increasing transmission 
and use of electric power at a frequency of 50 Hz in Europe. Consequently, public concern 
about adverse health impacts of ELF-EMFs, also directed to genetic integrity and cancer 
promotion, has been raising. Numerous investigations into biological effects of ELF-EMF 
exposure with epidemiological, molecular and biophysical approaches yielded inconsistent, 
sometimes conflicting, information. Conclusive evidence allowing an assessment of the risk of 
magnetic fields for human health has not been produced. Yet, epidemiology studies have 
correlated the exposure to EMFs of electric power lines with an increased incidence of 
childhood leukaemia (1-3) but not with other types of cancer (4,5). Since there is a well-
established relationship between radiation induced genotoxicity and carcinogenicity, it was 
hypothesized that ELF-EMFs, similar to ultraviolet light or ionizing radiation, may induce DNA 
damage with the mutagenic potential to increase the risk of carcinogenesis. Laboratory studies 
addressing genome integrity under ELF-EMF exposure conditions have been conducted in 
different model systems. These, however, produced inconsistent results, some revealing the 
occurrence of DNA aberrations under certain conditions (6-11), others not (12-15). However, 
the application of non-standardized exposure equipment and conditions as well as the use of 
different cell types or cell lines of different origin in these studies makes a direct comparison 
difficult. Additionally, the studies that produced positive results were heavily criticized with 
regard to conceptional and experimental shortcomings like the analysis method they used and 
the failure to exclude confounder effects from apoptosis or cell cycle changes (16). 
It seems counterintuitive that the energy transmitted with low frequency magnetic or 
electromagnetic fields is powerful enough to challenge the chemical integrity of the DNA, and it 
is generally accepted that ELF-EMFs do not damage DNA directly (17). Consequently, ELF-
EMFs are not considered direct genotoxic agents. Nevertheless, several hypotheses for how 
they might affect the DNA structure have been put forward. EMFs might influence DNA stability 
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by inducing secondary currents in the body (18) leading to a movement of electrons. If this 
happens in DNA, temporary guanine radicals may form that, upon reaction with water, will be 
converted to oxidative damage. Induction of electric currents in DNA was shown in vitro, using 
short dsDNA oligonucleotides (19,20), and electron migration was shown to occur over long 
distances, whereby guanines may act as electron sinks (21). Alternatively, it was proposed that 
EMFs may alter cellular processes that could indirectly affect DNA integrity or transactions 
(22,23). These include free radical production through an influence on the iron pool of the cell 
(24-26), modulation of enzymatic activities (27-29), acceleration of cellular proliferation (30-33), 
or perturbation of the cell cycle (34). 
The aim of this study was to revisit experiments by Ivancsits et. al. (11,35), which 
produced evidence for increased DNA strand breaks, micronuclei and chromosomal 
aberrations in cells intermittently exposed to 50 Hz ELF-EMF, and to expand the study to 
address some imminent conceptual, experimental, and mechanistic questions associated with 
these findings. Applying experimental conditions identical to those of Ivancsits et. al. (11), we 
were able to reproduce their finding of an ELF-EMF exposure dependent increase in the comet 
tail DNA, albeit at a lower level and with higher variability. This effect of DNA fragmentation 
was small but statistically significant and cell line dependent, implicating modulation by a 
genetic or physiological component. Our data further suggests that the impact of ELF-EMF 
exposure is unlikely due to reactive oxygen species (ROS) mediated induction of oxidative 
DNA damage but can be accounted for mainly by disturbance of S-phase associated 
processes and a small amount of apoptosis. 
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MATERIALS AND METHODS 
Cell lines and culture 
Human primary fibroblasts (ES-1, male, 6 years old; HR-1d, male, 42 years old) kindly 
provided by Prof. Rüdiger (Vienna) and HeLa cells were grown in Dulbecco´s modified Eagle´s 
medium (DMEM), supplemented with 10% FCS, 100 U/mL penicillin, 100 µg/mL streptomycin 
and 2 mM L-glutamine (Sigma-Aldrich, St. Louis, MO, USA). MRC-5 cells (human primary fetal 
lung fibroblasts) were grown in Minimum Essential Medium Eagle supplemented with 10% 
FCS, 2 mM L-glutamine, 100 U/mL penicillin, 100 µg/mL streptomycin and 1% Non-essential 
Amino Acids (Sigma-Aldrich). Cells were grown in 15-cm Petri dishes (Falcon 353025) at 37°C 
in a humified atmosphere containing 5% CO2 and were supplied with fresh medium every 48 h.  
24 h before exposure to EMF, cells were seeded into 10-cm Petri dishes (Falcon 
353003) to a confluency of about 30%. G1 blocked cells were obtained by culturing them in 
DMEM supplemented with 0.5% FCS (starving medium) for 48 h before as well as during 
exposure. In iron supplementation experiments, starving medium was supplemented with 
653.7 µg/L FeCl2. H2O2 treatment was done directly after harvesting of cells by centrifugation, 
keeping them in PBS supplemented with the indicated amounts of H2O2 on ice for 15 min. For 
cell survival experiments after ELF-EMF exposure, cells were cultured for 7 d, passaging them 
at day 2 after treatment. Finally, cells were counted with CASY Cell Counter (Model TT, 
Schärfe Systems GmbH, Reutlingen), according to the manufacturer’s instructions. 
 
ELF-EMF exposure 
The exposure system was built and provided by the Foundation for Information Technologies 
in Society (IT'IS foundation, Zurich, Switzerland), matching the one used in the comparative 
studies (11,35) . It is described in detail in (36). The setup consisted of two four-coil systems 
each of which was placed inside a µ-metal box chamber. The currents in the bi-filar coils could 
be switched parallel for field exposure or non-parallel for control (sham-exposure) and allowed 
magnetic fields up to 2.3 mT in the frequency range from DC to 1.5 kHz. Constant 
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environmental conditions (37°C, 5% CO2, 95% humidity) were ensured by two fans in both µ-
metal boxes and by placing them inside a commercial incubator (BBD 6220, Kendro). During 
exposure, the current of the coils and the temperature at the location of dishes was 
continuously monitored and data were stored in an encoded file. The temperature was 
maintained between 36.5 and 37.5°C and never exceeded 0.5°C difference between the two 
chambers. Except for sham-sham control, all exposure experiments were done under blind 
condition: the computer randomly determined which of the two chambers was exposed and 
decoding was done after analysis of the experiment by the IT’IS foundation.    
 
Comet assay 
Alkaline comet assay was performed basically as described by Singh et. al. (37). 104 cells 
were harvested and resuspended in 0.5% low melting point agarose (Cambrex) at 37°C. The 
cell/agarose suspension is laid onto microscope slides precoated with 1.5% normal melting 
point agarose (BioRad, Hercules, CA, USA), spread with a cover slip and let solidify for about 
15 min. Slides then were immersed in freshly prepared ice-cold lysis buffer (2.5 M NaCl, 100 
mM Na2EDTA, 10 mM Tris-HCl pH 10, 1% Triton X-100, 10% DMSO, pH 10) for 90 min, 
washed in ddH2O, drained and placed side by side in a gel electrophoresis tank. Slides were 
submerged with freshly made electrophoresis buffer (1 mM Na2EDTA, 300 mM NaOH, pH>13) 
and incubated for 30 min to allow DNA unwinding prior to electrophoresis at 25 V/ 300 mA for 
20 min. All steps after exposure were performed under dimmed light at 4°C. After 
electrophoresis slides were washed three times with 0.4 mM Tris-HCl pH 7.5 for 10 min, 
followed by fixation with EtOH absolute (2x 5 min) and air drying. Finally, nuclear DNA was 
stained with 20µg/mL ethidium bromide and analysed with a fluorescent microscope at 400x 
magnification. 
For the modified comet assay according to Pouget et. al.(38), the bacterial 
formamidopyrimidine DNA glycosylase (Fpg, New England BioLabs) was additionally added 
after cell lysis for 1 h. Slides were washed three times with 0.4 M Tris-HCl, pH 7.5 to remove 
 - 7 - 
remaining lysis buffer and twice with Fpg reaction buffer (20 mM Tris-HCl pH 8, 0.2 mg/mL 
BSA, 0.5 mM Na2EDTA, 0.1 M KCl, pH 8). Then 100 µL of either Fpg (0.04 U per slide in Fpg 
buffer) or Fpg buffer alone as control was laid on every slide. Cover slips were mounted and 
slides were incubated at 37°C for 45 min followed by DNA unwinding and electrophoresis as 
described above. 
 
Comet data collection and statistical analyses 
Data collection was done according to Anderson et. al. (39) with minor modifications by 
Ivancsits et.al. (11). For each individual exposure condition, two slides were subjected to the 
comet assay. Nuclei of 500 cells per slide were visually scored and classified into five 
categories corresponding to their amount of DNA in the tail (Figure 2c). Tailfactors (tf) were 
calculated with the following formula: tf (%) = ((A*F(A) + B*F(B) + C*F(C) + D*F(D) + 
E*F(E))/1000, where A is the number of cells classified to group A, F(A) the average of group 
A (2.5% of fragmented DNA), B the number of cells classified to group B, F(B) the average of 
group B (12.5%), C the number of cells classified to group C, F(C) the average of group C 
(30%), D the number of cells classified to group D, F(D) is the average of group D (67.5%), E 
the number of cells classified to group E, and F(E) the average of group E (97.5%). For 
automated comet analysis, slides were stained with Propidium Iodide and 100 cells per slide 
were analysed according to Frieauff et. al. (40), revealing tail moments (the product from tail 
length and % of DNA in tail). The two slides from each exposure condition were pooled.  
Each visually scored EMF exposure experiment was repeated 1-13 times and 
differences between sham and exposed cells were statistically analysed by the Student´s t-test 
applying it to percentage of cells in each category and to the tailfactors of all experimental 
replica. Additionally, the statistical significance of the difference between sham and exposed 
cells was tested by applying the chi-square test to the whole distribution of cells for each single 
experiment. The indicated numbers are mean p-values of all experiments. For automatically 
analyzed comet assays, the average and median tail moment of 100 nuclei per slide from 3 
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slides per condition of three independent experiments were calculated and statistically 
analyzed by the Student´s t-test. 
 
FACS analysis 
Propidium Iodide (PI) staining: 5x104 to 5x105 cells were harvested and fixed in cold 70% 
EtOH overnight (can be stored up to one week). Cells were collected by centrifugation with 800 
g for 5 min and resuspended in 300 µL RNase A (Qiagen, Venlo, The Netherlands  0.5 mg/mL 
in 0.1 M Tris-HCl pH 7.5, 0.1 M NaCl). After 30min incubation at 37°C, 300 µL pepsin (Fluka) 
was added (1 mg/mL in 0.4% HCl) and samples were incubated at 37°C for 15 min. 600 µL PI 
solution (20 µg/mL in PBS pH 7.4) was added followed by an incubation on ice for at least 30 
min. DNA content of cells was measured by a FACScan Cytometer (Beckton Dickinson) in the 
FL2 channel (575 nm). Raw data was quantitatively analysed for cell cycle phases (G1, S, G2 
and subG1) with the FlowJo analysing program (TreeStar, , Ashland, OR, USA). Statistics 
analysis was done by comparing percentage of cells in each cell cycle stage from sham and 
exposed cultures of 3-7 independent experiments with Student´s t-test. 
 Bromodeoxyuridin (BrdU) incorporation and staining: Replicating cells were labelled with 
10 µM BrdU within the last two hours of ELF-EMF exposure, then harvested and fixed in cold 
70% EtOH  overnight. Samples were centrifuged at 800 g for 5 min, resuspended in 2 M HCl 
and incubated at RT for 30 min, occasionally mixing. After centrifugation at 400 g for 15 min, 
they were washed in PBS-T (Phosphate buffered saline + 0.5% BSA + 0.2% Tween-20, pH 
7.4). 100 µL of 1:100 diluted FITC-labelled BrdU-antibody (Invitrogen, Carlsbad, CA, USA) was 
added and samples were incubated at RT for 45 min. After washing with PBS, samples were 
resuspended in 300 µL RNase A (Qiagen, 0.5 mg/mL in 0.1 M Tris-HCl pH 7.5, 0.1 M NaCl) 
and incubated at 37°C for 30min. 600 µL PI solution (20 µg/mL in PBS, pH 7.4) was added 
followed by an incubation on ice for at least 30min. Samples were analysed with FACS Cantoll 
Cytometer (Beckton Dickinson). The relative number of FITC-positive cells in exposed and 
sham replica was statistically analysed by the Student´s t-test. 
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Apoptosis measurement: 3x105 to 6x105 cells were harvested and resuspended in 30-
60 µL of Annexin-V labeling solution according to the manufacturer’s instruction (Annexin-V-
FLUOS staining kit, Roche; 2 µL PI and 1.4 µL Annexin-V-FITC per 100 µL incubation buffer). 
After incubation at RT for 15 min, 500 µL incubation buffer was added and samples were 
analysed for PI and FITC signals by the FACS Cantoll Cytometer (Beckton Dickinson). 
According to their fluorescence signals, cells were categorized into: living (FITC negative, PI 
negative), early apoptotic (FITC positive, PI negative), late apoptotic (FITC positive, PI 
positive) and necrotic (FITC negative, PI positive). Discrimination of the categories was done 
with non-stained and single-dye stained positive controls (MMS treated cells). The relative 
number of apoptotic cells (early + late) of replica were statistically analysed by the Student´s t-
test. 
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RESULTS 
Intermittent ELF-EMF exposure induces DNA fragmentation in primary human cells 
The ambiguous outcome of previous studies investigating the genotoxic impact of 50 Hz ELF-
EMFs on human cells prompted us to replicate key ELF-EMF exposure experiments, applying 
identical exposure conditions, cell lines, and comet assay procedures for DNA fragmentation 
analysis as published by Ivancsits et. al. (11). To start with, we thus measured possible DNA 
fragmentation by the comet assay, applying visual scoring (39), in four different cell lines: two 
human primary fibroblasts ES-1 and HR-1d (derived from a 6 years and 42 years old male, 
respectively), the primary fetal lung fibroblast cell line MRC-5 and the cervical carcinoma cell 
line HeLa. 
We exposed exponentially growing cells to a 50 Hz ELF-EMF at 1 mT for 15 hours. The field 
was alternating on for 5 min and off for 10 min because such intermittent exposure was shown 
to have the greatest impact in the comet assay (35). All experiments were done under strictly 
blinded conditions at least 2 times independently and in each experiment at least 400 cells on 
2 individual slides were scored. For all three primary human cell lines tested, we found a 
significant decrease in the fraction of cells falling into the comet stage A, representing 
undamaged nuclear DNA, and a corresponding increase in cells in one or more of the comet 
stages B to E, representing increasingly higher levels of DNA fragmentation (Figure 1A, 
Supplementary Table 1). By contrast, the ELF-EMF exposure did not change significantly the 
comet stage distribution of the HeLa cancer cells. Accordingly, the comparison of the relative 
distribution of cells in all comet stages by the chi-square test yielded significant differences 
between sham exposed and exposed cells for the primary fibroblast cell lines but not for the 
cancer cell line. Moreover, the comet tailfactors, a measure for the degree of DNA 
fragmentation in the population, were slightly but significantly increased by a factor of 1.6, 1.4 
and 1.7 in the human primary fibroblast HR-1d, ES-1 and MRC-5, respectively, but not so in 
HeLa cells. Note that in all three responding cell lines, stage E cells are significantly increased 
upon ELF-EMF exposure. Besides highly damages cells, stage E may contain apoptotic cells 
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at an early stage of DNA fragmentation (41). We also performed the continuous exposure 
experiments (50 Hz, 1 mT, 15 h) with the field on for the entire period of exposure (15 h). As 
observed before (11), this mode of exposure yielded no significant DNA fragmentation effects 
in the comet assay in all cell lines tested (Figure 1A). 
To exclude that the observed comet effects of ELF-EMF exposure originate from 
differences of the two exposure chambers, we performed sham-sham exposure experiments. 
When both ELF-EMF coils were set to sham exposure, differences in comet tailfactors and 
stage distribution disappeared for all cell lines (Figure 2A and data not shown), confirming that 
the comet effects measured upon ELF-EMF exposure are not due to chamber bias. To validate 
the visual scoring and staging of comets, we also performed fully automated comet analyses. 
For this purpose, HR-1d cells were intermittently (5’/10’) exposed to 50 Hz ELF-EMF at 1 mT 
for 15 h and analysed in parallel in comet assays with visual scoring and with fully automated 
analysis using a robotic system based on the Leitz MIAS image analysis system (40). Since 
the read-out of the two analyses, i.e. the tailfactor and the tail moment, are based on different 
scoring parameters and calculation algorithms, their absolute values are not directly 
comparable. However, the relative changes resulting from genotoxic insult should be similar. In 
these experiments, we measured a statistically significant 1.47-fold increased average 
tailfactor by the visual scoring method and an equally significant 1.33-fold increase of the 
median tail moment (1.58 fold average) in the automated analysis (Figure 2C). Our findings, 
thus, substantiate the previously reported increase of DNA fragmentation, as assessed by the 
comet assay, of human primary cell lines under intermittent ELF-EMF exposure. Controls that 
were not included in previous studies further establish that these comet effects are not due to a 
bias in the parallel exposure chambers or the visual scoring of comet events. Interestingly 
enough, this EMF effect is absent in an immortalized cell line and under continuous exposure 
of the same field strength (50 Hz, 1 mT for 15 h) in all tested cell lines. 
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Oxidative DNA damage by ELF-EMF exposure is unlikely the cause for the DNA 
fragmentation effect observed in comet assays 
Magnetic field exposure was proposed to affect the free radical pool in cells, leading to an 
increase of oxidative damage and, hence, to the observed DNA fragmentation (25). To test this 
hypothesis, we compared the comet effects resulting from the exposure of cells to ELF-EMF 
and to H2O2, in particularly stage distributions at doses producing similar tailfactor changes. As 
expected, exposure to the oxidizing agent H2O2 resulted in a dose dependent increase in the 
comet tailfactor in both HR-1d and HeLa cells, although more pronounced in the primary cell 
line HR-1d (Figure 2B). When treated with 150 µM H2O2, most of the HR-1d cells produced 
stage E comets, most likely reflecting early apoptotic responses of cells. Apoptosis is impaired 
in the p53 deficient immortalized HeLa cell line, and this might explain the absence of stage E 
comets in this cells line.  The relative increase of tailfactors after ELF-EMF exposure in the 
HR-1d cell line (1.6) best matches that of a 10 µM H2O2 treatment (1.3) (Figure 1A and Figure 
2B). In terms of comet stage distribution, however, the two treatments differ significantly: 10 
µM H2O2 increases almost exclusively stage B comets, indicating a relatively high number of 
cells with low amounts of damage, while ELF-EMF exposure mainly affects stages C and E, 
representing a smaller cell population with high amounts of damage or apoptosis. 
 To address the proposed involvement of oxidative DNA damage in ELF-EMF dependent 
comet effects from another angle, we combined the comet assay with a treatment with a 
bacterial purine glycosylase (Fpg), which excises a variety of oxidized guanine lesions 
including 8-oxo-G, the predominant form of oxidative DNA damage (38). This allows 
visualization of transiently unrepaired damage to purine bases that is otherwise not detectable 
in the comet assay. We first generated oxidative DNA damage using 10 µM H2O2 and found a 
1.7-fold increase of the comet tailfactor with the Fpg treatment (Figure 3). This shows that 
unrepaired oxidative purine damage exists following treatment of cells with doses of H2O2, that 
generate a comet tailfactor change comparable to that of 15 hours intermittent ELF-EMF 
exposure at 1 mT. We thus performed the Fpg comet assay after ELF-EMF exposure and 
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observed a relative increase of the tailfactor by 1.3-fold compared to the sham control. This 
increase is not different from 1.4-fold measured in the comet assay without Fpg (Figure 3). The 
data therefore suggests that the amount of unrepaired oxidative DNA damage in ELF-EMF 
exposed cells is not higher than in sham controls. So, if EMF exposure induces oxidative DNA 
damage, it must be below the detection limit of our assay, meaning that it does not contribute 
to the comet tailfactor changes observed. Altogether, these data do not support the hypothesis 
of increased oxidative DNA damage due to ELF-EMF exposure. 
 
DNA fragmentation upon ELF-EMF appears in proliferating cells only 
Replicating cells naturally contribute to the comet tailfactor, because they harbour DNA 
fragments at replication forks, which migrate into the tail (42). S-phase cells are also 
particularly sensitive to DNA damage, mainly due to the increased vulnerability of the DNA 
while it is being replicated. Hence, to address the role of DNA replication in the ELF-EMF 
induced comet tailfactor changes, we examined cells synchronized in G1 of the cell cycle. To 
exclude secondary effects of cell cycle blocking agents on DNA metabolism, we used serum 
starvation with 0.5% FCS to enrich for cells in G1. Comparing cycling and serum starved cells, 
the G1-phase population of HR-1d and ES-1 primary fibroblast cells increased from about 75% 
and 70% to about 90% and 80%, respectively, an the S-phase fractions dropped from 11.5% 
to 1.6% and from 11.5% to 2.6% respectively (compare Figures 4A and 5A). While maintaining 
the cells in G1-phase, they were intermittently exposed to an ELF-EMF of 50 Hz, 1 mT for 15 h 
and subsequently analysed for DNA fragmentation by comet assays. For both cell lines, we did 
not find significant changes under EMF exposure, neither for the tailfactor nor in the relative 
distribution of cells into comet stages (Figure 4B). Hence, unlike asynchronous cultures of HR-
1d and ES-1 cells (Figure 1A), G1-arrested cultures do not show ELF-EMF induced DNA 
fragmentation in the comet assay anymore, suggesting that the EMF affects predominantly 
replicating cells. 
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The synchronisation of cells in G1-phase by serum starvation, however, goes together with 
lowering the iron concentration of the medium. To rule out that the loss of DNA fragmentation 
following serum starvation is accounted for by the iron depletion, we supplemented serum-
starved HR-1d cells with iron concentrations typically present in full FCS medium. In the iron 
supplemented G1-arrested cultures, we measured increased DNA fragmentation in the comet 
assay compared to non-supplementation cultures. ELF-EMF exposure however, did not 
produce a significant comet tailfactor or stage changes in the iron supplemented culture 
(Supplementary Figure 2). It was not possible here to do a complementary approach using an 
iron chelator in FCS rich medium, because these compounds interfere with cell cycle 
progression (43,44). We therefore conclude that cycling of the cells is necessary to produce 
the comet effect of the electromagnetic field. 
 
ELF-EMF exposure slightly alters cell cycle profiles 
Our data show that ELF-EMF exposure induces DNA fragmentation in replicating cells only. 
Because unwound DNA at replication forks also migrates into the comet tail (42), we reasoned 
that the small effects of EMFs might in fact reflect an accumulation of exposed cells in S-
phase. Therefore, we assessed the cell cycle distribution of asynchronous ES-1 and HR-1d 
cultures after ELF-EMF exposure (50 Hz, 1 mT, intermittent for15h) by FACS analysis of PI-
stained cells. We did not measure notable difference in G1, S, and G2 populations between 
exposed and sham-exposed cells (Figure 5A). However, we noticed a small but still not 
significant increase in the subG1 population for both fibroblast cell lines, indicating that the 
fraction of apoptotic cells might increase during exposure. 
We then used BrdU incorporation to directly monitor DNA synthesis during the last 2 
hours of ELF-EMF exposure (50 Hz, 1 mT, intermittent for15h). In both fibroblast lines tested, 
the fraction of BrdU incorporating cells was slightly reduced but the reduction was statistically 
significant only for HR-1d, the cell line showing slightly higher DNA fragmentation in the comet 
assay following ELF-EMF exposure (Figure 5B). Although only about 1% of cells are 
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concerned, these data may indicate that a proportion of cells under EMF exposure have 
difficulties to enter S-phase, to initiate efficient DNA replication. 
 
Apoptosis contributes to the increase of comet tail DNA following ELF-EMF exposure 
We observed that ELF-EMF exposure (50 Hz, 1 mT, intermittent for15h) of the human 
fibroblast cell lines causes a small increase of the fraction of cells with a subG1 content of 
nuclear DNA (Figure 5A) as well as an increase in stage E comets (Figure 1A), representing 
cells with highly fragmented DNA. Because early stages of apoptotic DNA fragmentation are 
detectable as highly damaged cells in comet assays (45), the two findings might indicate that 
ELF-EMF exposure indeed induces apoptosis in a small fraction of cells. We addressed the 
question directly by Annexin-V and PI co-staining of cells following ELF-EMF exposure. 
Annexin-V binds to phosphatidylserine, which is externalized to the outer leaflet of the (still 
intact) plasma membrane early in apoptosis, preceding DNA fragmentation (46). Hence, flow 
cytometric analysis of these cells allows intact, early- and late apoptotic, and necrotic cells to 
be distinguished from each other. For ES-1 cells, we found only an insignificant increase of 
apoptotic cells (early apoptotic (Annexin-V positive, PI negative) plus late apoptotic (Annexin-V 
positive, PI positive) cells) following ELF-EMF exposure, while the apoptotic fraction in the HR-
1d cell line was significantly increased by about 1.5% (Figure 5C). This is a small fraction but 
nevertheless contributes to stage E comet events (1.5% of 2.4% cells in comet stage E) arising 
in the ELF-EMF exposed HR-1d population. 
 Since we detected a small increase of apoptotic cells shortly after exposure to EMF, we 
also investigated possible long-term effects on cell survival and proliferation. For ES-1 and HR-
1d cells, we counted the number of cells before, directly after and 24, 48, 72, 96 hours and 7 
days after intermitted exposure to ELF-EMF of 50Hz, 1 mT for 15 h. There was no statistically 
significant difference between sham and exposed cells for both cell lines at any time point 
(Supplementary Figure 1). We conclude that exposure to ELF-EMF may provoke apoptosis in 
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some cells, and this accounts partially for the comet tailfactor increases observed. Further cell 
death or proliferation arrest upon prolonged culturing following exposure is not observed. 
 
DISCUSSION 
Whether or not ELF-EMFs affect genome integrity in human cells is heavily debated in the 
scientific community as well as in the public, largely provoked by the conflicting experimental 
evidence available. Discrepant observations in different studies are difficult to interpret, mainly 
due the lack of standardized experimental procedures, making direct comparisons generally 
difficult. The aim of this work was therefore to replicate a previous study by Ivancsits et. al (35), 
the results of which revealed increased DNA fragmentation in a comet assay with ELF-EMF 
exposed human primary fibroblasts. Using an identical primary human fibroblast cell line (ES-
1), identical ELF-EMF exposure equipment and conditions (intermittent, 50 Hz, 1 mT, 15 h), 
and identical comet assay procedures, we were able to independently reproduce evidence for 
increased DNA fragmentation. We observed increased levels of comet tail DNA under 
intermittent but not under continuous EMF exposure. Generally, our comet effects were less 
pronounced and more variable than those reported previously but the differences between 
exposed and sham-exposed cultures were nevertheless statistically significant. 
Exactly why the ELF-EMF induced comet effects depend on intermittent exposure 
remains unclear. We tested the hypothesis that cells adapt to the field under continuous 
exposure. The results from an experiment with pre-exposed cells, however, indicate that 
adaptation does not occur. Regardless the reason, the absence of an increase in DNA 
fragmentation under continuous exposure clearly excludes thermal effects as cause. 
Increased DNA breaks were found in two additional human primary fibroblast cell lines 
(HR-1d and MRC-5), which excludes a cell line-specific response to ELF-EMF exposure. It 
appears that a fibroblast cell line originating from an older donor is more susceptible to the 
EMF than one from a younger donor, being in line with an age of donor-dependent EMF 
response previously observed (47). In contrast to the primary fibroblasts, the cancer cell line 
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HeLa does not show an increase in comet tail DNA under EMF exposure. This could be due to 
acquired physiological or genetic features such as increased repair capacities or the loss of 
apoptosis. 
Apoptotic cells indeed seem to contribute to the comet tailfactor increases observed 
under ELF-EMF exposure. The proportion of apoptotic cells rises from about 3% to 4.5% in the 
highly responsive HR-1d line under ELF-EMF exposure and the cell cycle profiles of exposed 
cells revealed a slightly increased subG1 population, presumably reflecting apoptotic or 
necrotic cells with a reduced DNA content. Supporting our findings, other studies reported 
more apoptosis (48-50) or altered expression of apoptosis-related genes like bcl-2, bax and c-
myc (51) after exposure to 50 Hz ELF-EMFs. But other studies did not find evidence for a 
direct effect of ELF-EMFs on apoptosis (52). Our results thus suggest that the increased DNA 
fragmentation of EMF responsive cells is partially due to the induction of apoptosis also 
explaining why immortalized cell lines like HeLa do not respond the same way as primary cells 
do. A contribution of apoptosis is also congruent with the relative changes in comet stages 
observed under exposure. The most pronounced increase is found for comet stage E, 
representing fragmented nuclear DNA, into which also apoptotic cells would be assigned to. In 
the HR-1d cell line, 2.4% increase in stage E is found and Annexin-V staining reveals, that 
1.5% of them could be apoptotic cells. 
Previous studies were criticized for the lack of a sham-sham control, or the visual 
scoring of the comets. Our sham-sham control shows that the exposure setup does not 
generate an experimental bias (e.g. intrinsic difference between the coils), hence, the comet 
effects measured under exposure depend on the EMF applied. Also, fully automated comet 
evaluation following ELF-EMF exposure reproduces a comet tail moment increase for the HR-
1d cell line in a range similar to the visual scoring. Hence, visual comet scoring in our hands 
did not introduce an experimental bias, and the same was found previously (53-55). We 
nevertheless decided to use visual scoring because this method allows a higher number of 
cells to be analyzed (1000 compared to about 50-100) per experiment, which provides a better 
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statistical representation of the relatively small numbers of damaged cells and allows a direct 
assessment of the type of biological responses involved on the basis of patterns of comet 
stage changes. 
Apoptosis could be induced by a critical amount of DNA damage saturating the cellular 
repair capacity. Although the energy deposited by ELF-EMFs is not sufficient to directly 
damage DNA, it was proposed that the field might enhance levels of bio-molecular or free 
radicals in cells and, thereby, indirectly provoke increased formation of oxidative DNA damage 
(24-26). EMF-induced radicals would be expected to randomly damage the cellular DNA and, 
thus, to lead to a gradual and dose-dependent shift of comet stages towards more DNA 
fragmentation. This is what we observed upon exposure of cells to H2O2, a well characterized 
oxidizing agent, but not upon ELF-EMF exposure, which typically induced a disproportional 
increase of comet stage E nuclei at comparable comet tailfactor effects. This difference 
suggests that the DNA directed effects of H2O2 and EMF exposure are of a different nature. In 
the same context, we also investigated the accumulation of unrepaired oxidative DNA damage 
making use of the combined Fpg comet assay, which processes the most prevalent oxidative 
base lesions into DNA strand breaks (38). Fpg pre-digestion did show the expected sensitivity 
enhancement of the comet assay, but no specific increase of the ELF-EMF induced effect. 
These data cannot definitely rule out the generation of a small amount oxidative DNA damage 
upon ELF-EMF exposure, but they argue strongly against a major contribution of such 
damage. However, others found that radical scavengers reduced ELF-EMF effects on DNA 
migration in the comet assay (56). This discrepancy might be due to cell type-specific 
responses or to influences of scavengers on cellular mechanisms such as cell cycle 
progression.  
EMFs were previously shown to affect the cell cycle, both in an inhibitory (57,58) and in 
a stimulatory way (31,33). A slight accumulation of S-phase cells upon ELF-EMF exposure 
could account for the increase of the comet tailfactor observed. We could not detect any 
significant differences in the cell cycle profiles of sham and field-exposed cells. The number of 
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cells actively synthesizing DNA during the last two hours of exposure, however, was slightly 
reduced, indicating that a fraction of cells is either disturbed in entering S-phase or in 
replicating DNA. Interestingly, this reduction correlated with the magnitude of the ELF-EMF 
induced comet effect. We therefore conclude that an accumulation of S-phase cells under field 
exposure does not account for the increased comet tailfactor. On the other hand, G1 arrested 
cultures do not show the comet effect, and the loss of the effect correlates with the reduction of 
S-phase cells. This clearly suggests that it is the S-phase fraction of cells that is responsible 
for the comet tailfactor increase. This may, at least partially, explain the varying outcomes in 
different studies, as the fraction of S-phase cells in a population is determined by the culture 
conditions and the cell lines used, and these parameters may vary between laboratories. For 
instance, the previously reported dependency of EMF effects on the cellular iron pool, which 
we did not observe in our experiments, might be due to the use of iron-chelators, which are 
known to induce G1 arrests. 
 In conclusion, we confirmed the previously reported increase in nuclear DNA 
fragmentation in comet assays upon exposure of cells to ELF-EMFs. For the primary human 
fibroblasts analyzed here, this genotoxic effect depends on cell proliferation, most likely the 
passage of cells through S-phase, rather than on radical mediated induction of oxidative DNA 
damage. Direct DNA damage induction by EMFs seems unlikely but cannot be ruled out 
definitely at this point. Our data suggests that cells entering S-phase under EMF exposure may 
encounter replication problems, which might increase the steady-state level of DNA 
fragmentation and eventually lead to the induction of apoptosis. Both would then contribute to 
an increased comet tailfactor. Exactly why ELF-EMFs affect S-phase cells more than non-
replicating cells remains speculative. It is possible though that the efficiency of enzymatic DNA 
transactions that occur during S-phase is slightly affected, which altogether increases the 
number of DNA replication and repair intermediates that will be scored as DNA fragmentation 
events in the comet assay.  
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FIGURE LEGENDS  
 
Figure 1. Intermittent ELF-EMF exposure results in an increased DNA fragmentation in primary 
human cell lines. HR-1d, ES-1, MRC-5 and HeLa cells were intermittently (5 min on / 10 min 
off) (A) or continuously (B) exposed to EMFs of 50 Hz, 1 mT, for 15 h. Nuclear DNA 
fragmentation was analysed with the alkaline comet assay and visual scoring. Each nucleus 
was assigned to comet stages A-E: stage A represents cells without DNA migration into the tail 
and stages B-E cells with increasing amounts of DNA in tail and tail length (see Figure 2C). 
The percentages of cells in comet stages A-E are displayed and statistically analysed. (n) is 
the number of experiments, error bars indicate standard errors of the mean and asterisks 
represent the significance levels of Student´s t-test comparing individual comet stage 
categories (* p<0.05; ** p<0.01; *** p <0.005). The horizontal line and p(c) show the mean 
significance of the chi-square tests analysing the comet stage distribution of sham and EMF-
exposed nuclei of individual experiments. The upper right boxes show the mean tailfactor 
values for sham and exposed cells as well as the significance level of the Student´s t-test on 
the tailfactors (p(s)).  
 
Figure 2. Control experiments for exposure equipment, data evaluation and DNA 
fragmentation by oxidative DNA damage confirm the impact of ELF-EMF exposure on genome 
integrity. (A) Alkaline comet assay of HR-1d and ES-1 fibroblasts after sham exposure in both 
coils with a 50 Hz, 1 mT intermittent (5/10) exposure for 15 h, comet stage distribution (stages 
A-E) and corresponding standard errors of the mean for coil 1 and coil 2. The upper right 
boxes contain mean tailfactor values for coil1 and coil2 cells and the significance level of the 
tailfactors by Student´s t-test (p(s)).  The horizontal bar and p(c) show the mean significance of 
the chi-square tests analysing the comet stage distribution of sham and EMF-exposed nuclei 
of individual experiments. (B) HR-1d and HeLa cells were exposed to increasing 
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concentrations of H2O2, which induces oxidative DNA damage, and the extend of DNA 
fragmentation was analysed by the alkaline comet assay. For the indicated H2O2 
concentration, the percentages of cells in comet stages A-E are displayed and the mean 
tailfactor values are indicated in the upper right box. Error bars indicated the SEM of (n) 
experiments.  (C) Visual and automated data analysis of alkaline comet assays were directly 
compared in HR-1d cells, intermittently exposed to an ELF-EMF of 50 Hz and 1 mT for 15 h. 
Cells of three independent experiments were analysed with a computer based fully automated 
analysis to obtain tail moments (right panels) and with the manual analysis used for the other 
experiments by assigning nuclei into the five different comet stages A-E and calculating 
tailfactors (left panels). Asterisks represent significance levels of the Student´s t-test applied on 
the tailfactor and tail moment of replica: * p<0.05; ** p<0.01; *** p <0.005.  
 
Figure 3. DNA fragmentation under EMF exposure condition is not caused by oxidative 
damage. HR-1d cells exposed to 50 Hz, 1 mT intermittent (5/10) ELF-EMF for 15 h were 
analysed for their tailfactors of standard (control) or of the modified alkaline comet assay (Fpg) 
including an enzymatic DNA nicking step at sites of unrepaired oxidative damage by the 
bacterial 8-oxoG glycosylase Fpg. Error bars indicate SEM. The mean tailfactors of two 
independent experiments were statistically analysed by the Student’s t-test. As positive control, 
cells treated with 10 µM H2O2 were included.  
 
Figure 4. Increased DNA fragmentation upon ELF-EMF exposure is detectable in proliferating 
cell only. The human primary fibroblast cell lines HR-1d and ES-1 were arrested in G1 phase 
by serum starvation prior and during exposure to an intermittent ELF-EMF of 50 Hz, 1 mT for 
15 h. Cells were harvested and subjected to cell cycle analysis by flow cytometry of propidium 
iodide-stained nuclei (A) as well as to DNA fragmentation analysis by the comet assay (B). (A) 
Cell cycle profiles of PI-stained cells after ELF-EMF exposure. Mean percentage of cells in the 
 - 30 - 
different phases of the cell cycle with SEM. (B) Alkaline comet assay: each nucleus was 
assigned to comet stages A-E: stage A represents cells without DNA migration into the tail and 
stages B-E cells with increasing amounts of DNA in tail and tail length (see Figure 2C). The 
percentages of cells in comet stages A-E are displayed and statistically analysed. (n) is the 
number of experiments, error bars indicate standard errors of the mean. The horizontal bar 
and p(c) show the mean significance of the chi-square tests analysing the comet stage 
distribution of sham and EMF-exposed nuclei of individual experiments. The upper right boxes 
show the mean tailfactor values for sham and exposed cells as well as the significance level of 
the Student´s t-test on the tailfactors (p(s)).  
 
Figure 5. A slight reduction of DNA synthesis in S-phase and an increase of the apoptotic 
fraction are observed in a human fibroblast cell line. HR-1d and ES-1 cells were exposed to 50 
Hz, 1 mT intermittent (5/10) ELF-EMF for 15 h, stained for the respective molecular markers 
and analysed for the cell cycle profile, DNA synthesis and apoptotic index. (A) Cell cycle 
profiles of PI-stained cells after ELF-EMF exposure. Mean percentage of cells in the different 
cell cycle phases with SEM. (B) Relative number of cells with BrdU incorporation during the 
last two hours of ELF-EMF exposure. Mean percentage of BrdU positive cells with SEM and p-
value of Student´s t-test are shown. (C) The percentage of apoptotic cells (Annexin-V positive 
cells, Q2+Q4) after ELF-EMF exposure of HR-1d and ES-1 cells (left panel). Representative 
pictures of FACS-sorted cells stained with PI and FITC-Annexin-V after sham- or EMF-
exposure or MMS-treatment as positive control (right panel). Cells in quadrant 4 (Q4, FITC 
positive) are recognized as early apoptotic, cells in Q2 (FITC/PI positive) as late apoptotic and 
PI-only cells (Q1) as necrotic, while cells in Q3 (double negative) are living cells. Cells in Q2 
and Q4 were counted together as apoptotic cells. Results are presented as average 
percentage of Q2+Q4 cells. Statistical analysis was done by Student´s t-test. 
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Supplementary Figure 1. Cell survival and proliferation after ELF-EMF exposure is not altered. 
HR-1d and ES-1 cells were exposed to intermittent ELF-EMF of 50 Hz, 1 mT for 15 h and cell 
proliferation was followed over time. Relative cell numbers were calculated by normalization to 
cell number prior to exposure. Shown are relative cell numbers t0 (directly before exposure) 
with standard errors.  
 
Supplementary Figure 2. DNA fragmentation induced by the exposure to ELF-EMF depends 
on cell cycling but not on presence of iron. HR-1d cells were serum starved for 48h before and 
during 15h intermittent (5/10) ELF exposure including iron supplementation. After harvest they 
were analysed by alkaline comet assay and assigned to comet stages A-E: stage A represents 
cells without DNA migration into the tail and stages B-E cells with increasing amounts of DNA 
in tail and tail length (see Figure 2C). The percentages of cells in comet stages A-E are 
displayed and statistically analysed. (n) is the number of experiments, error bars indicate 
standard errors of the mean. The horizontal bar and p(c) show the mean significance of the 
chi-square tests analysing the comet stage distribution of sham and EMF-exposed nuclei of 
individual experiments. The upper right boxes show the mean tailfactor values for sham and 
exposed cells as well as the significance level of the Student´s t-test on the tailfactors (p(s)). 
0
1 0
2 0
3 0
4 0
5 0
6 0
7 0
8 0
9 0
1 0 0
A B C D E
co m e t s ta g e
%
 
ce
lls
0
10
20
30
40
50
60
70
80
90
100
A B C D E
com et s tage
%
 
ce
lls
0
10
20
30
40
50
60
70
80
90
100
A B C D E
com et s ta ge
%
 
ce
lls
Focke et. al., Figure 1
MRC-5
0
1 0
2 0
3 0
4 0
5 0
6 0
7 0
8 0
9 0
1 0 0
A B C D E
co m e t s ta g e
%
 
ce
lls
0
1 0
2 0
3 0
4 0
5 0
6 0
7 0
8 0
9 0
1 0 0
A B C D E
c o m e t s ta g e
%
 
ce
lls
0
1 0
2 0
3 0
4 0
5 0
6 0
7 0
8 0
9 0
10 0
A B C D E
com e t s tag e
%
 
ce
lls
0
1 0
2 0
3 0
4 0
5 0
6 0
7 0
8 0
9 0
10 0
A B C D E
com e t s tage
%
 
ce
lls
0
10
20
30
40
50
60
70
80
90
1 00
A B C D E
co m et s ta ge
%
 
ce
lls
ES-1
HeLa
HR-1d
intermittent continuous
sham: 6.6
exp: 9.2
p(s) = 0.001
p(c) = 0.031
sham: 11.5
exp: 12.9
p(s) = 0.716
p(c) = 0.313
sham: 7.9
exp: 7.5
p(s) = 0.178
p(c) = 0.360
sham: 9.2
exp: 15.5
p(s) = 0.016
p(c) < 0.001
sham: 6.7
exp: 8.6
p(s) = 0.070
p(c) = 0.178
sham: 16.3
exp: 18.5
p(s) = 0.441
p(c) = 0.185
sham: 10.6
exp: 9.6
p(c) = 0.331
p(c) = 0.017
sham: 7.1
exp: 11.0
p(s) = 0.001
n = 13
n = 11
n = 3
n = 4
n = 3
n = 4
n = 3
n = 1
A B
AB
C
D
E
A B
C
0
1 0
2 0
3 0
4 0
5 0
6 0
7 0
8 0
9 0
1 0 0
A B C D E
c o m e t s ta g e
%
 
ce
lls
0
1 0
2 0
3 0
4 0
5 0
6 0
7 0
8 0
9 0
1 0 0
A B C D E
co m e t s ta g e
%
 
ce
lls
HR-1d
coil 1: 10.5
coil 2: 10.7
p(s) = 0.907
coil 1: 10.9
coil 2: 10.0
p(s) = 0.093
p(c) = 0.101
p(c) = 0.326
ES-1
n = 3
n = 3
%
 
ce
lls
0
1 0
2 0
3 0
4 0
5 0
6 0
7 0
8 0
9 0
1 0 0
A B C D E
co m e t s ta g e
%
 
ce
lls
co n tro l: 7 .4
1 0 µ M : 9 .4  
 5 0 µ M : 2 7 .1  
1 0 0 µ M : 4 3 .1  
1 5 0 µ M : 9 6 .7  
0
1 0
2 0
3 0
4 0
5 0
6 0
7 0
8 0
9 0
10 0
A B C D E
com et s tag e
%
 
ce
lls
co n tro l: 11 .2
10 µ M : 1 4 .6
50 µ M : 1 7 .7  
10 0 µ M : 1 9 .1  
HR-1d
HeLa
n = 2
n = 1
0
1
2
3
4
5
6
7
8
9
10
11
tail factor average tail moment
average
tail moment
median
∆ = 1.47x
∆ = 1.33x∆ = 1.58x
n = 3
tailfactor 
average
sham
exposed
Focke et. al., Figure 2
010
20
30
40
50
control Fpg
ta
ilfa
ct
or
sham
exp
10µM H2O2
n = 2
∆ = 1.40x
∆ = 1.30x
Focke et. al., Figure 3
0
1 0
2 0
3 0
4 0
5 0
6 0
7 0
8 0
9 0
1 0 0
G 1 S  G 2 <  G 1  
%
 
ce
lls
0
10
20
30
40
50
60
70
80
90
1 00
A B C D E
com et s tag e
%
 
ce
lls
A B
0
10
20
30
40
50
60
70
80
90
1 00
G 1 S  G 2 <  G 1  
%
 c
e
lls
HR-1d
ES-1
n = 3
n = 3
HR-1d
0
10
20
30
40
50
60
70
80
90
1 00
A B C D E
com e t s tag e
%
 
ce
lls
sham: 5.5
exp: 6.0
p(s) = 0.154
sham: 5.5
exp: 6.0
p(s) = 0.151
p(c) = 0.149
p(c) = 0.195
n = 3
n = 3
ES-1
sham
exposed
sham
exposed
Focke et. al., Figure 4
1 0
1 0 .5
1 1
1 1 .5
1 2
1 2 .5
1 3
1 3 .5
1 4
1 4 .5
H R -1 d E S -1
%
 
ce
lls
A
C
0
10
20
30
40
50
60
70
80
90
100
G 1 S  G 2  <  G 1  
%
 
ce
lls
0
1 0
2 0
3 0
4 0
5 0
6 0
7 0
8 0
9 0
10 0
G 1 S G 2 <  G 1  
%
 
ce
lls
ES-1
n = 5
HR-1d
n = 7
n = 4
lo
g 
Br
dU
PI
0 .0
0 .5
1 .0
1 .5
2 .0
2 .5
3 .0
3 .5
4 .0
4 .5
5 .0
H r-1 d E S -1
%
 
ce
lls
MMSsham exposed
n = 4
lo
g 
PI
log Annexin V
lo
g 
PI
lo
g 
PI
log Annexin Vlog Annexin V
sham
exposed
sham
exposed
sham
exposed
sham
exposed
Focke et. al., Figure 5
B
0
2
4
6
8
10
12
14
16
18
-15 0 24 48 72 96 7d
hours
re
la
tiv
e
 
n
u
m
be
r 
o
f c
e
lls
 
 
sham
 exp
0
2
4
6
8
10
12
14
16
18
-15 0 24 48 72 96 7d
hours
re
la
tiv
e
 
n
u
m
be
r 
o
f c
e
lls
 
 
sham
exp
ES-1HR-1d
n = 4n = 5
Focke et. al., supplementary Figure 1
re
la
tiv
e
 
n
u
m
be
r 
o
f c
e
lls
re
la
tiv
e
 
n
u
m
be
r 
o
f c
e
lls
HR-1d
p(c) = 0.051
n = 3
sham: 13.4
exp: 14.6
p(s) = 0.254
Focke et. al., supplementary Figure 2
0
10
20
30
40
50
60
70
80
90
1 00
A B C D E
co m e t s ta g e
%
 
c
e
lls
%
 
ce
lls
A B C D E total
tailfact
or
HR-1d
1 sham 847 131 33 13 32 1056 8.3
exposed 657 178 62 18 90 1005 15.6
2 sham 971 42 5 1 4 1023 3.5
exposed 1079 115 23 13 51 1281 8.3
3 sham 628 106 39 26 26 825 10.1
exposed 251 44 32 34 31 392 19.0
4 sham 365 67 10 10 27 479 11.2
exposed 631 118 88 23 155 1015 22.0
5 sham 738 42 18 3 0 801 3.9
exposed 700 58 35 3 4 800 5.1
6 sham 844 109 29 14 5 1001 5.8
exposed 931 113 54 16 10 1124 6.6
7 sham 781 149 40 14 18 1002 7.7
exposed 712 163 110 70 12 1067 12.2
8 sham 1173 194 83 31 19 1500 7.9
exposed 1144 209 106 62 42 1563 10.8
9 sham 1351 117 39 3 2 1512 4.2
exposed 1266 204 19 7 7 1503 5.0
10 sham 800 113 42 55 5 1015 8.7
exposed 803 117 46 55 26 1047 10.6
11 sham 823 105 44 33 5 1010 7.3
exposed 807 96 147 31 22 1103 10.8
12 sham 777 159 31 26 11 1004 7.7
exposed 736 186 55 23 21 1021 9.2
13 sham 854 103 24 12 9 1002 5.8
exposed 902 130 40 16 25 1113 7.7
Focke et. al., supplementary Table 1:
comet stage scores intermittent exposure
ES-1
1 sham 1081 80 4 1 1 1167 3.4
exposed 951 100 19 7 7 1084 4.9
2 sham 695 151 44 49 25 964 11.1
exposed 455 121 55 32 45 708 15.3
3 sham 872 60 17 16 39 1004 8.3
exposed 687 123 73 35 59 977 13.9
4 sham 765 156 41 14 25 1001 8.5
exposed 569 162 52 23 49 855 13.3
5 sham 897 78 16 4 6 1001 4.5
exposed 768 88 25 6 15 902 6.3
6 sham 467 24 16 0 3 510 4.4
exposed 501 73 22 5 9 610 6.6
7 sham 933 45 21 3 12 1014 4.8
exposed 904 66 24 8 8 1010 5.1
8 sham 745 135 146 16 25 1067 10.7
exposed 729 191 215 43 18 1196 12.8
9 sham 947 109 55 14 1 1126 5.7
exposed 807 72 50 36 12 977 8.2
10 sham 703 53 37 4 3 800 5.1
exposed 711 35 42 9 5 802 5.7
11 sham 426 36 32 4 2 500 5.9
exposed 405 36 36 7 13 497 8.6
Focke et. al., supplementary Table 1:
comet stage scores intermittent exposure
MRC-5 
1 sham 971 101 14 5 2 1093 4.2
exposed 794 134 48 18 38 1032 9.7
2 sham 456 90 20 28 25 619 11.6
exposed 385 73 38 43 37 576 16.5
3 sham 543 110 117 43 36 849 14.9
exposed 428 119 96 53 67 763 20.4
HeLa
1 sham 952 128 10 3 8 1101 4.8
exposed 899 118 15 9 18 1059 6.2
2 sham 686 204 37 11 59 997 11.9
exposed 767 210 46 19 59 1101 11.8
3 sham 844 116 21 10 9 1000 5.7
exposed 778 182 24 10 16 1010 7.1
4 sham 481 95 21 1 12 610 7.0
exposed 367 100 21 8 14 510 9.2
Focke et. al., supplementary Table 1:
comet stage scores intermittent exposure
A B C D E total
tailfac
tor
HR-1d
1 sham 790 137 44 22 21 1014 8.4
exposed 499 73 27 27 51 677 14.4
2 sham 854 46 29 40 153 1122 18.9
exposed 791 57 28 18 127 1021 16.8
3 sham 781 120 35 18 15 969 7.4
exposed 774 108 41 19 14 956 7.5
ES-1
1 sham 918 113 23 29 20 1103 7.5
exposed 883 114 37 19 33 1086 8.5
2 sham 890 44 13 7 88 1042 11.7
exposed 931 66 10 18 72 1097 10.7
3 sham 805 23 13 22 37 900 8.6
exposed 815 18 23 16 38 910 8.5
4 sham 939 53 7 1 5 1005 3.8
exposed 931 56 8 1 4 1000 3.7
MRC-5
1 sham 508 68 49 7 106 738 19.5
exposed 690 98 48 10 155 1001 20.2
2 sham 710 76 48 19 159 1012 20.7
exposed 567 64 86 30 194 941 27.4
3 sham 677 210 77 22 5 991 8.7
exposed 750 204 56 9 3 1022 6.9
HeLa
1 sham 707 156 58 42 58 1021 13.7
exposed 763 139 57 31 64 1054 13.0
Focke et. al., supplementary Table 2:
comet stage scores continuous exposure
A B C D E total
tailfact
or
HR-1d
1 coil 1 727 128 75 50 10 990 10.1
coil 2 777 118 68 35 12 1010 8.9
2 coil 1 588 93 56 58 6 801 11.0
coil 2 568 117 29 83 5 802 12.3
3 coil 1 794 85 57 70 4 1010 9.8
coil 2 728 119 64 84 5 1000 11.4
ES-1
1 coil 1 778 110 57 55 0 1000 8.7
coil 2 810 87 67 35 2 1001 7.7
2 coil 1 572 114 33 80 3 802 11.9
coil 2 578 107 37 76 2 800 11.5
3 coil 1 683 153 67 96 1 1000 12.2
coil 2 805 154 39 93 4 1095 10.8
Focke et. al., supplementary Table 3:
comet stage scores sham-sham exposure
A B C D E total
tailfact
or
HR-1d
1 control 406 49 29 14 2 500 7.3
10µM H2O2 293 68 27 14 4 406 9.2
50µM H2O2 171 68 72 108 5 424 26.5
100µM H2O2 0 167 139 201 93 600 41.9
150µM H2O2 0 0 0 10 592 602 97
2 control 437 52 35 18 1 543 7.6
10µM H2O2 366 72 34 18 7 497 9.5
50µM H2O2 221 96 94 138 19 568 27.7
100µM H2O2 0 172 144 198 56 570 44.4
150µM H2O2 0 0 0 18 485 503 96.4
HeLa 
1 control 438 115 76 35 3 667 11.2
10µM H2O2 348 98 103 49 3 601 14.6
50µM H2O2 357 108 135 75 7 682 17.7
100µM H2O2 313 133 111 91 6 654 19.1
Focke et. al., supplementary Table 4:
comet stage scores H2O2 treatment
A B C D E total
tailfact
or
HR-1d
1 sham 147 410 72 64 9 702 18.3
exposed 174 357 72 96 26 725 22.2
sham Fpg 14 368 197 111 10 700 27.2
exp Fpg 4 146 177 252 44 623 45.7
H2O2 96 355 146 138 28 763 27.7
H2O2 
Fpg 0 127 366 404 24 921 46.2
2 sham 183 377 158 81 34 833 22.1
exposed 103 307 159 183 71 823 34.0
sham Fpg 6 199 196 181 108 690 45.1
exp Fpg 2 174 224 199 128 727 47.9
Focke et. al., supplementary Table 5:
comet stage scores Fpg, intermittent exposure
A B C D E total
tailfact
or
HR-1d
1 sham 801 170 22 3 6 1002 5.6
exposed 820 157 16 8 8 1009 5.8
2 sham 857 261 15 16 1 1150 6.1
exposed 764 183 25 22 7 1001 7.1
3 sham 845 138 5 8 3 999 4.8
exposed 910 122 16 9 7 1064 5.2
ES-1
1 sham 912 242 10 5 10 1179 5.9
exposed 726 173 34 8 6 947 6.5
2 sham 794 181 39 6 1 1021 5.8
exposed 760 190 32 13 5 1000 6.6
3 sham 857 121 10 7 5 1000 4.9
exposed 867 104 14 12 3 1000 5.0
A B C D E total
tailfact
or
HR-1d
1 sham 698 179 131 57 23 1088 12.9
exposed 605 138 215 71 18 1047 15.5
2 sham 687 137 181 60 14 1079 13.2
exposed 664 89 189 71 12 1025 14.1
3 sham 695 162 115 85 24 1081 14.1
exposed 668 185 99 104 13 1069 14.3
Focke et. al., supplementary Table 6:
comet stage scores for G1 starved cells (+iron supplementation)
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Scientific misconduct and fraud allegations were recently raised against a 
study that showed DNA breakage in primary human fibroblasts following 
exposure to mobile-phone radiation. We aimed to clarify the issue by 
replicating and expanding this study, using identical experimental procedures 
and conditions. We were able to reproduce weak genotoxic effects of 
radiofrequency magnetic field exposure for one human fibroblast cell line but 
not for the cell line reported in the study under debate.  
 
Conflicting results have been published about genotoxic effects resulting from 
radiofrequency electromagnetic fields (RF-EMFs). Although a majority of studies 
produced negative evidence, genotoxicity was shown in a few cases (reviewed in [1, 
2]). Two recent scientific publications received considerable public attention and 
concern, because they reported enhanced DNA fragmentation in different human cell 
lines (ES-1, IH-9 and HW-2 fibroblasts) following exposure to unmodulated and talk-
modulated RF-EMF signals [3, 4]. These studies came under massive criticism on 
the ground of statistical considerations, culminating in allegations of data fabrication 
and scientific misconduct [5]. Indeed, a first partial replication study failed to 
reproduce genotoxic effects in human ES-1 fibroblasts, although these analyses 
focused on the 1.8 GHz carrier wave only, and did not systematically address effects 
of modulated signals [6]. Therefore, it remains unclear whether or not RF-EMFs have 
a genotoxic potential. We aimed to clarify the issue in a replication study. 
In the original study, ES-1 human primary fibroblasts were exposed to a 1800 
MHz RF-EMF at a SAR (specific absorption rate) of 2 W/kg (legal exposure threshold 
for the general population) for 4, 16 and 24 h and analysed with the comet assay [7]. 
Comet events were scored visually and nuclei classified into five categories 
representing increasing amounts of DNA fragmentation. A comet tailfactor was then 
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calculated to assess the average level of DNA fragmentation in the cell population. 
Continuous and intermittent (5´field on/10´field off) exposure to the carrier wave 
increased the comet tailfactor after 16 h and 24 h by about 1.6 to 2-fold. Exposure to 
a pulse modulated field as well as to a GSM talk modulated field (simulating a mobile 
phone conversation with the “Global System for Mobile Communication” standard 
net) also significantly increased the comet tailfactor by about 2-fold. Later, the effect 
of the RF-EMF carrier wave (intermittent exposure for 1, 4 and 24 h) could not be 
reproduced independently for the ES-1 cell line [6]. Unlike before, however, the 
comets in the latter study were scored with a computerized system, a method that 
analyzes smaller numbers of nuclei and yields a comet tail moment (product of comet 
tail length and percentage of DNA in tail) as a measure for DNA fragmentation. 
Here, we first exposed the ES-1 cell line to a GSM talk modulated intermittent 
RF-EMF at SAR values of 1 W/kg and 2 W/kg for 16 h. We then assessed DNA 
fragmentation by the comet assay, applying visual scoring Fig. 1A) as in [3] as well 
as fully automated, computerized analyses (Fig. 1B) [7]. We measure no statistically 
significant differences between sham and exposed ES-1 cells with either method of 
comet scoring (Fig. 1A, 1B). We noticed a trend towards more DNA fragmentation in 
exposed cells at a SAR value of 1 W/kg exposure, though, but not at a SAR of 
2W/kg. Given the absence of statistical significance, however, we interpret these data 
to mean that the RF-EMF exposure conditions applied do not induce DNA 
fragmentation in the ES-1 cell line. 
We then used a second human primary fibroblast cell line, HR-1d, which we 
found previously to show higher comet effects than ES-1 following extremely low 
frequency EMF exposure. With this cell line, we found a small but significant increase 
of the tailfactor (1.5 fold) after intermittent exposure to RF-EMF at a SAR of 1 W/kg 
and GSM talk modulation (Fig. 2A). The visual comet scoring revealed a decrease of 
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almost 7% of cells in comet stage A, representing undamaged cells. When exposing 
these cells intermittently to RF-ELF at a SAR of 2 W/kg, the tailfactor change was 
smaller (1.3 fold) but still statistically significant. Intermittent exposure to the 
unmodulated carrier wave (5´/10´) at a SAR value of 1 W/kg for 16 h did not produce 
significant differences between sham and exposed cells, although a trend towards 
more DNA fragmentation in exposed cells in discernible. Using fully automated comet 
analysis, we confirmed statistically significant differences after exposure of HR-1d 
cells to a GSM-talk modulated field at 1 W/kg, but not at 2 W/kg. These analyses also 
revealed no effect of the carrier wave exposure (Fig. 2B). Hence, these result support 
the visually scored data partially, i.e. for the condition that produced a slightly more 
robust tail factor differences (1 W/kg GSM talk modulated RF-EMFs). Applying the 
stringent requirement that a genotoxic effect is genuine only if both comet scoring 
techniques produce statistically significant differences, we conclude the RF-EMF 
exposure at 1W/kg slightly increases the steady-state level of DNA strand breaks in 
the HR1-d cell line.  
In conclusion, we are not able to reproduce results obtained in a previously 
published study showing RF-EMF induced DNA fragmentation in the ES-1 fibroblast 
cell line. A different human fibroblasts cell line (HR-1d), derived from an older donor, 
shows a small but significant increase of both, the comet tailfactor obtained by visual 
scoring and the tail moment obtained by fully automated computerized analysis, 
following exposure to a talk modulated field at a SAR value of 1W/kg. There are 
notable trends in other exposure conditions tested, which could still be biologically 
relevant although statistically not significant. 
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Figure legends 
Fig. 1. Comet analysis of RF-EMF exposed ES-1 fibroblasts. (A) Visual comet stage 
analysis with percentages of cells in comet stages A-E. Primary measurements for 
each single experiment are shown in supplementary Tables 1-3. (n) is the number of 
experiments, error bars indicate SEMs and asterisks represent the significance levels 
by the Student´s t-test comparing fraction of cell in individual comet stage: * p<0.05; 
** p<0.01; *** p <0.005. The horizontal bar and p(c) show the mean significance of 
the chi-square tests, analysing the comet stage distribution of sham and EMF-
exposed nuclei of individual experiments. The upper right boxes show the mean 
tailfactor values for sham and exposed cells as well as the significance level of the 
Student´s t-test on the tailfactors (p(s)). (B) Automated analysis: pooled tail moment 
values from 300 cells (100 cells from 3 slides) per condition for 3 independent 
experiments per exposure type are displayed together with median, interquartile 
range (boxes) and 10-90 percentile range (whiskers). Significance was tested with 
Student´s t-test comparing the medians of each single experiment. Mean medians for 
each exposure condition are given on the x-axis. 
 
Fig. 2. Comet assay results of RF-EMF exposed HR-1d fibroblasts. (A) Visual comet 
stage analysis with percentages of cells in comet stages A-E. Primary measurements 
for each single experiment are shown in supplementary Tables 1-3. (n) is the number 
of experiments, error bars indicate SEMs and asterisks represent the significance 
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levels of Student´s t-test comparing fraction of cells in individual comet stages: * 
p<0.05; ** p<0.01; *** p <0.005. The horizontal bar and p(c) show the mean 
significance of the chi-square tests, analysing the comet stage distribution of sham 
and EMF-exposed nuclei of individual experiments. The upper right boxes show the 
mean tailfactor values for sham and exposed cells as well as the significance level of 
the Student´s t-test on the tailfactors (p(s)). (B) Automated analysis, pooled tail 
moment values from 100 cells of 3 slides per condition for 3 independent 
experiments per exposure type are displayed together with median, interquartile 
range (boxes) and 10-90 percentile range (whiskers). Significance was tested with 
Student´s t-test comparing the medians of each single experiment. Mean medians for 
each exposure condition are given on the x-axis. 
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Supplementary Information 
 
Materials and Methods 
 
Radio frequency exposure system and exposure conditions. The RF-ELF 
exposure system sXcUMTS was built and provided by the Foundation for Information 
Technologies in Society (IT'IS foundation), Zurich, Switzerland and is described in 
detail on http://www.itis.ethz.ch/index/index_sxc1950.html. The setup is based on two 
R18 waveguides operating at 1950 MHz. Two waveguides (exposed, sham-exposed) 
were placed inside a commercial incubator to ensure constant environmental 
conditions (37°C, 5% CO2, 95% humidity). Six 35mm Petri dishes can be exposed 
simultaneously and are placed in the H-field maxima. The system provides an 
efficiency of > 50 W/kg per Watt input power, deviations from SAR uniformity of < 
30%, variability of < 6% and a temperature load of < 0.03°C per W/kg average SAR. 
A computer-controlled signal and monitoring unit was developed (1) to generate 
complex modulated GSM and UMTS signals, (2) to continuously monitor the field and 
environmental conditions (air temperature, fan cooling system) and (3) to realize 
blinded exposure protocols. 
 
The field was either applied without modulation of the signal (=carrier wave) or with 
modulation: GSM signals were amplitude-modulated by rectangular pulses with a 
repetition frequency of 217 Hz and a duty cycle of 1:8, yielding frames of a length of 
4.61 ms each including a 576 µs burst. Since every 26th frame is idle, an 8 Hz 
modulation component is integrated into the signal. In order to save battery power 
during active periods without speaking into the phone the number of active frames is 
reduced (=discontinuous transmission mode, DTX). GSM talk modulation simulates a 
mobile-phone conversation by alternating between GSM mode and DTX at an 
average rate of 97 and 50 s. 
 
Cell lines and culture. Human primary fibroblasts (ES-1, male, 6 years old; HR-1d, 
male, 42 years old) kindly provided by Prof. Rüdiger (Vienna) were grown in 
Dulbecco´s modified Eagle´s medium (DMEM), supplemented with 10% FCS, 100 
U/mL penicillin, 100 µg/mL streptomycin and 2 mM L-glutamine (Sigma-Aldrich, St. 
Louis, MO, USA). Cells were grown in 15-cm Petri dishes (Falcon 353025) at 37°C in 
a humified atmosphere containing 5% CO2 and were supplied with fresh medium 
every 48 h. 24 h before exposure to EMF, cells were seeded into 3-cm Petri dishes 
(Nunc) to a confluency of about 30%. 
 
Comet assay procedure and analysis. Alkaline comet assay was performed 
basically as described by Singh et. al. [1]. 104 cells were harvested and resuspended 
in 0.5% low melting point agarose (Cambrex) at 37°C. The cell/agarose suspension 
is laid onto microscope slides precoated with 1.5% normal melting point agarose 
(BioRad, Hercules, CA, USA), spread with a cover slip and let solidify for about 15 
min. Slides then were immersed in freshly prepared ice-cold lysis buffer (2.5 M NaCl, 
100 mM Na2EDTA, 10 mM Tris-HCl pH 10, 1% Triton X-100, 10% DMSO, pH 10) for 
90 min, washed in ddH2O, drained and placed side by side in a gel electrophoresis 
tank. Slides were submerged with freshly made electrophoresis buffer (1 mM 
Na2EDTA, 300 mM NaOH, pH>13) and incubated for 30 min to allow DNA unwinding 
prior to electrophoresis at 25 V/ 300 mA for 20 min. All steps after exposure were 
performed under dimmed light at 4°C. After electrophoresis slides were washed three 
times with 0.4 mM Tris-HCl pH 7.5 for 10 min, followed by fixation with EtOH absolute 
(2x 5 min) and air drying.  
 For visual analysis nuclear DNA was stained with 20 µg/ml ethidium bromide and 
analysed with a fluorescent microscope at 400x magnification. Data collection was 
done according to Anderson et. al. [2] with minor modifications by Ivancsits et.al. [3]. 
For each individual exposure condition, two slides were subjected to the comet 
assay. Nuclei of at least 450 cells per slide were visually scored and classified into 
five categories corresponding to their amount of DNA in the tail (Figure 2c). 
Tailfactors (tf) were calculated with the following formula: tf (%) = ((A*F(A) + B*F(B) + 
C*F(C) + D*F(D) + E*F(E))/1000, where A is the number of cells classified to group 
A, F(A) the average of group A (2.5% of fragmented DNA), B the number of cells 
classified to group B, F(B) the average of group B (12.5%), C the number of cells 
classified to group C, F(C) the average of group C (30%), D the number of cells 
classified to group D, F(D) is the average of group D (67.5%), E the number of cells 
classified to group E, and F(E) the average of group E (97.5%). For automated comet 
analysis, slides were stained with Propidium Iodide and 100 cells per slide were 
analysed with a coputerized automated system according to Frieauff et. al. [4].  
 
Each visually scored EMF exposure experiment was repeated 3-6 times and 
differences between sham and exposed cells were statistically analysed by the 
Student´s t-test applying it to percentage of cells in each category and to the 
tailfactors of all experimental replica. Additionally, the statistical significance of the 
difference between sham and exposed cells was tested by applying the chi-square 
test to the whole distribution of cells for each single experiment. The indicated 
numbers are mean p-values of all experiments. For automatically analyzed comet 
assays, the median tail moments of 100 nuclei per slide from 3 slides per condition of 
three independent experiments were calculated and statistically analyzed by the 
Student´s t-test. 
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2Abstract
Background: 5-Fluorouracil (5-FU), a chemotherapeutic drug commonly used in 
cancer treatment, imbalances nucleotide pools, favoring misincorporation of uracil 
and 5-FU into genomic DNA. The processing of these bases by DNA repair activities 
was proposed to account for the DNA-directed cytotoxicity of the drug, but underlying 
mechanisms have not been resolved. Methodology/Principle Findings: In this study, 
we investigated an unexpected role of thymine DNA glycosylase (TDG), one of four 
mammalian uracil DNA glycosylases (UDG), in the cellular response to 5-FU. Using 
mouse genetic and biochemical tools, we found that inactivation of TDG significantly 
increases resistance of cells towards 5-FU, and that excision of DNA-incorporated 5-
FU by TDG generates persistent DNA strand-breaks, delays S-phase progression, 
and activates DNA damage signaling. In the absence of TDG, repair of 5-FU induced 
DNA strand-breaks is more efficient. Conclusions/Significance: Hence, excision of 5-
FU by TDG but not by other UDGs (UNG2, SMUG1) prevents efficient downstream 
processing of the repair intermediate, thereby mediating DNA-directed cytotoxicity.
The status of TDG expression in a cancer is therefore likely to determine its response 
to 5-FU based chemotherapy.
3Introduction
The antimetabolite 5-fluorouracil (5-FU) is an analogue of uracil with a fluorine
substitution at the C5 position. Developed as an inhibitor of thymidylate synthase (TS) 
[1], it has become an important compound in the first-line treatment of a range of 
human cancers, most prominently colorectal carcinomas [2]. Inside cells, 5-FU is
converted to different active metabolites, including fluorodeoxyuridine 
monophosphate (FdUMP), fluorodeoxyuridine triphosphate (FdUTP), and 
fluorouridine triphosphate (FUTP) [2]. These metabolites have been implicated in 
both, global RNA metabolism due to incorporation of the ribonucleotide FUMP into 
RNA, and DNA metabolism due to TS inhibition or direct incorporation of FdUMP into
DNA. The therapeutic importance of the DNA-directed actions is emphasized by a 
direct correlation of TS activity with the response rate of tumors or cancer cell lines to 
the treatment with 5-FU [3,4,5]. TS converts deoxyuridine monophosphate (dUMP) to 
deoxythymidine monophosphate (dTMP), but FdUMP inactivates the enzyme 
irreversibly upon docking to the nucleotide binding site and formation of a stable 
complex with TS and its cofactor 5,10-methylenetetrahydrofolate [6,7]. Thus, TS 
inhibition deprives the cell of its capacity to synthesize dTMP from dUMP and, 
thereby, elevates deoxyuridine triphosphate (dUTP) levels at the expense of
deoxythymidine triphosphate (dTTP). The resulting dUTP/dTTP imbalance then
favors the misincorporation of dUMP during DNA replication, giving rise to a dose 
dependent increase in the steady-state level of DNA uracil [8,9].
It has been argued that the therapeutic effects of TS inhibition base on the 
fragmentation of genomic DNA as a result of massive uracil excision by the 
replication associated uracil DNA glycosylase (UDG) UNG2 and/or of futile cycles of 
base excision repair (BER) [2,10,11]. This, however, is not entirely consistent with the 
4experimental evidence available. Although UNG2 constitutes a major activity against 
the accumulation of uracil in genomic DNA [12], its expression status does not affect 
the cellular resistance towards TS inhibition [13] and, hence, the survival of 5-FU
treated cells [14]. Thus, uracil excision by UNG2 unlikely accounts for the DNA-
directed cytotoxicity of 5-FU. In light of a recent report, however, showing that 
FdUMP gets itself incorporated into genomic DNA in 5-FU treated cells, with levels 
even exceeding those of misincorporated uracil [9], it may be that the 5-FU rather 
than the uracil in the DNA is cell toxic.
While UNG is the most efficient and specific UDG present in mammalian cells, it 
is not the only one. Single-strand-selective monofunctional uracil-DNA glycosylase 1 
(Smug1) [15], thymine DNA glycosylase (TDG) [16] and methyl-CpG-binding domain 
protein 4 (MBD4) [17,18] represent additional activities. All these enzymes are
capable of processing uracil as well as 5-FU in DNA, albeit with different kinetic 
properties. Smug1 was shown to provide resistance to 5-FU exposed cells [9],
whereas MBD4 may contribute to the toxicity of the drug, arguably through DNA 
damage signaling [19]. Human TDG, originally discovered as a G•T mismatch-
specific thymine DNA glycosylase [20], processes a broad range of substrates,
including uracil and 5-FU. Although its has a strong preference for bases mispaired 
with a guanine, TDG excises 5-FU with a high efficiency irrespective of whether the 
opposite base is a guanine or an adenine [16,21,22]. Consistently, plasmid based in
vitro repair assays with immunodepleted cell lysates have revealed a significant
contribution of TDG to 5-FU excision [23].
Due to the redundancy of UDG activities that can contribute to 5-FU processing 
in cells, it is difficult to predict in which way and to what extent one or the other 
contributes to the cellular response to 5-FU, and thus to the efficacy of cancer 
therapies including 5-FU. Moreover, recent evidence from in vitro repair studies has 
5implicated the postreplicative mismatch repair system (MMR) in the processing of 5-
FU•G base pairs [23]. In part, this account for the increased resistance of MMR 
deficient cells to treatment with fluoropyrimidines [24,25,26]. Given the general 
nucleotide imbalance induced by TS inhibition, however, the MMR dependent toxicity 
of 5-FU is best explained by excessive formation and repair of DNA mispairs during 
replication [25,27]. Hence, the DNA-directed effects of 5-FU may reflect two lines of 
responses; the excision 5-FU or U from DNA (5-FU/U•A, 5-FU/U•G) mainly by UDGs 
and the excision of mismatched nucleotides mainly by MMR. 
The objective of this study was to clarify the role of TDG in this context. We 
examined cellular and molecular responses to 5-FU exposure of matched Tdg
proficient and deficient mouse embryonic fibroblasts and stem cells. We show that 
TDG, of all UDGs, is responsible for the accumulation of DNA strand-breaks, a delay 
in S-phase progression and a persistent activation of DNA damage signaling upon
treatment of cells with 5-FU, and that inactivation of Tdg by mutation causes 
hyperresistance towards the drug. We conclude that TDG, unlike UNG2 and Smug1, 
mediates the DNA-directed cytotoxic effects of 5-FU.
6Results
TDG deficiency confers hyper-resistance towards 5-FU
To investigate the role of TDG during 5-FU treatment of cells in culture, we 
established SV40 immortalized mouse embryonic fibroblasts (MEFs) with 
homozygous or heterozygous Tdg disruptions (Tdg+/+, Tdg+/-, Tdg-/-) from embryos 
(ED 9.5) of heterozygous matings. The Tdg knockout allele, generated by classical 
gene targeting, had a replacement of exons 6 and 7, encoding parts of the catalytic 
core of TDG, with a neomycin resistance cassette (Lettieri et al., unpublished data).
We then used litter-matched MEF lines for phenotypic examination. Western blotting 
with a polyclonal anti-mouse TDG antibody confirmed that neither full-length nor 
truncated versions of TDG were present in whole cell extracts of the homozygous 
knockout MEFs, while heterozygous cells produced about half endogenous levels of 
the protein (Figure 1A, data not shown). Continuous exposure of these MEFs to 5-FU
for 48 hours reduced living cell counts in a dose-dependent manner. However, 
compared to wildtype, TDG deficient cells displayed a remarkable hyperresistance 
(Figure 1B), and heterozygous cells showed an intermediate 5-FU sensitivity (suppl.
Figure 1). These findings implicated a rate limiting contribution of TDG to 5-FU
mediated cytotoxicity. A differential response of TDG proficient and deficient MEFs to 
5-FU treatment was also observed in a real-time assessment of growth behavior. 
Whereas TDG proficient MEFs started to die after 36 hours of 5-FU exposure, TDG
deficient cells responded with a dose dependent growth retardation only (suppl. 
Figure 2).
Since immortalization by the SV40 large-T antigen (LTA) occurs through 
inactivation of antiproliferative proteins such as p53 or pRb and, thus, can affect the 
cellular DNA damage response [28,29], we also included spontaneously 
7immortalized MEF cell lines in our analysis. To this end, we set up isogenic Tdg
proficient and deficient MEF lines by stable transfection of a single clone with either a 
complementing Tdg transgene under the control of an SV40 promoter or the 
corresponding expression vector only (Figure 1A). Survival tests then showed that 
Tdg expression sensitized the Tdg deficient cells to treatment with 5-FU to a level 
comparable to Tdg proficient MEFs (Figure 1B). This confirmed that the 5-FU
hyperresistance of Tdg knockout cells is a direct consequence of the loss of TDG 
rather than of unspecific effects by SV40 LTA immortalization or other differences in 
clonal backgrounds.
To validate the hyperresistance phenotype in cells that are naturally immortal, we
examined the 5-FU response of Tdg+/- and Tdg-/- mouse embryonic stem (ES) cells 
generated in our laboratory (Figure 1A) (Y. Saito, et al., unpublished data). Also 
there, the loss of TDG was associated with a remarkable increase in resistance 
towards 5-FU (Figure 1B). Hence, the mechanism by which TDG mediates 
cytotoxicity of 5-FU is active in very divergent cell-types, including immortalized 
differentiated cells as well as undifferentiated stem cells.
Finally, to examine the drug specificity of the phenotype, we assessed the 
sensitivities of TDG proficient and deficient MEFs towards the monofunctional DNA
alkylating agent MMS methyl methansulfonate (MMS) (Figure 1C). At MMS 
concentrations yielding !10% cell survival, the TDG status did not significantly affect 
cellular sensitivity. At higher concentrations (" 5% survival), however, TDG deficient 
cells were slightly hypersensitive. This indicated that, although TDG may contribute
to the repair of MMS induced DNA lesions, it does not mediate cytotoxicity as it does 
in the case of 5-FU.
TDG contributes to A•FU repair in nuclear extracts
8Biochemical studies revealed that the human TDG acts on a rather broad range 
of substrates, including G•U and G•FU mispairs but also 5-FU base-paired with 
adenine. 5-FU in fact turned out to be the only base that is efficiently processed by 
TDG in normal base pairing configuration or even in single-stranded DNA [21]. We 
thus reasoned that the excision of 5-FU and/or uracil from genomic DNA by TDG
might be the source of 5-FU mediated killing in wildtype cells. To test this hypothesis, 
we first validated the 5-FU and uracil processing abilities of purified mouse TDG in 
base release assays. This showed that, like its human counterpart, the mouse protein
excises thymine, uracil and 5-FU opposite guanine but also 5-FU paired with 
adenine, all with comparable efficiencies (Figure 2A). A•U containing homoduplex 
DNA, however, was hardly processed, suggesting that mouse TDG does not 
contribute significantly to the repair of A•U base pairs.
To assess the contribution of the endogenous mouse TDG to overall uracil and 5-
FU processing, we analyzed the activities present in nuclear extracts of Tdg wildtype,
heterozygous and null mutant MEFs. G•T processing served as a control and was 
detectable in extracts from wildtype cells but not from homozygous Tdg knockout 
cells (Figure 2A). Heterozygous Tdg knockout cells showed reduced thymine 
excision activity compared to homozygous wildtype cells, which is in line with the
reduced levels of TDG in these cells (Figures 2B, 1A). Thus, TDG constitutes the 
major and rate-limiting mismatch-specific thymine excision activity in these cells,
suggesting that MBD4, another G•T processing DNA glycosylase [30,31], is not or 
only poorly active. Since a lack of MBD4 activity was also observed with protein 
extracts from mouse ES cells (data not shown) and in previous studies with different 
cell systems [23,32], the role of this DNA glycosylase in mismatch processing 
remains uncertain. Considerably higher amounts of nicked DNA products were 
detected for all uracil and 5-FU containing substrates. Removal of uracil and 5-FU
9from G•U, G•FU and A•U was equally efficient irrespective of the TDG status. 
Excision of 5-FU from an A•FU substrate, however, was significantly reduced in 
extracts from Tdg-/- MEFs (Figure 2B). The remaining activity on A•FU, but also the 
efficient processing of A•U, G•U and G•FU in extracts from Tdg knockout MEFs is
most likely attributed to the presence of other UDGs with overlapping substrate 
spectra. As the highly efficient, replicative UNG2 was inhibited by addition of 
saturating amounts of UGI peptide in these assays (data not shown), and MBD4 
activity was not detected, Smug1 most likely represents the redundant uracil and 5-
FU processing activity observed here. The data therefore suggest that, under
conditions of low UNG2 activity in cells, such as outside of S-phase when UNG2 is 
downregulated [32,33,34], TDG constitutes a major and rate-limiting A•5-FU
processing activity. 
This is consistent with measurements of 5-FU incorporation into genomic DNA 
following 5-FU treatment. The genomic levels of uracil and 5-FU upon treatment with 
10 #M 5-FU  for 48 hours were four and eleven times higher in TDG knockout MEFs 
(3.4 x 105 U-residues; 1.7 x 106 5-FU residues) than in wildtype cells (8.2 x 104; U 
residues; 1.5 x 105 5-FU residues), respectively, and this compares to the levels 
measured in 5-FU treated Smug1 knockdown cells (D. Barnes, personal 
communication; [9]). Not only do these data confirm that 5-FdUMP gets incorporated 
into genomic DNA, they also establish that both TDG and Smug1 constitute the major 
activities processing these lesions, whereas UNG2 does not appear to contribute 
significantly as also implicated by incorporation measurements and sensitivity tests 
with Ung-/- knockout cells (2.1 x 105 U; 1.5x105 5-FU) [9,14].
5-FU treatment induces TDG dependent DNA strand-breaks
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5-FU treatment has been associated with the generation of DNA strand-breaks
[2,10,11]. In the light of our biochemical evidence implicating TDG in processing 
genomic A•FU base pairs, this might be accounted for by an accumulation 
apyrimidinic/apurinic sites (AP-site) in DNA. Through further processing by the BER 
system (APE1), spontaneous breakage or stalling of DNA polymerases, these could 
give rise to increased levels of single-stranded DNA breaks (SSBs) in cells. To test 
this hypothesis, we applied alkaline Comet analyses to assess 5-FU induced AP-site
and/or SSB formation in TDG proficient and deficient MEFs, as well as in 
complemented knockout cells stably expressing an ectopic wildtype or catalytic 
mutant Tdg (Figure 3A). To avoid Tdg over-expression artifacts in the latter [32], we
made use of constructs that drive Tdg expression from its endogenous promoter 
(Schürmann et al., unpublished results). Automated analyses of Comet tail moments 
then showed similar background levels of DNA strand-breaks in all untreated cell 
populations. Following treatment with 5 µM 5-FU for 24 hours and a recovery of 
another 24 hours, however, the tail moments increased significantly above 
background in TDG proficient populations, whereas no significant increase was 
detected for TDG deficient cells (Figure 3B). Remarkably, cells complemented with 
the catalytic inactive mutant form of TDG did not show significantly elevated tail 
moments after 5-FU treatment. These data indicate that base excision by TDG 
accounts for the increase in steady-state levels of DNA strand-breaks observed upon 
treatment of cells with 5-FU.
Base excision generates single-stranded DNA breaks, feeding into a SSB repair 
pathway whereby XRCC1 plays a central role [35]. To address a possible 
engagement of SSB repair following 5-FU treatment, we quantified nuclear XRCC1 
foci by immunofluorescence detection of the endogenous protein with specific mono-
and polyclonal antibodies [36]. This showed indeed that the median number of 
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XRCC1 foci per cell increased after 24 hours of low dose 5-FU treatment and a 
recovery of 24 hours in the absence of the drug (Figure 3C). We therefore conclude 
that uracil/5-FU excision from genomic DNA activates SSB repair processes at the 
site of the lesion. Remarkably, 5-FU treatment induced significantly more XRCC1 foci 
in Tdg knockout cells, indicating higher SSB repair activity in these cells, most 
probably downstream of uracil/5-FU excision by the remaining UDG activities. Thus, 
in wildtype cells TDG may compete with these glycosylases for the 5-FU substrates, 
generate AP-sites, but then prevent efficient downstream processing of the repair 
intermediates by the SSB repair pathway.
5-FU arrests MEFs in S-phase and actives DNA damage responses
5-FU treatment was shown to delay or even arrest S-phase progression in HeLa 
and DT40 cells [37,38]. To address the role of TDG in this context, we determined
the cell cycle profiles of TDG proficient and deficient MEFs following 5-FU treatment. 
Relative to the mock control, treatment for 24 hours with 5 µM 5-FU and subsequent 
cultivation in drug-free medium for additional 24 hours resulted in a significant
enrichment of Tdg wildtype cells in the S (2-fold) and G2/M phases (1.3-fold) of the 
cell cycle (Figure 4A). This enrichment occurred at the expense of the G1 cell 
population, which was reduced by a factor of three. By contrast, the 5-FU induced 
changes in cell cycle distribution of TDG deficient MEFs were less pronounced and 
not statistically significant (Figure 4A). Since treatment with hydroxyurea (HU) 
impeded S-phase progression equally in both cell lines (data not shown), the lack of 
a cell cycle response to 5-FU of TDG deficient MEFs was unlikely the result of a 
defect in the intra-S phase DNA damage checkpoint in these cells. To corroborate 
the TDG dependence of the 5-FU mediated S-phase delay, we compared the 
response of Tdg knockout cells complemented by stable expression of endogenous 
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levels of wildtype Tdg with that of a vector control. Also in this setting, the S-phase
delay induced by 5-FU treatment was significantly more pronounced in the Tdg
expressing cell line (1.7-fold vs. 1.2 fold) (Figure 4B). Thus, TDG contributes to cell 
cycle responses following 5-FU treatment.
5-FU induced cell cycle arrest in early S-phase was shown previously to depend 
on Chk1, a DNA damage and replication checkpoint effector kinase [37,38] that gets 
activated through ATR dependent phosphorylation at serine residues 317 and 345
(Chk1-p) [39]. We examined the role of TDG in checkpoint activation following 
treatment of cells with 10 µM 5-FU for 24 hours and a recovery in drug-free medium 
for another 24 hours. Immunoblotting of whole cell extracts with a S345 phospho-
specific Chk1 antibody confirmed significant activation of the kinase in Tdg wildtype
cells (Figure 5A). In extracts of 5-FU treated Tdg knockout cells, however, 5-FU
induced Chk1 phosphorylation was hardly detectable. This was not due to an 
absence of Chk1 or an inability to phosphorylate the kinase in these cells; 
immunodetection of total Chk1 protein confirmed similar levels in wildtype and 
knockout extracts (Figure 5A), and the replication inhibitor hydroxyurea (HU) induced 
Chk1 phosphorylation in both cell types (Figure 5C). The reduced TDG protein levels 
detected in the extracts of 5-FU treated wildtype MEFs (Figure 5A) reflected the 
accumulation of the cells in S-phase, where TDG is not expressed [32]. Finally, 
stable transfection of a TDG expressing plasmid restored 5-FU inducible Chk1 
phosphorylation in the Tdg knockout cells (Figure 5B). 
To address the dynamics of Chk1 activation, we monitored S345 phosphorylation 
during a 24 hour treatment with 10 µM 5-FU and an additional recovery time of 24 
hours in the absence of 5-FU. Weak Chk1 phosphorylation became detectable after
16 hours of treatment both in Tdg wildtype and knockout MEFs. This initial signal 
persisted throughout a treatment period of 24 hours (Figure 5C), but declined 
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gradually during the subsequent recovery period. Strikingly, however, in TDG 
proficient cells, Chk1 phosphorylation reappeared at 40 hours into the time course, 
which is 16 hours after removal of the drug (Figure 5C). Thus, 5-FU elicits an early 
checkpoint response that is independent of TDG and a late response that depends 
on TDG.
Another readout of ATM or ATR dependent DNA damage responses is the formation 
of nuclear foci containing a phosphorylated variant of histone H2AX [40]. !H2AX is 
considered a marker of DNA damage, including DNA double strand-breaks that may 
occur during DNA replication when moving forks encounter damage in the parental 
strands. We thus measured changes in the steady state levels of !H2AX foci in TDG 
proficient and deficient MEF populations upon treatment with 5 #M 5-FU for 24 hours
and additional recovery for 24 hours in drug-free medium. Although both mock 
treated cell lines showed similar levels of !H2AX foci, the wildtype MEFs
accumulated significantly higher numbers of !H2AX foci than the TDG deficient cells 
during 5-FU treatment (Figure 5D). This corroborates that 5-FU treatment induces 
DNA strand-breaks and consequently DNA damage signaling in a TDG dependent 
manner.
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Discussion
Despite many years of clinical application, the mode of action underlying the 
therapeutic efficacy of the antimetabolite 5-FU has remained elusive. Circumstantial 
evidence, however, has suggested that a significant part of its cancer directed 
cytotoxicity is mediated through the excision of misincrorporated uracil or 5-FU from 
genomic DNA, saturating the cellular SSB repair capacity [2]. Such a scenario clearly 
implicates a critical role for UDGs in mediating the cytotoxicity. However, Smug1 was 
reported to protect cells from the cytotoxic effects of 5-FU, and the status of UNG2, 
the catalytically most efficient UDG of all, does not seem to affect cellular sensitivity 
at all [9,13,14]. MBD4 deficient cells were shown to have a survival benefit on 5-FU
[19], but this may not be linked to its DNA glycosylase activity since immunodepletion
of the enzyme did not alter the 5-FU repair capacity of nuclear extracts [23]. Thus,
whether or not and to what extent UDG activities are responsible for the DNA 
directed 5-FU toxicity remained unclear.
Our data now establish a significant contribution of TDG to 5-FU cytotoxicity. We
show that inactivation of TDG in MEFs but also in ES cells results in a marked
cellular hyperresistance towards 5-FU, which can be complemented by expression of 
wildtype Tdg. This phenotype is specific to 5-FU as the TDG deficient MEFs showed
no hyperresistance when treated with MMS. Recently, An et al. [9] demonstrated the 
accumulation of appreciable amounts of FdUMP in genomic DNA following 5-FU
treatment of cells, and presented genetic data consistent with 5-FU rather than uracil 
in DNA being the toxic lesion. Our data show that nuclear extracts from TDG deficient 
cells excise 5-FU from A•5-FU base pairs with significantly reduced efficiency when 
compared to wildtype extracts. Although this difference is detectable only upon 
inhibition of the highly active UNG2 by the UGI peptide, it nevertheless implicates a 
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rate limiting contribution of TDG to the excision of 5-FU in non S-phase cells, where 
UNG2 activity is down regulated [32,33,34]. In agreement with this, we found TDG 
deficient MEFs to accumulate significantly higher levels of 5-FU in their DNA than 
TDG proficient cells following 5-FU exposure. Hence, TDG processes 5-FU in 
genomic DNA and may thus contribute to the cytotoxicity of the drug. Given the 
inability of TDG to excise U from A•U base pair on the one hand [20,21], and the 
comparably high contribution of TDG to A•5-FU processing in nuclear extracts on the 
other hand, we argue that the primary TDG relevant cytotoxic DNA lesion is the A•5-
FU base pair.
Consistent with a concept of DNA repair generating lethal DNA strand-breaks
upon 5-FU treatment [2], our comet data show an increase of the tailmoment in 5-FU
treated MEFs, and this effect is largely dependent on the presence of a catalytically 
active TDG. At the same time, we observed a significant increase of the number of 
XRCC1 foci per cell, suggesting that 5-FU treatment triggers DNA SSB repair [35].
Strikingly, after 5-FU treatment, Tdg knockout cells produced significantly higher 
levels of XRCC1 foci than their wildtype counterparts, suggesting that the loss of 
TDG enhances overall SSB repair activity while reducing lethal 5-FU processing. 
Why then is the excision of 5-FU (or uracil) by TDG cytotoxic, whereas excision 
by other UDGs, particularly Smug1, protects against cell death [9]. The difference 
may relate to the distinct modes of action of these enzymes. Both, TDG and Smug1
bind AP-sites in DNA, albeit with different affinities. The dissociation of the 
glycosylases from these repair intermediates is therefore rate limiting for further 
processing [22,41]. However, whereas Smug1 can be made to turnover in the 
presence of APE1, the downstream acting endonuclease competing for the AP-site
[41], efficient AP-site release (and stimulation by APE1) of TDG requires a SUMO 
modification induced conformational change that reduces its DNA binding affinity 
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[42,43]. Thus, base excision by Smug1 may connect to a straightforward downstream 
repair process, while base excision by TDG may be associated with delayed repair of 
the AP-site, possibly due to saturation of the SUMOylation system. Some AP-sites
generated by TDG would thus escape repair until they eventually interfere with DNA 
replication, leading to fork stalling and collapse and activation of replication stress or 
DNA damage checkpoints [44]. Indeed, we and others found 5-FU treatment to affect 
the progression of cells through S-phase [38,45], and this effect was associated with 
activation of the Chk1 kinase that contributes to S and G2/M checkpoints [46]. Both, 
an accumulation of cells in S-phase and the activation Chk1 upon 5-FU exposure 
was virtually absent in TDG deficient MEFs, and was in line with reduced levels of 5-
FU-induced DNA strand-breaks and !H2AX foci in these cells.
We reported previously that TDG is absent from S-phase cells due to 
programmed degradation by the proteasome system at the G1-S boundary [32]. This
is consistent with the dynamics of Chk1 activation and cell death in our experiments, 
both indicating that the TDG dependent cytotoxic action is temporally separated from 
the incorporation of 5-FU (and U) into DNA. On the basis of these findings, we can 
now put forward a model for how temporally separated 5-FU/uracil misincorporation 
and repair processes can determine the cellular responses to 5-FU (Figure 6). Upon 
exposure to 5-FU, 5-FU/uracil will be misincrorporated into DNA during DNA 
replication in S-phase of the cell cycle. In this context, UNG2 will act efficiently on 
uracil (A•U and G•U) but less so on 5-FU [9], whereas Smug1 (and MBD4) may 
process the same lesions but with lower efficiencies. These repair events will activate 
the first wave of checkpoint response that is TDG independent. Due to saturation of 
uracil repair, considerable amounts of A•5-FU base pairs will persist in the DNA into 
the subsequent phases of the cell cycle, where UNG2 is down-regulated and they will 
be attacked mainly by TDG and Smug1. AP-sites generated by TDG will be protected 
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from repair due to rate limiting dissociation of the glycosylases and, hence, 
accumulate and interfere with the replication machinery in the subsequent S-phase.
This will give rise to a second wave checkpoint activation (Chk1 phosphorylation, 
formation of !H2AX), this time TDG dependent, which is correlated with the 
occurrence of DNA stand-breaks, even if the cells are no longer cultivated in the 
presence of 5-FU.
Notably, according to a recent report, breast cancer patients carrying a specific 
polymorphism in XRCC1 have a significantly reduced risk of recurrence and show 
better long time survival following a combination therapy with cyclophosphamide-
methotrexate-5-FU [47]. The same polymorphism was previously reported to reduce 
DNA repair activity of XRCC1 [47,48], suggesting that inactivation of DNA single 
strand-break repair can improve the efficacy 5-FU treatment. The data presented 
here for TDG and previously for Smug1 [9] is consistent with 5-FU excision being 
responsible for the generation of a significant fraction of AP-sites and DNA single 
strand-breaks following 5-FU treatment. It is now becoming clear that the efficiency of 
coupling downstream repair with base excision, presumably through XRCC1, 
depends on the biochemical properties of the DNA glycosylase engaged and critically 
determines the cellular responses to the drug. It will therefore be important to 
examine to what extent the status of TDG activity correlates with the response of 
tumors to 5-FU based chemotherapy.
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Materials and methods
Reagents, antibodies and Tdg expression constructs
Chemicals and reagents were purchased from Sigma (Switzerland), CompleteTM
protease inhibitor from Roche (Switzerland), RNase from Qiagen (Switzerland) and 
UGI from New England Biolabs (USA). LIF was from Chemicon-Millipore (USA), 
sodium pyruvate from Invitrogen (USA) and all other supplements or cell culture 
media from Sigma (Switzerland). The polyclonal rabbit anti-mTDG antiserum was 
newly generated by immunization with recombinant full length mouse TDGa (Primm
Labs, UK). Rabbit anti-Chk1 (#2345) and rabbit anti-Chk1-Ser345p (#2341) 
antibodies were from Cell Signaling (USA), the mouse anti-$-actin (ab8226) antibody 
was from Abcam (UK), the rabbit anti-XRCC1 (X0629) was from Sigma (Switzerland) 
and the mouse anti-!H2AX (#05-636) was from Chemicon-Millipore (USA). The 
secondary horse-radish-peroxidase conjugated antibodies against mouse (NXA931) 
or rabbit (NA934V) were purchased from GE Healthcare Life Sciences (Germany), 
the secondary Cy2 conjugated donkey anti-mouse IgG (715-225-151) and anti-rabbit
IgG (711-225-152) antibodies and donkey serum (017-000-001) were from Jackson 
ImmunoResearch Laboratories (USA). 
For bacterial expression of an N-terminally 6xHis tagged mouse TDG, the murine 
TdgA cDNA (GenBank: NM_172552 ) was cloned into pET28c (Novagen-Merck,
Germany). Mammalian expression constructs were obtained by PCR cloning of the 
mouse TdgA sequence into pSG5-HH25 [43] or pTCO4 (unpublished results) for 
expression controlled by the SV40 or the authentic Tdg promoter, respectively. In
vitro mutagenesis of mouse Tdg was performed using the QuikChange site-directed
mutagenesis kit (Stratagene, USA). PCR primer sequences and vector maps are 
available on request.
19
Cell culturing
For immortalization of cell lines see Supplemental data. Immortal MEFs were 
cultivated in growth medium (DMEM, 10% FCS, 2 mM L-glutamine) containing 
penicillin/streptomycin (pen/strep) at 37°C with 5% CO2. For complementation, Tdg
-/-
cell lines were transfected at 70% confluency with 1 #g of plasmid DNA and the 
Transfectin reagent (BioRad, USA). Puromycin-resistant cells were selected and 
further maintained in medium supplemented with 1.5 #g/ml puromycin. For protein 
extraction, comet assays or FACS analysis, 1 x 106 (mock) or 2 x 106 (Fu) cells were 
seeded into 10 cm culture dishes and incubated for 24 h. Cells were treated with 
indicated 5-FU concentrations for 24 h and washed with PBS. After additional 
incubation for 24 h in drug-free medium, cells were harvested by trypsinization. 
Mouse embryonic stem cells (ES) with a homozygous disruption of the Tdg gene 
were selected with increasing concentrations of neomycin from ES cells
heterozygous for Tdg. ES cells were passaged in ES medium (DMEM, 15% heat-
inactived FCS, 2 mM L-glutamine, 0.1 mM $-mercaptoethanol, 1 mM sodium 
pyruvate, 1x non-essential amino acids, 1x pen/strep, 1’000 U/ml LIF) in the 
presence of !-ray inactivated feeder cells, which were removed prior to sensitivity 
assays.
Protein extraction and western blotting
Cells were washed with ice-cold PBS and lysed for 30 min on ice in lysis buffer 
(50 mM Na-phosphate pH 8.0, 125 mM NaCl, 1% NP-40, 0.5 mM EDTA, 1 mM 
PMSF, 1 mM DTT, 1x CompleteTM protease inhibitors, 2x phosphatase inhibitor 
cocktail 1 and 2). Extracts were clarified by centrifugation (15 min, 20’000g, 4°C). 
Protein concentrations were determined using the Bradford reagent (BioRad, USA). 
50 µg of soluble protein was separated in 10% SDS-polyacrylamide gels and 
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transferred to a nitrocellulose membrane (Millipore, USA). Membranes were washed 
once with TBS-T (100 mM Tris/HCl pH 8.0, 150 mM NaCl, 0.1% Tween20) and
incubated with blocking buffer (TBS-T, 5% dry milk) for 1 h at room temperature (RT). 
Blocked membranes were washed once with TBS-T for 5 min before incubation with 
the primary antibody for 1 h at 33°C (anti-mTDG) or RT (anti-$-actin) in blocking 
buffer or overnight at 4°C in TBS-T containing 5% BSA (anti-Chk1, anti-Chk1-
Ser345p). Dilutions were: 1:10’000 for the rabbit anti-mTDG antibody and the mouse 
anti-$-actin, 1:1’000 for the rabbit anti-Chk1 and the rabbit anti-Chk1-Ser345p. The 
washing steps after hybridization were: once at 33°C and twice at RT for 15 min 
(anti-mTDG), three times at RT for 10 min (anti-$-actin) and three times for 5 min at 
RT (anti-Chk1, anti-Chk1-Ser345p). Both secondary horse-radish-peroxidase
conjugated antibodies were diluted 1:5’000 in blocking buffer and hybridized to the 
membranes for 1 h at RT. After three washing steps of 10 min at RT, detection of the 
signals was carried out using the Immobilon Western Chemiluminescent HRP 
Substrate (Millipore, USA).
Cell sensitivity assays
Cell viability was measured by the Cell Counting Kit-8 (Dojindo, Japan). Triplicate 
cultures of each cell line were plated in 96-well plates at 1 x 103 cells per well and 
pre-incubated in the respective growth medium. 5-FU or MMS was added to final 
concentrations as indicated. Cells were exposed for 48 h to 5-FU (1 h to MMS and 
additional 47 hours in normal growth medium), washed with PBS before incubation in 
medium containing the WST-8 substrate at 37°C. After incubation for 2 h (MEF) or 4 
h (ES) the cell density was measured indirectly by quantification of the solubilized 
formazan product at 450 nm with a SpectraMax340 microplate spectrophotometer 
(Molecular Devices, USA).
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Purification of recombinant mTDGa
For expression of mTDGa, 2 L of Superbroth containing 50 µg/ml kanamycin 
were inoculated with an overnight culture of E. coli BL21(DE3) transformed with pET-
28c-mTdgA. The culture was grown to an A600 of 0.6 and cooled to 15°C. TDG 
expression was induced by the addition of 200 µM IPTG and incubation was allowed
to proceed at 15°C for 23 h. Cells were collected by centrifugation (Sorvall SLC-
6000, 5000 rpm, 4°C, 30 min), and the pellets were resuspended in 3 ml/g sonication 
buffer (50 mM Na-phosphate pH 8.0, 750 mM NaCl, 20% glycerol, 1 mM imidazole, 
10 mM $-mercaptoethanol, 1 mM phenylmethylsulfonyl fluoride). After shock freezing 
in liquid nitrogen cells were stored at -80°C. Crude extracts were prepared by 
sonication (12 times for 30s on ice with intermittent chilling), and clarified by 
centrifugation (Sorvall SS34, 18’000 rpm, 4°C). All steps were performed at 4°C. The 
supernatant was applied to a disposable column packed with 1.5 ml preequilibrated 
Ni-NTA agarose (Qiagen) at a flow rate of 15 ml/h. After washing with 120 ml 
sonication buffer, bound proteins were eluted with 10 ml sonication buffer containing 
500 mM imidazole and dialyzed against buffer H50 (50 mM Na-phosphate pH 8.0, 50 
mM NaCl, 20% glycerol, 10 mM $-mercaptoethanol, 1 mM phenylmethylsulfonyl 
fluoride). After loading the dialyzed fraction onto a 5 ml HiTrap Heparin HP column 
(GE Healthcare, Germany) at a flow rate of 1 ml/min and washing with 10 ml H50, 
bound protein was eluted with a liner gradient of 50-800 mM NaCl in 50 ml. Purest 
fractions were pooled, dialysed against buffer Q20 (50 mM Na-phosphate pH 8.5, 20 
mM NaCl, 10% glycerol, 10 mM $-mercaptoethanol, 1 mM phenylmethylsulfonyl 
fluoride), and loaded on a 1 ml HiTrap Q HP at a flow rate of 1 ml/min. After washing 
with 10 ml Q20 buffer, bound proteins were eluted with a linear gradient of 20-500
mM NaCl in 15 ml. The fractions containing TDG with >98% homogeneity were 
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pooled, dialyzed against storage buffer (50 mM Na-phosphate pH 8.0, 50 mM NaCl, 
10% glycerol, 10 mM $-mercaptoethanol, 1 mM phenylmethylsulfonyl fluoride), frozen 
in liquid nitrogen and stored at -80°C.
Base release assays
Nuclear protein extracts were prepared according to [32]. For base release
assays 20 #g of nuclear proteins were incubated with 1 pmol of a fluorescein labeled 
homoduplex or mismatched DNA substrate (2) in reaction buffer (50 mM Tris-HCl pH 
8.0, 1 mM EDTA, 1 mM DTT, 1mg/ml BSA, 2 U UGI) for 20 h at 37°C. Generated 
AP-sites were cleaved by the addition of NaOH to a final concentration of 100 mM 
and heating to 95°C for 10 min. Subsequently, DNA was ethanol precipitated 
overnight at -20°C in 0.3 M Na-acetate pH 5.2 and in the presence of 0.4 mg/ml 
carrier tRNA. The DNA was collected by centrifugation (20 min, 20’000g, 4°C) and 
washed in 80% ethanol. Air-dried pellets were resuspended in loading buffer (1x 
TBE, 90% formamide), heated at 95°C for 5 min and immediately chilled on ice. 
Reaction products were separated on 15% denaturing polyacrylamide gels in 1x 
TBE. The fluorescein-labeled DNA was visualized with a Typhoon 9400 (GE 
Healthcare, Germany) and quantified using the ImageQuant TL software (GE 
Healthcare, Germany).
Alkaline comet assays
Comet assays were performed according to [49] with minor modifications 
described by [50]. After treatment, cells were trypsinized, collected by centrifugation 
(5 min, 450g, RT) and washed with PBS. 10’000 cells were resuspended in 100 µl 
low-melting-point agarose (PBS, 0.5% LMPA; Lonza, Switzerland) at 37°C, and 
casted onto microscope slides precoated with 1.5% normal melting agarose (BioRad, 
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USA). After gelling, cells were lysed by immersion of the slides in freshly prepared 
ice-cold lysis buffer (2.5 M NaCl, 100 mM EDTA, 10 mM Tris/HCl pH 10, 1% TritonX-
100, 10% DMSO) for 90 min at 4°C. Slides were then washed with ddH2O and 
covered with fresh electrophoresis buffer in an electrophoresis tank (1 mM EDTA, 
300 mM NaOH, pH>13). After DNA unwinding for 30 min at 4°C, electrophoresis was 
performed at 25 V and 300 mA for 20 minutes. All above steps were done under 
dimmed light. Neutralization was carried out by three washings of 10 minutes with 0.4 
M Tris/HCl pH 7.5 at RT. After two fixation steps of 5 minutes in 100% EtOH at RT, 
slides were air-dried and stained with 50 µl PI solution (Vectashield, 2.5 µg/ml 
propidium iodide). Comet tail moments of 100 to 150 cells per slide were analysed by 
automated analysis [51] using a Leitz MIAS image analyzer (Leitz Messtechnik,
Germany) together with a Leica DM RBE microscope (Leica Microsystems, 
Germany).
FACS analysis
5 x 105 to 5 x 106 cells were fixed overnight in 5 ml 70% ethanol at 4°C, collected 
by centrifugation (5 min, 800g, 4°C) and resuspended in 0.3 ml RNase solution (100 
mM Tris/HCl pH 7.5, 100 mM NaCl, RNase 0.5mg/ml,). RNA digestion was 
performed at 37°C for 45 min. 0.3 ml of PE-solution (0.4% HCl, pepsin 1mg/ml) were 
added to the samples during the last 15 min of incubation. The DNA was stained by 
the addition of 0.6 ml PI solution (PBS, 50#g/ml propidium iodide) on ice for 30 min. 
Samples were analyzed by flow cytometry with a FACS Canto ll cytometer (Beckton 
Dickinson, USA). Cell cycle distribution was analyzed using the FlowJo software 
(TreeStar, USA).
Immunofluorescence
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MEFs were cultivated on cover slips for 24h. Cells were then treated with 5 µM 5-
FU for 24 h followed by cultivation in drug free medium for another 24 h. Cover slips
were then washed twice in PBS and the cells fixed for 15 min with PF-buffer (PBS,
2% paraformaldehyde) at RT, washed 4 time 10 min in PBS at RT, and 
permeabilized in ice cold P-buffer (PBS, 0.2% TritonX100) for 5 min. Coverslips were 
incubated for another 5 min in ice-cold P-buffer containing 0.2% NaBH4. After 
blocking twice in H-buffer for 10 min (PBS, 1% BSA) and once in D-buffer for 10 min 
(PBS, 1:20 donkey serum), samples were hybridized with the anti-XRCC1 (1:100
dilution in H-buffer) or the anti-!H2AX (1:500 dilution in H-buffer) antibody for 1 h at 
RT. Following four washes of 10 min in H-buffer the samples were hybridized with the
respective Cy2 conjugated secondary antibody at a dilution of 1:500 (XRCC1) or 
1:200 (!H2AX) in H-buffer for 1 h at RT. After four washes of 10 min in PBS, the
cover slips were dried and embedded in Mowiol (Calbiochem, Germany). XRCC1 or
!H2AX signals were visualized on an Axiovert 200M microscope (Zeiss, Germany) 
using a FITC filter (exitation 492 nm, emission 520 nm).
Statistical analysis
Statistical analyses were done using the Prism 5 software (GraphPad Software, 
Inc., USA). Comet tail moments data were analyzed according to P. Duez et al., 2003 
by two-way ANOVA of medians and 75% percentiles obtained from 3 independent 
experiments, followed by the Bonferroni post test. XRCC1 and !H2AX foci 
distributions were tested for normality by the Shapiro-Wilk test and further evaluated 
by one-way ANOVA using the non-parametric Kruskal-Wallis test followed by the 
Dunn’s multiple comparison analysis comparing treated with untreated samples. 
Analysis of cell cycle data was done by the Fisher's exact test from contingency 
tables comparing the distributions of G1-, S- and G2-cells.
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Figure legends
Figure 1. TDG deficient mouse cells are hyperresistant to 5-FU. (A) Western blot 
analysis of whole cell protein extracts derived from SV40 immortalized mouse 
embryonic fibroblast lines (MEFs, left panel), spontaneously immortalized MEFs 
(middle panel), and embryonic stem cell lines (right panel) used. Tdg genotypes were 
as indicated. A highly specific polyclonal anti-mouse TDG antibody (TDGab) was used 
to detect TDG and beta-actin staining served as loading control ($-actab). TDG is 
undetectable in extracts from Tdg-/- cells and levels are reduced in heterozygous 
MEFs. Stable transfection of a Tdg expression construct (pTdg) restores TDG levels 
in knockout MEFs. (B) TDG deficient MEF and ES cells exhibit increased 5-FU
resistance, and ectopic expression of wildtype Tdg in knockout MEFs restores 5-FU
sensitivity. The sensitivity to increasing amounts of 5-FU was measured for the 
different cell lines after a continuous treatment of 48 hours. Shown are survival 
curves as percentages of mock-treated cells. (C) TDG deficient MEFs are not 
generally hyper-resistant to induced DNA base damage. Sensitivity to MMS was 
measured after a treatment for one hour with increasing concentrations of MMS.
Shown are survival curves as percentages of mock-treated cells. Data are presented 
as means ± SEM from at least three independent experiments. pC, vector control; 
pTdg, Tdg expressing vector.
Figure 2. Involvement of TDG in processing of uracil and 5-FU. (A) Base release 
activities of purified recombinant mouse TDG (mTDG) and nuclear protein extracts of 
TDG wildtype (Tdg+/+), heterozygous (Tdg+/-) and knockout (Tdg-/-) MEFs on uracil, 5-
FU and G•T containing synthetic 60-mer DNA duplexes. Shown are representative
results of base release assays with the intact substrate DNA strands (S) and the 
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cleaved products (P) resolved on denaturing polyacrylamid gels. All reactions were 
performed in the presence of the UNG inhibitory UGI peptide. Purified TDG 
processes thymine, uracil and 5-FU when opposite guanine as well as 5-FU paired 
with adenine, but only inefficiently uracil opposite adenine. (B) Quantitation of base 
release activities in nuclear extracts. G•T processing activity is reduced in protein 
extracts of heterozygous cells and absent form knockout extracts. Tdg knockout 
extracts also show a significant reduction of A•5-FU processing. All other uracil and 
5-FU containing substrates were processed with similar efficiencies by all three 
nuclear extracts. Data are presented as means ± SD from three independent 
experiments. *, 5'-Fluorescein-labelled strand.
Figure 3. 5-FU induced DNA strand-breaks are reduced in TDG deficient cells
while overall repair activity is increased.
(A) Complementation of Tdg knockout MEFs with wildtype and catalytically deficient 
TDG. Stable transfectants of Tdg-/- MEFs ectopically expressing either TDG variant 
from the native promoter show about endogenous TDG levels as detected by 
Western blotting. (B) Reduced levels of 5-FU induced DNA strand-break in cells 
lacking active TDG. Steady-state levels of DNA single and double strand-breaks in 
the cell lines indicated were assessed by the alkaline comet assay using automated 
comet tail moment analysis. 5-FU treatment resulted in a significant tail moment 
increase in wildtype but not in Tdg knockout MEFs. The generation of 5-FU specific 
DNA strand breaks in Tdg knockout cells was restored by complementation with 
wildtype Tdg but not with the catalytically inactive mutant. Shown are boxplots with 
individual moments per cell, medians, interquartile ranges (boxes), 2.5 – 97.5 % 
percentiles (whiskers) and outliers (dots) of pooled data (600 to 900 cells) obtained 
from three independent experiments. (C) 5-FU treatment triggers DNA single-strand
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break repair in TDG wildtype and knockout cells. The top panel shows nuclei of Tdg
proficient and deficient cells stained with a polyclonal anti-XRCC1 antibody 
(XRCC1ab) after 5-FU treatment. The statistical analysis of XRCC1 foci per cell 
across the populations analyzed (n ! 100 cells per population) is shown as scatter 
plot with medians and the interquartile ranges. pC, empty vector; pTdg, vector
expressing TDG; pTdgcat, vector expressing a catalytic variant of TDG.
Figure 4. 5-FU treatment induces a TDG dependent S-phase delay. The
histograms show the effect of the 5-FU treatment on the relative cell cycle distribution 
(% cells) of TDG proficient and deficient MEFs (A), and of TDG knockout cell lines 
stably transfected with a plasmid expressing Tdg from its authentic promoter (B). 5-
FU treatment of TDG proficient cells results in a significant accumulation cells in S-
phase at the expense of G1 cells, whereas TDG deficient cells show only insignificant 
changes in cell cycle distribution. Expression of wildtype Tdg in knockout MEFs 
partially restored the 5-FU dependent S-phase delay. The data shown represent 
averages of three independent experiments with fold changes upon 5-FU treatment.
pC, empty vector; pTdg, vector expressing TDG.
Figure 5. TDG dependent activation of DNA damage responses upon 5-FU
treatment. (A-C) TDG mediates late Chk1 activation following 5-FU treatment.
Activation of Chk1 in TDG proficient and deficient MEFs (A) as well as in 
complemented knockout cells (B) was determined by Western blotting with an S345 
phospho-specific antibody against Chk1 (Chk1-Pab). After treatment with 10 µM 5-FU,
wildtype but not TDG deficient MEFs show a strong accumulation of S345 
phosphorylated Chk1. Total Chk1 protein is the same in both MEF lines before and
after 5-FU treatment (Chk1ab). TDG levels in wildtype cells, detected with a specific 
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anti-mTDG antibody (TDGab), are reduced in 5-FU exposed cells, reflecting an 
accumulation of cells in S-phase where TDG is absent. Tdg knockout MEFs stably 
expressing an ectopic copy of Tdg (B) contain low levels of TDG, which is sufficient 
to induce Chk1 activation upon 5-FU treatment. (C) Dynamics of Chk1 activation in 
TDG proficient and deficient MEFs during and after exposure to 5-FU or hydroxyurea 
(HU). The drug containing medium was exchanged after treatment with 10 µM 5-FU
or 2.5 mM HU for 24 or 16 hours, respectively. Samples were taken at the timepoints 
indicated and analyzed for Chk1 S345 phoshorylation by Western blotting. After 16 
hours into treatment, activated Chk1 appears equally in extracts from 5-FU and HU 
treated cells; at 24 hours, the Chk1-p signal is undetectable in the HU treated 
samples and significantly reduced in 5-FU treated cells; at 40 hours, significant levels 
of phosphorylated Chk1 reappear in 5-FU exposed TDG proficient MEFs but not in 
TDG deficient MEFs. (D) The induction of !H2AX foci by 5-FU treatment is 
significantly reduced in TDG deficient MEFs. The top panels show examples of MEFs 
immuno-stained with a monoclonal antibody against !H2AX (!H2AX mab) after 
treatment with 5 µM 5-FU. The statistical analysis of !H2AX foci per cell across the 
populations analyzed (n > 95 cells per population) is depicted in the lower panel as 
scatter plot with medians and the interquartile ranges. pC, empty vector; pTdg, vector 
expressing TDG; TDG-S, TDG modified with SUMO; *, unspecific cross-reaction of 
the secondary antibody
Figure 6. TDG dependent 5-FU cytotoxicity. Illustrated are the cell cycle 
distribution of the three relevant UDGs, TDG, UNG2 and Smug1 (top), together with 
expected levels of genomic 5-FU, uracil, AP-sites and the observed Chk1 activation 
following 5-FU treatment (bottom). TDG is present during the G2/M and G1 phases 
but is degraded prior to and absent from S-phase. UNG2 shows a strictly inverse 
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regulation whereas Smug1 is expressed throughout the entire cell cycle. Treatment
with 5-FU for 24 hours gives rise to misincorporation of appreciable levels of 5-FU
and uracil during S-phase (S1), resulting in Chk1 activation by ongoing replication
associated UNG2 and Smug1-dependent BER. Although Smug1 and UNG2 will
initiate faithful repair of uracil and 5-FU bases directly after DNA synthesis, these
pathways will become saturated under 5-FU exposure and, in addition, are relatively 
inefficient in processing the 5-FU•A base pairs. Hence, some of them will persist in 
the DNA into the subsequent G2 and G1 phases of the cell cycle. There TDG will
initiate repair but turnover with a low rate, leading to an accumulation of AP-sites
and/or DNA single strand-breaks. During the subsequent S-phase, these repair 
intermediates will interfere with DNA replication, causing replication fork stalling, fork 
collapse, DNA double strand breaks and a second round of Chk1 activation. Due to 
genome fragmentation cells will then induce apoptosis.
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2Supplemental experimental procedures
Analysis of growth
For real-time analysis of cell growth during 5-Fu treatment, cells were seeded in 
12-well plates at ~5% confluence. Following a preincubation of 24 hours, the growth 
medium was exchanged with medium containing 5-FU concentrations as indicated in 
the figure. The assessment of cell growth was performed with automated IncuCyte™
microscope (Essen Instruments, USA) by taking nine pictures per well and hour. The 
calculation of confluence and further analysis was performed with the IncuCyte™
software interface.
Supplemental figure legends
Figure S1. MEFs heterozygous for TDG display an intermediate Fu sensitivity.
The sensitivity of TDG+/+, TDG+/- and TDG-/-cell lines to increasing amounts of Fu was 
measured after a continuous treatment of 48 hours. The panel shows cell survival as 
percent of untreated cells averaged from three independent experiments. When 
compared to wt MEF cells carrying a homozygous disruption of the TDG gene were 
hyperresistant to Fu treatment. The sensitivity of a cell line with heterozygous TDG
genotype was in between the sensitivities measured for wt and knockout MEF. Error
bars represent standard deviations.
Figure S2. Different effects of 5-Fu treatment on cell growth of TDG proficient 
and deficient MEFs. The growth of asynchronic TDG wildtype (Tdg+/+) and knockout 
(Tdg-/-) MEF cultures was monitored in real-time during treatment with different 
concentrations of 5-FU. Whereas 5-FU treatment resulted in cell toxicity for wildtype 
cells, it only caused slow growth in the case of knockout MEF cultures. Curves 
3represent the mean confluence at the respective time points and error bars represent 
standard deviations of 3 independent cultures.
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ABSTRACT
Human Thymine-DNA Glycosylase (TDG) is a
member of the uracil DNA glycosylase (UDG) super-
family. It excises uracil, thymine and a number of
chemical base lesions when mispaired with guanine
in double-stranded DNA. These activities are not
unique to TDG; at least three additional proteins
with similar enzymatic properties are present in
mammalian cells. The successful co-evolution of
these enzymes implies the existence of non-
redundant biological functions that must be coordi-
nated. Here, we report cell cycle regulation as a
mechanism for the functional separation of appar-
ently redundant DNA glycosylases. We show that
cells entering S-phase eliminate TDG through the
ubiquitin–proteasome system and then maintain a
TDG-free condition until G2. Incomplete degrada-
tion of ectopically expressed TDG impedes S-phase
progression and cell proliferation. The mode of cell
cycle regulation of TDG is strictly inverse to that of
UNG2, which peaks in and throughout S-phase
and then declines to undetectable levels until it
appears again just before the next S-phase.
Thus, TDG- and UNG2-dependent base excision
repair alternates throughout the cell cycle, and
the ubiquitin–proteasome pathway constitutes the
underlying regulatory system.
INTRODUCTION
Uracil (U) arises in DNA either by erroneous incorpora-
tion of dUMP opposite adenine (A) during DNA
synthesis or by deamination of cytosine (C), which
generates a U mispaired with guanine (G). To what
extent AU base pairs affect the function of DNA is
unclear; GU mispairs, however, give rise to C!T
mutations if a DNA polymerase replicates across. Uracil
DNA glycosylases (UDGs) (1) have evolved to eliminate
this irregular base from the DNA. They hydrolyze the
N-glycosidic bond linking the U to the sugar moiety of the
nucleotide, thereby initiating a base excision repair (BER)
process (2) that restores the canonical Watson–Crick base
pair. Mammalian cells posses at least four enzymes with
UDG activity, namely UNG, TDG, SMUG1 and MBD4
(3–6), and the successful co-evolution of these enzymes
implies that each of them fulfils specific non-redundant
biological functions. The question then is how cells
achieve the functional separation of these enzymatically
redundant activities. One way would be to control their
spatial and temporal distribution as exemplified by the
UNG proteins. Differential expression of the human UNG
gene from two alternative promoters generates two
isoforms, UNG1 and UNG2, that localize to mitochon-
dria and to nuclei, respectively (7). Moreover, UNG2
expression is up-regulated during S-phase of the cell cycle
where the protein associates with PCNA and RPA at
replication foci, implicating a role for this UDG in the
removal of misincorporated U during DNA replication
(8,9). Whether similar forms of regulation apply
to other UDGs and, thus, could provide a cellular
mechanism for functional coordination of uracil repair is
not known. Here, we report that Thymine-DNA
Glycosylase (TDG), a mismatch-specific UDG, underlies
strict cell cycle regulation. TDG has a comparably broad
substrate spectrum including the deamination product of
5-methylcytosine, i.e. a T mispaired with a G, but its
most efficiently processed physiological substrate is a GU
mispair (6). Cells entering S-phase eliminate this glycosy-
lase through the ubiquitin–proteasome pathway and
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maintain a TDG free state until DNA replication is
completed. Degradation of TDG is critical for S-phase
progression and cell proliferation, implicating that this
UDG interferes negatively with vital processes of DNA
replication. Strikingly, TDG levels decline just when
UNG2 expression comes up and vice versa, suggesting
that uracil repair is handled by distinct pathways
throughout the cell cycle that are coordinated by the
ubiquitin–proteasome system.
MATERIAL AND METHODS
Reagents and antibodies and expression constructs
The completeTM protease inhibitor tablets were purchased
from Roche (Switzerland). All other chemicals and
reagents were from Sigma (Germany). All media and
supplements used for cell culture were purchased from
Gibco BRL (Invitrogen, UK). The polyclonal and
monoclonal (99) anti-TDG antibodies were described
earlier (Hardeland et al., 2002), anti-ubiquitin (P4D1)
and anti-cyclin B1 (GNS 1) antibodies were from Santa
Cruz Biotechnology, Inc. (CA, USA), anti-HA (3F10)
antibody from Roche (Switzerland), anti cyclin A
(BF 683) from Milliporee (MA, USA) and anti-cyclin E
(Ab-1, Ab-2) antibodies from Labvision (CA, USA),
and anti-UNG (ab23926) and anti MBD4 (ab12187)
antibodies from Abcam (UK). The anti-b-tubulin anti-
body (N37) and the secondary horse-radish-peroxidase
conjugated antibodies were purchased from GE
Healthcare Life Sciences (Germany). The plasmid
constructs expressing HA-TDG or HA-TDGN140A have
been previously described (10).
Cell culturing, cell cycle synchronizations, protein extractions
MRC5 cells were cultured in Nutrition Mix Ham’s F-10
medium with Glutamax I, HeLa, HeLa S3 and 293T cells
were grown in Dulbecco’s modified Eagle’s (DMEM)
medium containing 2mM L-glutamine, both supplemen-
ted with 10% fetal calf serum and antibiotics (penicillin/
streptomycin). For HeLa cells stably or transiently
transfected with TDG expression constructs, the medium
was supplemented with 0.8 or 0.2mg/ml puromycin,
respectively. Stably transfected 293T cells were grown in
the presence of 1.5 mg/ml puromycin. All cultures were
incubated at 378C in a humidified atmosphere containing
5% CO2. All transfections were done at 30% confluency
with 1 mg (HeLa cells) or 8 mg (293T cells) of vector
DNA using the Fugene reagent (Roche, Switzerland).
The efficiency of plasmid delivery was estimated by
transfection of pEGFP-N1 (Clontech, USA) under
identical conditions and quantitation of EGFP positive
cells by fluorescence microscopy. Transiently transfected
cells were cultured for 48 h unless stated otherwise.
For cell cycle analysis, 293T cells were seeded onto
microscope slides at a confluency of 50% and allowed to
attach for 7 h in medium at 378C. The slides were then
washed three times in PBS and cells fixed in acetone for
2min at 208C. After short rehydration with PBS, the
slides were covered with staining solution (50 mg/ml
propidium iodide, 200 mg/ml RNaseA) and incubated for
30min at 378C in a humidified chamber. After quick
rinsing in PBS, the slides were covered with 50% glycerol
in PBS and a coverslip and their DNA content analysed
on a laser scanning cytometer, LSC-1 (LSC CompuCyte,
USA). In parallel, cell cycle analyses were done by
standard flow cytometry.
Cell cycle arrest experiments were performed by
treatment of 5 106 HeLa cells at 50% confluency with
either 2.5mM hydroxyurea (HU, 2M stock in H2O),
0.8 mg/ml nocodazole (NO, 1mg/ml stock in DMSO) or
respective amounts of DMSO only. After 16 h, denaturing
extracts were prepared by scraping cells from the culture
plates in 400 ml of lysis buffer I (8M urea, 200mM DTT,
120mM Tris/HCl pH 6.8, 4% SDS, 20% glycerol, 0.01%
bromphenolblue) and heating for 10min at 958C. Equal
sample volumes were then analysed by 10% SDS–
polyacrylamide-gel-electrophoresis (SDS-PAGE) and
western blotting. HeLa S3 cells were synchronized by
harvesting and reseeding detached mitotic cells as follows.
Cells were first cultured to 70% confluency in 8 flasks of
175 cm2 size. To remove all loosely attaching cells, the
cultures were extensively washed with pre-warmed
medium. The washing procedure was repeated after
another 2 h of incubation. After further 2 h, the medium
containing detached mitotic cells was removed and cells
collected by centrifugation. 1.3 106 cells per time point
were replated and grown for the times indicated. At each
time point, cells were washed with 1 PBS pH 7.4 on the
plate and the proteins extracted by direct lysis in 200 ml
lysis buffer I. Equal amounts of extract were then analysed
by SDS-PAGE and western blotting. MRC5 cells were
synchronized by serum starvation followed by mimosine
treatment as described in (11). After release, samples were
taken at different time points and cell extracts prepared for
western blotting (11).
For proteasome inhibition 5 106 HeLa cells at 50%
confluency were treated for 12 h with 20 mM MG132
(20mM stock in DMSO) or an equivalent of DMSO only.
The cells were then washed with PBS and directly lysed by
addition of 400 ml lysis buffer I. For the preparation of
soluble and insoluble protein fractions 2.5 107 MG132
treated cells were lysed with 2ml of lysis buffer II
(50mM Na-phosphate pH 8.0, 125mM NaCl, 1%
NP-40, 0.5mM EDTA, 1mM PMSF, 1 completeTM
protease inhibitors). Soluble and insoluble proteins were
then separated by centrifugation for 15min at 14 000
r.p.m., 48C. After removal of the supernatant (soluble
proteins) the pellet (insoluble proteins) was resuspended in
the same volume. Equal amounts of both fractions were
separated by SDS-PAGE and analysed by western
blotting. Denaturing extracts of MG132 treated cells
were obtained by scraping cells from culture dishes in lysis
buffer III (50mM Tris/HCl pH 7.5, 1% SDS, 5mM DTT)
and heating the suspensions for 10min at 958C.
Immunoprecipitation and western blotting
M-280 tosylactivated Dynabeads (Invitrogen, UK) were
coated with affinity purified rabbit polyclonal anti-TDG
antibody or BSA according to the manufacturer’s proto-
col. An aliquot of 400 ml of the denaturing extracts
of MG132 treated HeLa cells was diluted 1:10 in dilution
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buffer (50mMTris/HCl pH 7.5, 120mMNaCl, 5% glycer-
ol, 1% NP-40, 1mM EDTA, 1mM PMSF and 1
completeTM protease inhibitors) before the addition of
equilibrated Dynabeads (2.4 107 beads/assay). After
incubation for 4 h at 48C under rotation, unbound
proteins were removed and the beads washed three times
with dilution buffer at 48C. Bound proteins were then
eluted in 40 ml of 2 SDS-sample-buffer (200mM DTT,
120mM Tris/HCl pH 6.8, 4% SDS, 20% glycerol, 0.01%
bromphenolblue) and incubation at 958C for 5min.
Following protein separation by 8 or 10% SDS-PAGE,
western blotting was done with antibodies against
TDG and ubiquitin following standard procedures.
All antibodies were diluted in TBS-T (100mM Tris/HCl
pH 8.0, 150mM NaCl, 0.1% Tween20) containing 5%
dry milk as blocking reagent; the polyclonal anti-TDG
antiserum was diluted 1:10 000, the monoclonal anti-TDG
and anti-ubiquitin antibodies 1:1000. Detection of the
signals was carried out using the enhanced chemilumines-
cent (ECLTM) substrate system (GE Healthcare Life
Sciences, Germany).
Immunofluorescence
HeLa cells were grown on coverslips to a confluency of
30%. After washing extensively in PBS, the cells were fixed
for 5min in pre-chilled methanol (208C), re-hydrated for
4 times 10min at room temperature (rT) in PBS, and
permeabilized for 5min in ice-cold P-buffer (PBS, 0.2%
TritonX100). To reduce autofluorescence, the coverslips
were incubated for another 5min in ice-cold P-buffer
containing 0.2% NaBH4. Soluble protein was then washed
out by gently shaking the coverslips in PBS for 10min at
rT. After blocking for 10min at rT in hybridization buffer
(PBS, 1% BSA), samples were hybridized with affinity-
purified polyclonal rabbit anti-TDG- (1:100 dilution) and
a FITC coupled anti-PCNA (1:500, Leinco Technologies,
MO, USA) antibodies at 48C overnight. After four
washing steps of 10min in hybridization buffer at rT,
samples were hybridized with an anti-rabbit IgG Alexa-
546 conjugated secondary antibody (1:200, Invitrogen,
UK) at rT for 1 h. After four washing steps of 10min
in PBS, the coverslips were dried and embedded in
Mowiol containing 1 mg/ml DAPI. TDG and PCNA
signals were visualized on a Axiovert 200M microscope
(Zeiss, Germany) using TRITC (exitation 560 nm,
emission 580 nm) and FITC (exitation 490, emission
520 nm) filters, respectively.
Northern blot analyses
Total RNA was isolated from MRC5 cells using the
TRIzol reagent. RNA concentrations were determined by
A260 measurement and the quality was checked by
electrophoresis on 1% formaldehyde agarose gels.
Twenty microgram of total RNA in formamide loading
buffer were separated in a 1% agarosegel containing
formaldehyde. After washing the gel twice for 10min in
8mM NaOH, the RNA was transferred to a Zeta Probe
membrane (BioRad, CA, USA) overnight in 8mM
NaOH. After a brief washing step with 2 SSC the
transferred RNA was fixed by baking at 808C. Following
pre-hybridization of the membrane at 658C in
hybridization buffer (0.5M Na2PO4 pH 7.2, 7% SDS)
for 5min, hybridization with probe was done for 20 h at
658C. A 32P-labeled PCR fragment (Megaprime Kit, GE
Healthcare Life Sciences, Germany), representing the 50
part of the TDG cDNA served as specific probe. After
hybridization the membrane was washed twice with wash
buffer I (40mM Na2PO4 pH 7.2, 5% SDS) for 20min at
658C, followed by one washing steps with wash buffer II
(40mM Na2PO4 pH 7.2, 1% SDS) at 658C for 10min.
After exposition of the membrane to a phosphoimager
screen, signals were visualized on a Storm phosphoimager
(GE Healthcare Life Sciences, Germany).
Ubiquitylation in vitro
In vitro ubiquitylation reactions were performed with the
ubiquitin conjugation Enzyme Kit (Biotrend, Germany)
according to the manufacturer’s instructions. An aliquot
of 20 ml reactions contained 1MgATP, 5 mg conjugating
fraction I, 5 mg conjugation fraction II, 26 mg ubiquitin
(Biotrend), 200 ng ubiquitin-aldehyde and 10 ng of recom-
binant TDG protein. The reactions were incubated at
378C for 0 and 2 h and stopped by the addition of 4 ml 6
SDS-sample buffer (600mM DTT, 360mM Tris/HCl pH
6.8, 12% SDS, 60% glycerol, 0.03% bromphenolblue).
After heating at 958C for 5min the reaction products were
analysed by 7.5% SDS-PAGE and western blotting with
the polyclonal anti-TDG antibody.
Base release assays
Nuclear extracts were prepared from 108 HeLa cells
harvested after HU (or mock) treatment. Cells were
resuspended in ice-cold hypotonic buffer (20mM HEPES
pH 8.0, 5mM KCl, 1.5mMMgCl2, 0.5mM PMSF, 1mM
DTT, 1 completeTM protease inhibitors) at a cell density
of 1 108 cells/ml and allowed to swell for 20min on ice.
Cells were broken up in a Dounce homogenizer on ice
to achieve 480% lysis and the liberated nuclei were
harvested by centrifugation at 3000g and 48C. After
estimation of the packed nuclear volume (pnv) the pellet
was resuspended in 1/2 pnv low salt buffer (20mM
HEPES pH 8.0, 25% glycerol, 1.5mM MgCl2, 20mM
KCl, 0.2mM EDTA, 0.5mM PMSF, 0.5mM DTT,
1 completeTM protease inhibitors). Nuclear proteins
were extracted by the addition of 1/2 pnv high salt buffer
(low salt buffer but 0.8M KCl) and incubation at 48C
under constant mixing for 30min. The extracted nuclei
were pelleted for 20min at 20 000g and 48C. The super-
natant was dialyzed against storage buffer (20mM
HEPES pH 8.0, 10% glycerol, 1.5mM MgCl2, 5mM
KCl, 0.2mM EDTA, 0.5mM PMSF, 0.5mMDTT, 0.25
completeTM protease inhibitors). The dialyzed extracts
were clarified by centrifugation for 20min at 20 000g and
48C and stored in aliquots at 808C. Protein concentra-
tions were estimated by the Bradford method (BioRad)
using BSA as standard. Base release assays were then done
according to (12) with slight modifications. An aliquot of
40 ml reactions contained 25 mg nuclear extracts and
1 pmol of either double-stranded homoduplex or mis-
matched DNA substrate (12). The reactions were incu-
bated for 24 h at 378C in reaction buffer (50mM Tris-HCl
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pH 8.0, 1mM EDTA, 1mM DTT, 1mg/ml BSA) contain-
ing 2 U UGI. Quantitative cleavage of AP sites was
achieved by the addition of 100mM NaOH and heating at
958C for 10min. Subsequently, DNA was ethanol
precipitated overnight at 208C in 0.3M sodium acetate
pH 5.2 and in the presence of 0.4mg/ml carrier tRNA.
The DNA was then pelleted by centrifugation (20min,
20 000g, 48C), washed once in 80% ethanol, air-dried,
resuspended in formamide loading buffer (1 TBE, 90%
formamide), heated at 958C for 5min and immediately
chilled on ice. The reaction products were separated by
electrophoresis in preheated 15% denaturing polyacryla-
mide gels and 1 TBE buffer. Visualization of the
fluorescein labelled DNA was carried out on a Typhoon
9400 (GE Healthcare, Germany) and the data were
quantified using the ImageQuant TL software (GE
Healthcare, Germany).
RESULTS
S-phase progression requires cell cycle regulation
of TDG-mediated BER
We found in different human cell models (HeLa, 293T,
MRC5) that expression of high levels of TDG is
incompatible with cell proliferation. Although transfec-
tion of various constructs designed for stable TDG
expression produced transiently up to 30-fold the endo-
genous level, any attempt to maintain expression at levels
above 5-fold in culture was unsuccessful. Cell cycle
analyses then revealed that, following transfection with a
TDG expressing construct, a fraction of cells accumulated
specifically in S-phase of the cell cycle. This, however, was
not observed in cell populations transfected with a
catalytically inactive variant of TDG (Figure 1A),
although transient expression levels were equally high.
As previously observed (13), overexpressed TDG localized
strictly to the cell nucleus (data not shown). Upon
cultivation of the cells under conditions selecting for
stable TDG expression, this cell cycle effect disappeared
concomitantly with the drop of TDG protein to55-fold
the endogenous level (Figure 1B). These observations
indicated that high levels of TDG lead to a disturbance of
S-phase progression, thus conferring a selective advantage
to low TDG expressing cells, i.e. the loss of high
expressing cells, in the culture.
These findings prompted us to examine whether TDG
expression underlies cell cycle regulation. To this end, we
made use of two stably transfected HeLa cell populations,
one expressing an N-terminally HA-tagged TDG from an
SV40 promoter at 5-fold the level of the endogenous
protein (10), the other serving as a vector control and,
thus, producing endogenous TDG only. We treated these
cells with hydroxyurea (HU) or nocodazole (NO) to
induce S- or G2/M-phase arrests, respectively, and then
assessed TDG protein levels in denaturing cell extracts by
immunoblotting with anti-TDG or anti-HA antibodies.
To monitor the cell cycle status, we probed the membranes
additionally with antibodies against cyclin E or cyclin B1
(Figure 2A). This showed that endogenous (Figure 2B) as
well as ectopically expressed (Figure 2C) TDG was
Figure 1. 293T cells expressing high levels of TDG accumulate
in S-phase. (A) 293T cells were transiently co-transfected with a
plasmid overexpressing either active HA-TDG (pTDG), the catalyti-
cally inactive variant HA-TDG/N140A (pTDGN140A), or a vector
control (pHH), and a EGFP expressing plasmid at a 10:1 ratio. The
histogram shows the cell cycle distribution of transfected cells gated for
EGFP positive cells, as determined by flow cytometry. The bottom
panel documents TDG protein levels of the respective total cell
population as determined by western blotting. TDG levels in cell
populations carrying the overexpression construct were elevated by
20–30-fold. High levels of HA-TDG expression significantly increased
the fraction of S-phase cells. This change in cell cycle distribution
required TDG to be active, as overexpression of HA-TDG/N140A
failed to produce the same effect. (B) The histogram shows the cell
cycle distribution of 293T cells expressing active HA-TDG (pTDG) two
days after transfection (2d) or after two weeks of selection for stable
expression (2w). A vector control was also included (pHH). TDG
expression levels are documented by western blots in the bottom panel.
Shortly after transfection, TDG protein levels were 20–30 times higher
than normal, but dropped to about three times the amount of
endogenous TDG after selection. Concomitantly, the cell cycle effect
seen after transfection disappeared. P-values (asterisk) were obtained
by the Fisher’s exact test from contingency tables comparing the
distributions of G1-, S- and G2-cells. (Open circle) Unspecific cross-
reaction of the primary antibody. (Filled square) Faster migrating
forms of TDG. HA-/TDG-S: SUMO-modified HA-TDG and endo-
genous TDG, respectively.
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virtually undetectable in S-phase arrested cells. Residual
TDG signals likely reflected traces of protein from
contaminating G2/M cells, as indicated by the low
amounts of cyclin B1 in these extracts. Base excision
assays with nuclear extracts (12) then revealed a425-fold
reduction of GT glycosylase activity in HU-arrested
HeLa cells (Figure 2D), and this correlated directly with
the decline of TDG protein. MBD4, another mismatch-
specific thymine-DNA glycosylase (5), did not contribute
notably to GT processing in these extracts (Figure 2D).
Given the slight enrichment of the enzyme in S-phase
arrested cells and that recombinant MBD4 is active under
identical experimental conditions (data not shown), this
must be interpreted to mean that GT processing by BER
is largely TDG dependent and does not occur during
S-phase. By contrast, GU processing did not correlate
with TDG protein levels. Considering that these base
release reactions were done in the presence of a 4-fold
saturating amount of the UNG-inhibitory UGI peptide
and that MBD4 appears to be poorly active in these
extracts, the uracil processing observed in the S-phase
arrested cells most likely reflected the activity of SMUG1.
In the absence of the UGI-peptide, however, UNG2 was
clearly the predominant uracil processing activity in these
extracts (data not shown). Together, these experiments
showed that HeLa cells down-regulate TDG protein and
activity during S-phase and are able to do so even when it
is stably expressed from an SV40 promoter at levels up to
five times higher than normal.
To exclude that the HU treatment itself affects TDG
stability, we examined its levels in synchronously cycling
cell populations. Mitotic shake off experiments with
HeLaS3 cells confirmed that TDG protein peaks during
G1 and drops in S-phase (Figure 3A). Here, the
disappearance of TDG coincided with the appearance of
cyclin A (14), suggesting that downregulation occurs at
the G1/S boundary. This experiment also confirmed the
strict cell cycle regulation of the nuclear form of the highly
efficient UNG (8,9) and thus, established that the
expression of TDG and UNG2 is perfectly anti-cyclic
with at most two short phases of overlap in late G1 and
early G2 of the cell cycle.
Next, we performed immunofluorescence (IF) micro-
scopy to correlate TDG expression with the PCNA status
in an asynchronous HeLa cell population. This confirmed
the absence of TDG from nuclei with focal PCNA pattern,
i.e. from S-phase nuclei (Figure 3B). Ninety-two percent
of cells with PCNA foci were TDG negative, whereas 96%
of cells with diffuse PCNA staining had a strong nuclear
TDG signal. Moreover, more than two-thirds of the nuclei
with PCNA foci were in an early stage of DNA replication
(15) and the vast majority of them (89%) were TDG
negative. Together, these data establish that the decline of
TDG in HeLa cells occurs at the G1–S transition, the
latest in early S-phase.
Finally, we ascertained the cell cycle regulation of TDG
in human primary fibroblasts. We synchronized MRC5
cells in early S-phase by serum starvation and mimosine
treatment (16) and extracted protein and RNA from
cells harvested at different time points following release
into S-phase. Examination of the protein extracts by
immunoblotting then showed that TDG was virtually
undetectable at the mimosine block and for 10 h post-
release (Figure 4A). According to the cyclin E and B1
expression patterns, this time period represented the
progression of the cell population through S-phase. In
G2, the TDG levels started to increase until they reached a
maximum in the subsequent G1-phase. Examination of
the steady-state levels of the TDG transcript by northern
blotting showed only marginal fluctuations throughout
Figure 2. TDG is absent in S-phase arrested HeLa cells. (A) Schematic
illustration of expression of cyclin E, cyclin A and cyclin B during the
cell cycle. (B and C) HeLa cells expressing endogenous TDG alone or
together with HA-TDG were blocked in S-phase with hydroxyurea
(HU) or in G2/M with nocodazole (NO). Untreated asynchronous cells
(-) and DMSO (DM) mock-treated cells were analysed in parallel.
Denaturing cell extracts were examined by western blotting with
antibodies against TDG or the HA-tag as indicated. Antibodies against
Cyclin E and Cyclin B1 were applied to monitor the cell cycle arrest;
b-tubulin staining served as a loading control. A monoclonal anti-TDG
antibody (TDGmab) detected endogenous TDG in extracts of untreated,
mock treated or G2/M arrested cells, but none in extracts from S-phase
arrested cells (B). Ectopically expressed HA-TDG also declined in HU
arrested cells, although faint TDG (TDGmab) and HA- (HAmab) -
specific signals were still discernible (C). (D) Base release assays with
a fluorescent-labelled synthetic 60-mer DNA duplex document a
significant reduction of GT processing activity in nuclear extracts
from HU-arrested HeLa cells. The assay was done with 25 mg of
nuclear extract supplemented with 2U of UNG2 inhibitory UGI
peptide. A denaturing polyarcylamide gel with the intact DNA strand
migrating at the top (S) and the cleaved products occurring as a
consequence of GT processing (P) are shown. Immunoblots of the
corresponding cell extracts with TDG and MBD4-specific antibodies
are shown on the right. (Filled square) Faster migrating forms of TDG.
HA-/TDG-S: SUMO-modified HA-TDG and endogenous TDG,
respectively.
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the cell cycle (Figure 4B), which cannot account for the
dramatic changes seen at the protein level. Hence, cell-
cycle-dependent expression of TDG applies to different
human cell types and does not involve regulation at the
levels of promoter activity or mRNA stability.
TDG is targeted by ubiquitin for proteasomal degradation
We then addressed a possible role of posttranslational
modifications in the regulation of TDG. To examine
whether the glycosylase is subject to degradation by the
ubiquitin–proteasome system (17), we measured the effect
of MG132, a reversible inhibitor of the 26S proteasome,
on the TDG protein level in asynchronously proliferating
HeLa cells. Cells treated with MG132 had clearly elevated
steady-state levels of TDG (Figure 5A). This effect,
however, was only apparent when extracts were prepared
under denaturing conditions, the reason being a change in
TDG solubility upon proteasome inhibition. While TDG
extracted predominantly in the soluble protein fraction in
untreated cells, a substantial amount became insoluble
after MG132 treatment (Figure S1A), just like the
majority of ubiquitin-conjugated proteins (Figure S2B).
Following these indications for ubiquitylation of TDG, we
prepared denaturing extracts from HeLa cells, again
expressing either endogenous TDG alone or together
with HA-TDG, for immunoprecipitation (IP). IP with an
affinity-purified polyclonal TDG antibody then led to the
expected enrichment of the glycosylase as evident from
immunoblotting with a monoclonal TDG antibody
(Figure 5B, left panel). The same antibody, however,
Figure 3. Cell cycle regulation of TDG in non-arrested cells.
(A) HeLa S3 cells were synchronized by mitotic shake off.
Following re-plating, TDG, UNG2 and MBD4 expression was
examined in a time course (TC) of 21 h. At the time point indicated,
cell extracts were prepared under denaturing conditions and
analysed by western blotting with specific antibodies as indicated
on the left. The cell cycle phases indicated at the bottom were
deduced from the expression of cyclin A (S–G2/M) and E (G1–S).
b-tubulin detection served as loading control. The monoclonal
anti-TDG antibody detected TDG in mitotic and G1 cells (TC 0-9)
and in G2/M cells (TC 18). No TDG was detectable in S-phase cells
(TC 12,15). The disappearance of TDG at 12 h coincided with the
de novo expression of cyclin A, indicating a downregulation of
TDG at the G1/S boundary. By contrast, nuclear UNG2 was
detectable between 9 and 18 h with a peak at 12 h, representing cells
in S-phase. Mitochondrial UNG1 did not fluctuate throughout the
cell cycle, nor did MBD4, which shows only slightly increased
expression around S-phase. (B) Immunofluorescence staining of
endogenous TDG and PCNA illustrate the absence of TDG
from S-phase nuclei. Upper cell, TDG positive cell with diffuse
PCNA staining; lower cell, TDG negative cell with PCNA staining
indicating early to mid S-phase; middle cell, TDG negative
cell with fewer and larger PCNA foci indicating late S-phase.
Shown are typical events of 500 randomly chosen cells scored and
classified as indicated in the table at the bottom. Asterisk: statistically
significant difference, P50.0001 by contingency tables and Fisher’s
exact test; TDG-S: endogenous TDG modified with SUMO.
Figure 4. TDG protein levels fluctuate during the cell cycle in primary
cells but mRNA is constitutively transcribed. MRC5 primary fibro-
blasts were synchronized in early S-phase by serum starvation and
mimosine treatment. (A) Western blot analyses of protein extracts
prepared from asynchronous cells (AS), serum starved cells (ST) and
cells harvested at indicated times (TP hours) after release from the
mimosine block. Proteins examined were endogenous TDG, Cyclin E,
Cyclin B1 and b-tubulin as a loading control. TDG-specific signals
appeared at 12 h after release into S-phase and increased gradually to
the levels found in the asynchronous culture. Expression of cyclin
E and cyclin B1 coincided with the lack or the presence of TDG,
respectively. (B) Northern blot analysis of TDG and GAPDH mRNAs
(loading control) at corresponding time points, showing that TDG-
specific mRNA was detectable throughout the cell cycle. TDG-S:
endogenous TDG modified with SUMO.
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also detected a smear of high molecular weight proteins in
the TDG-IP’s from extracts of proteasome inhibited cells.
These signals were more pronounced in the extracts
containing additional HA-TDG. Probing of the mem-
brane with a specific anti-ubiquitin antibody revealed
proteins at high molecular weight, resembling the pattern
observed with the TDG antibody (Figure 5B, right panel).
Thus, polyubiquitylated protein species co-precipitated
with a TDG-specific antibody from extracts of proteasome
inhibited cells. Unspecific binding of ubiquitylated pro-
teins to the beads did not occur (see control IP), and, given
the denaturing conditions applied for extract preparation,
unspecific binding of ubiquitylated proteins to TDG can
also be virtually excluded. We therefore conclude that the
proteins recognized by the anti-ubiquitin antibody must
be TDG isoforms carrying polyubiquitin chains of
different lengths. To formally prove its susceptibility to
ubiquitin conjugation, we subjected bacterially produced
TDG to ubiquitylation in an in vitro reconstituted assay.
This indeed produced TDG isoforms of increased
molecular weight (Figure 5C). The reaction, however,
was inefficient, indicating that ubiquitylation in vivo may
require priming of TDG, possibly by phosphorylation, to
stimulate its interaction with an E3 ubiquitin ligase (18).
Taken together, our data strongly suggest that polyubiq-
uitylation and proteasomal degradation is the mechanism
underlying the disappearance of TDG at the G1/S
boundary of the cell cycle. TDG was also shown to be
target for SUMO conjugation in cells (10). To address
whether SUMO modification contributes to the cell cycle
regulation of TDG, we examined the behaviour of an
ectopically expressed SUMOylation-deficient TDG var-
iant (HA-TDGK330A) upon HU or NO treatment of the
cells. The protein was absent from S-phase cells and
enriched at the G2/M stage, exactly as the wild-type
control (Figure S1C), establishing that SUMO modifica-
tion neither positively nor negatively interferes with TDG
ubiquitylation and proteasome degradation.
DISCUSSION
Our data establish that two prominent members of the
UDG family, TDG and UNG2, underlie strict anticyclic
cell cycle regulation. While TDG is highly expressed
throughout the G2-M and G1 phases its levels rapidly
Figure 5. TDG is polyubiquitylated and stabilized by proteasome inhibition. (A) Asynchronous HeLa cultures were treated with the proteasome
inhibitor MG132 (20 mM) or DMSO. Cell extracts prepared under denaturing conditions were analysed by western blotting with a polyclonal
anti-TDG (TDGab) and an anti-b-tubulin antibody (b-tubab). SUMOylated and unmodified TDG increased after proteasome inhibition. (B) HeLa
cells stably transfected with a HA-TDG (pTDG) expression construct or the vector (pHH) were treated with MG132 or DMSO. Cell extracts
prepared under denaturing conditions were subjected to TDG-IP with an affinity purified polyclonal anti-TDG antibody (TDGab). Bound protein
fractions were analysed by western blotting with the monoclonal anti-TDG (TDGmab, left panel) or an anti-ubiquitin antibody (ubiquitinab, right
panel). Strong signals appeared in the TDG-IPs but none in the IP-controls. TDG-specific signals smearing towards higher molecular weights
indicated an accumulation of modified TDG in extracts of MG132 treated cells. The anti-ubiquitin antibody detected proteins with comparable
migration properties in the corresponding TDG-IP protein fractions. (C) 10 ng of purified recombinant TDG were subjected to in vitro
ubiquitylation. Shown is a western blot with the polyclonal anti-TDG antibody of aliquots taken at 0 and 2 h of incubation, and of a control reaction
lacking TDG. The appearance of TDG-dependent high molecular weight bands after 2 h indicates ubiquitylation of TDG. (Asterisk), protein
co-precipitating in TDG-IP and cross-reacting with the secondary antibody used; (Open circle) Components of the ubiquitylation system cross-
reacting with the anti-TDG antibody.
Nucleic Acids Research, 2007, Vol. 35, No. 11 3865
decline at the G1–S transition just when UNG2 starts to
rise above background. The UNG2 protein then peaks
at the beginning of S-phase and gradually declines
towards termination of DNA replication (see also
reference 9), when TDG expression resumes. This
implicates that the two biochemically redundant UDGs
control non-redundant, cell cycle stage-specific pathways
for uracil repair; while UNG2 is active during DNA
replication, TDG functions in non-replicating DNA,
notably, when U arises mainly through deamination of
cytosine. Strikingly, although the pattern of cell cycle
regulation of the two UDGs is diametrically opposed, the
underlying mechanism appears to be the same. As shown
here for TDG and reported previously for UNG2 (9),
both are subject to cell cycle controlled ubiquitylation and
proteasome degradation. Thus, the ubiquitin–proteasome
system appears to be at the heart of the coordination of
redundant BER pathways, which would be an as yet
unrecognized function. Whether this interesting concept of
coordination is a feature restricted to TDG and UNG2
only, or whether it applies more generally to DNA repair
remains to be resolved.
We wanted to get some insight into why TDG needs to
be eliminated before S-phase from ectopically expressing
the glycosylase to levels saturating its degradation.
TDG expression at430-fold the endogenous level could
readily be obtained by transient transfection, and such
amounts were indeed saturating in the sense that low
amounts of the protein remained detectable in S-phase
arrested cell populations. Yet, attempts to maintain high
expression in culture failed; upon selection of stable
clones, TDG expression declined to levels 55-fold that
were compatible with complete degradation of the protein
in S-phase. Thus, the presence of TDG in S-phase seems
incompatible with cell cycle progression and proliferation,
and this is in line with the observation that 293T cells
transiently expressing high levels of wild-type TDG
accumulate in S-phase.
Interference with S-phase progression might occur at
the level of U excision (1). If misincorporated, U must be
eliminated from newly synthesized DNA in a way that is
coordinated with the replication process. Given its
enzymatic properties, TDG would be totally unsuited
for this task; by processing AU only inefficiently (19)
and binding to AP sites with high affinity (10,20), it would
perturb the replication process. By contrast, UNG2
would be the glycosylase of choice here; it processes
UA with a comparably high rate, and it associates with
replication factors at the replication fork. Consistently,
UNG was shown to keep genomic uracil levels low
(1,8,21,22).
Considering the rather broad substrate spectrum of
TDG (19), however, its presence in S-phase might cause
other forms of interference. TDG could induce the
formation of DNA double-strand breaks either directly,
if it removed substrate bases close to each other in
opposite DNA strands, or indirectly, through the genera-
tion of replication blocking lesions such as AP sites or
single-strand breaks. The latter would be aided by
the inability of TDG to dissociate freely from AP sites
(12,20). In vitro, AP-site release is facilitated by a
SUMOylation-induced conformational change in TDG,
a rate-limiting step that appears useful for a temporary
protection of the labile intermediate in the repair process
(10,23). The protective nature of this dissociation delay,
however, may turn into a disadvantage in the context of
DNA replication; it might generate situations where TDG
is bound to AP sites in front of an approaching replication
fork where it acts as a road block, causing fork stalling
and eventually collapse.
A special case of mutagenic interference during S-phase
may relate to TDG’s ability to remove T from GT
mismatches. While this feature provides an excellent
means to counter mutagenesis by deamination of 5-meC,
it may represent a disadvantage during DNA replication,
where GT mispairs arise predominantly by DNA
polymerase errors. The inability of TDG to discriminate
between parental and newly synthesized DNA strands
would fix C to T transition mutations in cases where the T
is in the parental strand. In addition, TDG induced
postreplicative GT repair in the parental DNA strand,
particularly in the parental lagging strand, could destabi-
lize the replication fork and thereby impede the replication
process. Thus, GT correction during DNA synthesis
should be left to the postreplicative mismatch repair
system, which is designed to correct the error in the newly
synthesized DNA strand.
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Summary
Alterations in DNA repair lead to genomic instability
and higher risk of cancer. DNA base excision repair
(BER) corrects damaged bases, apurinic sites, and
single-strand DNA breaks. Here, a regulatory mecha-
nism for DNA polymerase b (Pol b) is described. Pol
b was found to form a complex with the protein argi-
ninemethyltransferase 6 (PRMT6) andwas specifically
methylated in vitro and in vivo. Methylation of Pol b by
PRMT6 strongly stimulated DNA polymerase activity
by enhancingDNAbinding andprocessivity, while sin-
gle nucleotide insertion and dRP-lyase activity were
not affected. Two residues, R83 and R152, were identi-
fied in Pol b as the sites of methylation by PRMT6. Ge-
netic complementation of Pol b knockout cells with
R83/152K mutant revealed the importance of these
residues for the cellular resistance to DNA alkylating
agent. Based on our findings, we propose that PRMT6
plays a role as a regulator of BER.
Introduction
Mammalian cells developed multiple mechanisms for
the maintenance of their genome integrity (Hoeijmakers,
2001). DNA base excision repair (BER) corrects dam-
aged bases, apurinic sites, and single-strand DNA
breaks (Nilsen and Krokan, 2001). In mammalian cells,
BER can proceed through at least two pathways, desig-
nated as ‘‘short-patch’’ and ‘‘long-patch’’ BER (Hoeij-
makers, 2001). The two pathways are distinguished
not only by the repair patch sizes but also by the contri-
bution of factors involved (Biade et al., 1998; Klungland
and Lindahl, 1997).
Mammalian DNA polymerase b (Pol b) is a small, con-
stitutively expressed DNA polymerase (Hubscher et al.,
2002) implicated in BER (Idriss et al., 2002; Sobol et al.,
1996). The multifunctional, single polypeptide enzyme
consists of 335 amino acids that build two functional do-
mains connected by a protease-sensitive hinge region
(Idriss et al., 2002). TheN-terminal 8 kDa domain harbors
the dRP-lyase activity, whereas the 31 kDa C-terminal
domain constitutes the nucleotidyltransferase function
(Casas-Finet et al., 1991; Matsumoto and Kim, 1995;
Prasad et al., 1998). Structurally, the 31 kDa domain is
composed of the fingers, palm, and thumb subdomains
arranged to form a DNA binding channel reminiscent of
the architecture of the Klenow fragment of Escherichia
coli Pol I (Sawaya et al., 1994) and many other pols
(Steitz, 1999). Pol b has the ability to fill in short single-
stranded DNA gaps up to 12 nucleotides (Singhal and
Wilson, 1993) but lacks an associated exonuclease or
proofreading activity. Furthermore, it catalyzes the
b elimination of 50 dRP residues generated by the AP-en-
donuclease during BER (Matsumoto and Kim, 1995).
Knockout (2/2) mice deficient in Pol b are nonviable,
and fibroblast cell lines derived from Pol b2/2 embryos
display marked hypersensitivity toward monofunctional
DNA alkylating agents (Sobol et al., 1996).
The enzymatic activities of Pol b have to be tightly co-
ordinated in order to guarantee accurate repair of dam-
aged DNA bases. The regulation of the polymerase
activity of Pol b by posttranslational modification such
as phosphorylation has already been described in vitro
(Tokui et al., 1991). We provided earlier evidence that
Pol b is acetylated by the transcriptional coactivator
p300 (Hasan et al., 2002). Acetylation at K72 in vitro spe-
cifically reduces the dRP-lyase activity of Pol b, while its
polymerase and AP-lyase activities were not affected
(Hasan et al., 2002).
Protein arginine methylation is a posttranslational
modification that results in symmetrical or asymmetrical
dimethylarginines (Gary and Clarke, 1998). In humans,
protein arginine methyltransferases (PRMTs) represent
a family of eight known enzymes that utilize S-adenosyl
methionine as a methyl donor (McBride and Silver,
2001). Despite the high degree of homology within the
methyltransferase domain, there is only minor overlap
in the protein substrate specificity of the mammalian
PRMTs (Bedford and Richard, 2005). PRMTs were de-
scribed to be involved in various signaling pathways
(Aletta et al., 1998) including mitogen (Fabbrizio et al.,
2002; Lin et al., 1996), steroid hormone (An et al., 2004;
Metivier et al., 2003; Strahl et al., 1999), cytokine (Kwak
et al., 2003; Covic et al., 2005), DNA damage (An et al.,
2004), PMA (Ma et al., 2004), and interferon signaling
(Mowen et al., 2001). The diversity of reported methyl-
ated substrates suggests that this typically eukaryotic
modification may parallel other modifications in their
level of complexity. Protein arginine methyltransferase
6 (PRMT6) was recently identified by sequence searches
of the human genome for new PRMTs (Frankel et al.,
2002; Miranda et al., 2004). PRMT6 displays automethy-
lation activity and has distinct substrate specificity when
*Correspondence: hottiger@vetbio.unizh.ch
4These authors contributed equally to this work.
compared to PRMT1 and PRMT4/CARM1 (Frankel et al.,
2002).
To date, several proteins involved in BER have been
shown to be regulated by different posttranslational
modifications (Fan and Wilson, 2005). In this study, we
show that Pol b forms a complex with and is methylated
by PRMT6. Furthermore, we demonstrate that in vitro-
methylated Pol b possesses significantly higher DNA
polymerase activity when compared to that of unmodi-
fied enzyme. The increase in DNA polymerase activity
uponmethylation was due to the enhanced DNA binding
and processivity of Pol b. Mutation of methylation sites
identified in Pol b significantly reduced the ability of en-
zyme to protect complemented Pol b2/2 cells against
MMS-induced DNA damage. Together, our results sug-
gest that PRMT6, a member of the methyltransferase
family, might play a direct role in the regulation of DNA
repair processes.
Results
Pol b Forms a Complex with PRMT6
To examine whether members of the PRMTs are able to
interact with Pol b, we performed immunoprecipitations
of PRMTs from total extracts of 293T cells transfected
with different myc-tagged PRMTs and supplemented
with recombinant Pol b. Pol b was specifically coimmu-
noprecipitated with PRMT6, suggesting that both pro-
teins may form specific complexes (Figure 1A and data
not shown).
To investigate whether PRMT6 directly interacts with
Pol b, we performed in vitro GST pull-down experiments.
Purified full-length His-tagged Pol b was incubated with
affinity-purifiedGST-PRMT6 fusion protein or GST alone
immobilized on glutathione-Sepharose beads. After
extensive wash of the beads, bound proteins were sep-
arated by SDS-PAGE, and Pol bwas detected by immu-
noblot analysis. We observed that purified GST-PRMT6,
but not GST, efficiently pulled down Pol b (Figure 1B),
suggesting that PRMT6 directly interacts with Pol b.
The Lyase Domain of Pol b Is Required
for the Interaction with PRMT6
To further characterize the interaction of Pol b with
PRMT6, different deletion mutants of Pol b were gener-
ated, expressed in E. coli, and purified as His-tagged
proteins (Figure 1C). Two of these mutants lacked the
C-terminal thumb or both thumb/palm subdomains,
Figure 1. Pol b Directly Interacts with PRMT6
through Its dRP-Lyase Domain
(A) Myc-PRMT6 was immunoprecipitated
from 293T extracts supplemented with re-
combinant 6His-Pol b using an anti-myc anti-
body (or a mouse antibody as a control).
Coimmunoprecipitated proteins were ana-
lyzed by immunoblot using an anti-Pol b anti-
body.
(B) GST pull-down experiment using 6His-
tagged Pol b and GST-PRMT6 (or GST as
a control).
(C) Schematic representation of Pol b and de-
letion mutants.
(D) Full-length Pol b and deletion mutants of
Pol b were analyzed in GST pull-down exper-
iments usingGST-PRMT6 (orGST as control).
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respectively. A third mutant lacked the N-terminal lyase
domain. GST pull-down experiments were performed
with these deletion mutants of Pol b using GST-PRMT6
or GST alone as a negative control. This experiment re-
vealed that Pol b lacking the lyase domain was no longer
able to interact with PRMT6 (Figure 1D). In contrast, de-
letion of the thumb or thumb/palm regions in Pol b did
not affect the interaction of Pol bwith PRMT6. Together,
these results indicate that the lyase domain of Pol b is
strictly required for the interaction with PRMT6.
Pol b Is Methylated In Vitro by PRMT6
Since PRMT6 and Pol b interacted directly, we next in-
vestigated whether Pol b could serve as a substrate
for PRMT6 in an in vitro methylation assay. GST-
PRMT6 expressed and purified from bacteria was incu-
bated with recombinant Pol b in the presence of radiola-
beled S-adenosyl methionine (C14-SAM) as a donor of
the methyl group. Core histones and Fen-1 were used
aspositive and negative controls ofmethylation, respec-
tively. Pol b was strongly methylated by GST-PRMT6
bound to glutathione beads (Figure 2A). Moreover,
methylation of Pol b was observed with baculovirus ex-
pressed and purified full-length PRMT6 (data not
shown), indicating that methylation of Pol b was indeed
mediated by PRMT6. Quantitation of the methylation ef-
ficiency revealed that 20% of the Pol b molecules were
methylated in standard reactions in the presence of
a 10-foldmolar excess of C14-SAM (one site of modifica-
tion was considered).
Identification of PRMT6 Methylation Sites in Pol b
To identify the methylated residues, in vitro-methylated
Pol bwas digestedwith trypsin or chymotrypsin, and the
resulting peptides were analyzed by LC/MS/MS. Two
monomethylated peptides, LPGVGTKIAEKIDEFLATG
KL(metR83) and RIP(metR152)EEMLQMQDIVLNEVK,
were found. The identified peptides harbored a triple
positive charge and had a significant Xcorr factor higher
than the threshold limit of 2.5. Furthermore, their theo-
retical masses corresponded to those measured by
mass spectrometry. Together, these data indicate that
arginine 83 and 152 were methylated by PRMT6.
To confirm these findings, the corresponding argi-
nines were replaced with lysine residues by site-di-
rected mutagenesis. Substitution of arginine to lysine
maintains the positive charge at the position and causes
only minimal changes in the local environment of the
protein. Wild-type or mutated Pol b harboring R83K,
R152K, or both R83/152K substitutions were expressed
and purified from E. coli. Subsequently, all proteins were
subjected to in vitro methylation by PRMT6.While meth-
ylation of Pol b mutated at single R83 or R152 was only
slightly affected, mutation of both R83 and R152 signif-
icantly reduced methylation of Pol b (Figure 2B). These
results clearly indicated that R83 and R152 were targets
for modification by PRMT6 in vitro. Nevertheless, after
prolonged exposure, some residual methylation of the
R83/152K Pol b mutant was detected. The presence of
an additional methylation site(s) in Pol b can therefore
currently not be excluded. Together, these data provide
strong evidence that R83 and R152 of Pol b were the
principal targets for PRMT6-mediated methylation.
Pol b Is Methylated In Vivo by PRMT6
In order to investigate whether Pol b is methylated in
vivo, 293T cells were transfected with either a vector ex-
pressing HA-tagged Pol b or an empty vector. The cells
were treated with 0.5 mM MMS for 1 hr and then were
metabolically labeled with L-[methyl-3H]-methionine
for 3.5 hr in the presence of translation inhibitors as de-
scribed by Kzhyshkowska et al. (2001). Recombinant
Pol bwas immunoprecipitated with an anti-HA antibody,
Figure 2. Pol b Is Methylated In Vitro by PRMT6 at R83 and R152
(A) GST-tagged PRMT6 was incubated with C14-SAM and histones
(10 mg), Pol b (5 mg), or Fen-1 (10 mg). The proteins were resolved us-
ing 15% acrylamide SDS-PAGE gels, stained with Coomassie blue
(lower panel), and analyzed by autoradiography (upper panel).
(B) In vitro methylation of wild-type Pol b and Pol bmutants harbor-
ing mutations at methylation sites by GST-PRMT6. The proteins
were resolved using 12% acrylamid SDS-PAGE gel, stained with
Coomassie blue (lower panel), and analyzed by autoradiography
(upper panel).
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separated by SDS-PAGE, and analyzed by autoradiog-
raphy. While Pol b methylation was detectable in un-
treated cells (Figure 3A), the levels increased after
MMS treatment (Figure 3A). To investigate the involve-
ment of PRMT6 in Pol b methylation in vivo, wild-type
Pol b or R83/152K mutant was cotransfected with
PRMT6. Expression of recombinant proteins was con-
trolled by Western blotting with indicated antibodies
(Figure 3B). In vivo activity of recombinant PRMT6 ex-
pressed in 293T cells wasmonitored as automethylation
of the enzyme (Figure 3A). The level of Pol bmethylation
was substantially higher in cells overexpressing PRMT6
when compared to that in cells transfected with Pol
b alone (Figure 3A). Importantly, the R83/152K mutant
was methylated to a less extent than wild-type Pol b
under comparable conditions. However, the residual
Figure 3. Functional Relevance of Pol b Methylation In Vivo
(A) Methylation of Pol b by PRMT6 in vivo. 293T cells were labeled 24 hr after transfection with L-[methyl-3H]-methionine as described in Exper-
imental Procedures. Recombinant HA-tagged Pol b and myc-tagged PRMT6 were immunoprecipitated from the cell lysates and analyzed by
SDS-PAGE (lower panel) followed by autoradiography (upper panel).
(B) Expression of HA-Pol b andmyc-PRMT6 was analyzed in total cell lysates by immunoblot with anti-HA and anti-myc antibodies, respectively.
(C) Growth inhibition curves of Pol b2/2 cells (solid line) or Pol b2/2 cells stably complemented with either wild-type Pol b (broken line) or the R83/
152K Pol b mutant (dotted line) treated with different concentration of MMS (left panel). Error bars represent SEM of three independent exper-
iments. Expression of recombinant myc-Pol b wt and myc-Pol b R83/152K mutant in the complemented cell lines (right panel).
(D) Effect ofMMSon induction of apoptosis in complemented Pol b2/2MEFs. Pol b2/2MEFs complementedwith control vector, wild-type, or the
R83/152Kmutant of Pol bwere exposed to 0.5mMMMS for 1 hr and then incubated in normalmediumwithout the drug. Cells, both adherent and
floating, were harvested after 24 hr and analyzed by flow cytometry. The percentage of the sub-G1 fraction is indicated.
(E) Occurrence and persistence of DNA strand breaks uponMMSexposure. Complemented Pol b2/2 cell lines were exposed to 0.25mMMMS for
1 hr and then examined by alkaline COMET assays. The graphs represent COMET TF changes relative to mock-treated controls at different time
points before and after MMS treatment. Shaded and nonshaded areas indicate exposure and postexposure periods, respectively. The TFs in-
dicated and the fold changes plotted were calculated from three independent experiments, each comprising more than 2500 scored COMET
events (nuclei). Error bars represent SEM.
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methylation of the R83/152K mutant suggested the
presence of an additional methylation site(s) in Pol
b that can be modified by PRMT6 in vivo. Together,
these results indicate that Pol b is an in vivo substrate
for arginine methylation by PRMT6.
R83 and R152 Are Important for Pol b-Mediated
Repair of MMS-Induced DNA Damage
To investigate whether Pol b methylation of R83 and
R152 is biologically relevant, we subjected Pol b2/2 cells
to genetic complementation by retroviral transduction
with wild-type or the double mutant (R83/152K) cDNAs
of Pol b. After selection of infected cells, the expression
of recombinant Pol b was analyzed by Western blotting
with an anti-myc antibody. This confirmed that the ex-
pression levels of the recombinant wild-type andmutant
Pol b proteins were comparable in these cell lines (Fig-
ure 3C, right panel). Also, there was no difference in
growth for cells complemented with wild-type Pol b or
R83/152K mutant under the normal growth conditions
(data not shown). Pol b2/2 cells and the complemented
cells were subsequently treated with different concen-
trations of MMS, and cell growth inhibition was analyzed
as described by Sobol et al. (2000). Cells transduced
with the control vector were hypersensitive to MMS
and stopped growing at a concentration of 0.5 mM
MMS (Figure 3C, right panel). In contrast, complementa-
tion of Pol b2/2 cellswith recombinantwild-type Pol b re-
duced the MMS hypersensitivity as previously de-
scribed (Sobol et al., 2000; Figure 3C and data not
shown). In the presence of 0.5 mM MMS, growth retar-
dation of wild-type Pol b-expressing cells was only
about 35%. Complementation with the double mutant
variant (R83/152K), however, was much less efficient.
These cells were significantly more sensitive to MMS
than those complemented with the wild-type Pol b (Fig-
ure 3C, left panel). These results clearly demonstrated
that both residues R83 and R152 are important for the
function of Pol b in vivo after MMS treatment.
The effect of MMS on the cell cycle distribution and
the induction of apoptosis in these cell lines were further
analyzed by FACS analysis. MMS induced transient S
phase delay followed by a late arrest in both G1 and
G2/M phases (data not shown). After 24 hr of recovery,
the majority of cells restored normal cell cycle progres-
sion similar to that of untreated cells. However, we ob-
served a substantial increase of cells with a sub-G1
DNA content, which is an indicator of apoptosis
(Figure 3D). The amount of cells with a sub-G1 DNA con-
tent was 44.5%, 2.9%, and 8.6% for the cells comple-
mented with control vector, wild-type, or the R83/152K
mutant of Pol b, respectively.
Next, we examined the role of R83/152K methylation
in repair of MMS-induced DNA strand breaks. Using
the same set of control and complemented Pol b2/2
cell lines, we assessed steady-state levels of DNA frag-
mentation immediately before and at different time
points after exposure of cells to MMS. To be able to de-
tect all possible intermediates of BER, i.e., abasic sites
and DNA single- and double-strand breaks, as quantita-
tively as possible, we performed COMET assays under
alkaline conditions. We then evaluated both the COMET
tail factors (TFs) and the overall distribution of COMET
events into defined stages of DNA fragmentation
(Figure 3E and see Figure S1 in the Supplemental Data
available with this article online). These stages range
from cells with no DNA fragmentation (stage A, <5%
fragmentation) to cells with heavy DNA fragmentation
(stage E, >95% fragmentation). To avoid a contribution
of apoptotic cells to the outcome of the COMET assay,
we adjusted the concentration of MMS to a level that
was tolerable by all three cell lines and excluded rarely
occurring apoptotic nuclei from the analysis. Figure 3E
shows the COMET TFs as calculated from the distribu-
tion of individual cells/events into the five distinct
COMET stages (Anderson et al., 1994). The TFs thus rep-
resent an average degree of DNA fragmentation in the
cell populations. Untreated controls revealed that all
three cell lines had relatively high levels of spontaneous
DNA strand breaks, with TFs ranging between 31.4
and 32.3. Immediately after MMS exposure, all cell
lines showed severe amounts of DNA damage, translat-
ing into TFs higher than 95. Twenty-four and 48 hr
posttreatment, however, differences between the cell
lines became apparent. The cells complemented with
wild-type Pol b showed a stronger reduction of the TFs
than those complemented with the R83/152K mutant
(p < 0.05, Student’s t test), i.e., they had significantly
lower levels of persisting DNA strand breaks up to 48
hr after exposure. The more thorough examination of
the COMET stage distributions confirmed a highly sig-
nificant difference betweenwild-type and R83/152 com-
plemented cells 24 and 48 hr posttreatment (p < 0.001,
contingency tables, chi-square test, Figures S1A and
S1B, and data not shown).
Methylation of R83 and R152 Does Not Affect
the Functionality of Pol b in Short-Patch BER
We used an in vitro-reconstituted short-patch BER as-
say to investigate a possible role of R83 and R152 meth-
ylation in this repair process (Figure 4). A BER intermedi-
ate was first generated by digestion of a 60-mer GU
mismatched oligonucleotide with uracil DNA glycosy-
lase (UDG). The resulting AP site containing DNA was
then treated either sequentially or simultaneously with
purified recombinant human AP-endonuclease, methyl-
ated or unmethylated human Pol b, and the XRCC1/LIG3
complex. These reactions were done in the presence of
either dCTP or dNTPs and varying concentrations of Pol
b, providing an excess or limiting amounts of the poly-
merase relative to the substrate. Testing a wide range
of conditions, we were not able to see any qualitative
or quantitative effect of Pol b methylation (Figure 4) on
BER. The same was true when we applied variants of
the BER assay to monitor nucleotide insertion, strand
displacement synthesis, and dRP lyase activity sepa-
rately (Hasan et al., 2002) (data not shown). We therefore
concluded that, in the context of a short-patch repair
process, neither single nucleotide insertion nor dRP-ly-
ase activity nor strand displacement synthesis is af-
fected by PRMT6-mediated methylation of Pol b.
Methylation of R83 and R152 Stimulates
DNA Polymerase Activity of Pol b in a Primer
Extension Assay
To gain further insight into the importance of PRMT6-
mediated methylation of Pol b, we investigated whether
methylation of R83 and R152 affects the DNA
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polymerase activity of Pol b in a primer extension assay.
To address this question, different amounts of the wild-
type, single R83K and R152K or double R83/152K mu-
tants of Pol b were methylated by PRMT6 in vitro and
subsequently analyzed using a 17/73-mer primer/tem-
plate. Methylated wild-type Pol b possessed signifi-
cantly higher DNA polymerase activity when compared
to that of the nonmethylated wild-type enzyme
(Figure 5A). The observed effect was not due to the pres-
ence of PRMT6, since the nonmethylated samples were
also incubated with the same amount of PRMT6 but
without SAM. Moreover, the presence of SAM in the re-
action mixture did not interfere with the DNA polymer-
ase activity of Pol b (Figure 5A, left panel). Interestingly,
both single mutants of Pol b (R83K and R152K) showed
a substantially lower rate of DNA synthesis after PRMT6
methylation when compared to the wild-type Pol b. It is
also important to notice that the DNA polymerase activ-
ities of the R83K and R152K mutants were comparable
under the tested conditions. This may suggest an equal
importance of these residues for PRMT6-mediated
stimulation of Pol b DNA polymerase activity. Moreover,
we have observed a complete abolishment of the meth-
ylation-dependent increase in DNA synthesis when the
double R83/152K mutant of Pol b was tested. This indi-
cated that the observed effect of PRMT6 on Pol b poly-
merase activity was directly mediated by methylation of
R83 and R152 residues.
Methylation of Pol b Enhances Its DNA Binding
and Processivity
To understand the mechanism of Pol b stimulation by
PRMT6, we investigated the effect of methylation on
the ability of Pol b to bind a DNA template. Purified
Pol b was methylated by PRMT6 in vitro and subse-
quently tested in an electromobility shift assay (EMSA).
The experiments demonstrated that methylation of Pol
b by PRMT6 strongly stimulated binding of the polymer-
ase to DNA (Figure 5B). Pol b mutation of either R83 or
R152 to lysine decreased PRMT6-mediated stimulation
of DNA binding. Furthermore, we found that methylation
of R83 and R152 had an additive effect on the affinity of
the polymerase to the DNA template. Indeed, simulta-
neous mutation of both R83 and R152 residues leads
to a further decrease in DNA binding of Pol b under the
tested conditions. These results correlated well with
Figure 4. Methylation of Pol b Does Not Af-
fect Its Functionality in Short-Patch BER
BER intermediate was generated by incubat-
ing 1 pmol of GU mismatched oligonucleo-
tide (60 nt) with 0.5 units UDG and 0.2 pmol
APE1. The resulting incised AP site product
was further incubated with varying concen-
trations of unmodified (A) or methylated (B)
Pol b and 0.75 pmol of XRCC1/LIG3 complex
in the presence of dCTP or dNTPs as indi-
cated. BER intermediates were separated
on a denaturing 14% polyacrylamide gel, vi-
sualized, and quantified on a fluorescent
scanner. Fragments migrating at a length of
23 nt represent AP site incisions and those
at 24 nt single nucleotide insertions; the lad-
der (panels on the right) documents the ca-
pacity of Pol b to incorporate multiple nucle-
otides by limited strand displacement.
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the methylation-induced DNA polymerase activity of Pol
b observed in Figure 5A.
Finally, the effect of methylation on the processivity
of Pol b was tested. In the presence of a 100-fold mo-
lar excess of unlabeled DNA as a trap, methylation of
Pol b increased the processivity by a factor of 20
(Figure 6), while the R83/152K mutant of Pol b did
not possess a PRMT6-mediated increase in processiv-
ity. These data clearly demonstrated that methylation
of Pol b at R83 and R152 substantially increased its
binding to DNA.
Discussion
In this study, we have addressed the role of PRMT6
in the regulation of human Pol b. We found that Pol
b forms a complex with PRMT6. Their direct physical
interaction was confirmed with bacterially expressed
Figure 5. PRMT6 Methylation of Pol b Stimulates Its Polymerase Activity by Enhancing Its DNA Binding Activity
(A) DNA polymerase activities of wild-type Pol b or mutants R83K, R152K, and R83/152K were measured in a primer extension assay using a 17/
73-mer DNA template. Recombinant proteins were methylated with GST-PRMT6 prior to the DNA polymerase reaction as described in Exper-
imental Procedures.
(B) EMSA using wild-type Pol b or mutants R83K, R152K, and R83/152K. Recombinant proteins were methylated with GST-PRMT6 prior to the
EMSA as described in (A).
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recombinant proteins. Mutation analysis of Pol b indi-
cated that the lyase domain was strictly required for
the interaction with PRMT6. Lyase domains have also
been identified in pols g (Longley et al., 1998), i (Bebenek
et al., 2001), and l (Garcia-Diaz et al., 2001). Whether or
not these also interact with PRMT6 remains to be eluci-
dated.
Pol b was methylated in vitro by PRMT6 at R83 and
R152. The X-ray structure of Pol b (Davies et al., 1994;
Sawaya et al., 1994) shows that both arginines are ex-
posed on the surface, allowing easy access for
PRMT6. Surprisingly, no commonmotifs were found be-
tween the amino acid sequences surrounding R83 and
R152. Moreover, both arginine residues do not reside
within a glycine-rich (GAR) consensus sequence ob-
served in other type I arginine-methylated proteins
(Clarke, 1993; Gary and Clarke, 1998). Consistently,
PRMT4/CARM1 was not able to methylate Pol b in vitro
under the similar conditions (data not shown). These re-
sults confirmed the unique substrate specificity of
PRMT6 and correlated with an earlier report demon-
strating that PRMT6 did not recognize the same sub-
strate motifs as PRMT4/CARM1 and displayed limited
substrate overlap with PRMT1 (Frankel et al., 2002).
The relevance of these findings was confirmed by the
ability of PRMT6 to methylate Pol b in vivo. Pol bmethyl-
ation was stimulated in cells treated with the DNA alky-
lating agent MMS, suggesting that methylation of Pol
b follows genotoxic stress. The inducible nature of Pol
b methylation would require the presence of mecha-
nisms that negatively control this modification. Re-
cently, PADI4 was shown to deiminate unmodified argi-
nine and monomethyl (but not dimethyl) arginine to
citrulline in histone H3 antagonizing the transcriptional
activation mediated by arginine methylation (Cuthbert
et al., 2004). Whether deimination antagonizes arginine
methylation of Pol b remains to be investigated.
Stable complementation of Pol b2/2 cells with either
a control vector, wild-type Pol b, or the R83/152Kmutant
has revealed that methylation at R83 and R152 is impor-
tant for the ability of the enzyme to protect cells against
MMS-induced DNA damage. Importantly, the introduc-
tion of the R83K and R152K mutations did not affect
the specific intrinsic activities of Pol b, i.e., the DNApoly-
merase activity, the dRP-lyase activity, and the binding
to DNA template (Figures 5A and 5B and data not
shown). This minimizes the possibility that the R83/
152K Pol b mutant harbors defects other than methyla-
tion.
Pol b was not required for the activation of cell cycle
checkpoints, since similar profiles of cell cycle distribu-
tion were observed for the complemented Pol b2/2 cells
afterMMS treatment. However, methylation of Pol b very
strongly influenced the efficiency of the repair of MMS-
induced DNA damage. Cells complemented with the
R83/152K variant of Pol b were less efficient in DNA
strand break repair following MMS exposure and, con-
sequently, had a higher propensity to enter apoptosis.
It was previously reported that the dRP-lyase activity
of Pol b is sufficient to reverse hypersensitivity of Pol
b
2/2 cells to MMS, suggesting that removal of the dRP
group is a pivotal step in BER in vivo (Sobol et al.,
2000). However, BER can not be completely restored
in Pol b2/2 cell extracts by a Pol b mutant lacking DNA
polymerase activity, strengthening the importance of
the DNA synthesis mediated by Pol b (Podlutsky et al.,
2001). To further understand the differences between
cells complemented with wild-type Pol b or the R83/
152K mutant in response to MMS, we investigated
howmethylationmay influence specific enzymatic activ-
ities of Pol b. In the context of a short-patch BER pro-
cess, single nucleotide incorporation, limited strand dis-
placement synthesis, and dRP-lyase functions of Pol
b were not notably affected by PRMT6-mediated
Figure 6. Methylation of Pol b Increases Its
Processivity
Primer extension assay was performed using
2 ng (50 fmol) of wild-type (wt) polb or mu-
tants R83K, R152K, and R83/152K in the
presence of 2 pmol of trap DNA template. Re-
combinant proteins were methylated with
GST-PRMT6 prior to the DNA polymerase re-
action as described in Experimental Proce-
dures.
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methylation. However, methylated Pol b induced an en-
hanced binding to a primer extension substrate and thus
an increased DNA polymerase activity and processivity
when compared to the nonmethylated enzyme. These
results are in a good agreement with earlier studies,
which suggest that R83 is one of the critical residues in-
volved in DNA binding of Pol b (Beard andWilson, 2000).
Furthermore, our results provide first evidence that
R152 might also be important for the binding of Pol
b to DNA.
Together, our results suggest that methylation-
induced changes in DNA synthesis activity of Pol b are
responsible for the modulation of Pol b-dependent cell
sensitivity to MMS. However, other methylation-depen-
dent mechanisms may also play a role in determining
efficiency of cellular BER. In fact, methylation-induced
increase in DNA binding of Pol b may not only affect
Pol b-specific activities but also be important for other
functional properties of the polymerase. For example,
a stronger affinity of methylated Pol b to DNA may
have a direct implication in BER via stabilization of Pol
b-specific protein complexes at the sites of DNA dam-
age. Pol b was previously found to form a complex
with the XRCC1-LIG3 heterodimer (Kubota et al.,
1996). In vitro reconstitution experiments indicated
that a mutant XRCC1-LIG3 heterodimer, in which
XRCC1 has a pointmutation (V86R) resulting in an inabil-
ity to interact with Pol b, exhibits inefficient ligation
activity compared to the wild-type XRCC1-LIG3 hetero-
dimer (Dianova et al., 2004). Consistently, XRCC1-
deficient CHO cells transfected with the V86R mutant
of XRCC1 are more sensitive to DNA damage than
wild-type complemented counterparts (Dianova et al.,
2004). These observations imply a mechanism by which
Pol b helps to recruit the XRCC1-LIG3 complex to the
DNA substrate to facilitate BER. It will be of interest to
investigate whether methylation of Pol b affects the re-
cruitment of this and other BER factors to DNA. Alterna-
tively, methylated Pol b could more efficiently protect
DNA due to the higher affinity of the enzyme to DNA re-
pair intermediates generated in BER. Further studies will
be needed to clarify this issue.
Previous studies indicate that alkylating agents acti-
vate both the short-patch and the long-patch BERs
(Miller and Chinault, 1982; Hammond et al., 1990). It is
also well known that Pol b is involved in both of these
BER processes as the primary polymerase. This raises
the question for the role of Pol b methylation in the
short-patch and the long-patch BERs. Here, we demon-
strated that single nucleotide incorporation was not af-
fected by methylation of Pol b as assessed in reconsti-
tuted short-patch BER with a nonchromatinized
template. This suggests that methylation of Pol b has
no functional consequences for short-patch BER. How-
ever, consistent with the effects seen in primer exten-
sion assays, methylation of Pol b is likely to improve its
efficiency (and accuracy) in repair processes in which
processive DNA synthesis provides an advantage, i.e.,
in long-patch BER.
To date, the role of protein arginine methylation in
DNA damage checkpoint responses and DNA repair is
largely unknown. In this view, our findings represent an
interesting aspect that is additionally emphasized by
the fact that the specific cellular role of PRMT6 is still un-
known.When fused to GFP, PRMT6 resided solely in the
nucleus (Frankel et al., 2002), suggesting that this meth-
yltransferase may participate in nuclear processes. In-
terestingly, HIV-type I Tat protein has recently been
found as an exogenous PRMT6 substrate (Boulanger
et al., 2005). In contrast to its acetylation, methylation
of Tat by PRMT6 negatively regulated its transactivation
activity (Boulanger et al., 2005). Our study presents
strong evidence that Pol b is a specific endogenous sub-
strate for PRMT6, suggesting the involvement of PRMT6
in the regulation of BER. A similar scenario was recently
discussed for PRMT1 (Boisvert et al., 2005). PRMT1 was
shown to methylate MRE11, and the mutation of the
methylation sites severely impaired the exonuclease ac-
tivity of MRE11. Interestingly, the cells containing hypo-
methylated MRE11 displayed intra-S phase DNA dam-
age checkpoint defects (Boisvert et al., 2005). It would
also be important to investigate whether PRMT6 can
functionally interact with other repair proteins involved
in BER.
In conclusion, we propose that PRMT6 plays a regula-
tory role in BER via physical interaction with Pol b and
stimulation of Pol b polymerase activity by methylation.
Experimental Procedures
Oligonucleotides and Plasmids
The full-length Pol b and the Pol b DLyase domain were cloned into
pQE30 vector (Invitrogen) as previously described (Hasan et al.,
2002). Pol bDThumb andPol bDThumbDPalm fragmentswere ampli-
fied by PCR from the pQE30-6HIS-Pol b plasmid and were then
cloned into BamHI site of pQE30 vector.
R83K, R152K, and double R83/152K mutants of Pol bwere gener-
ated by site-directed mutagenesis according to the standard proce-
dure.
The pRRL lentiviral transfer vector used in this study has been pre-
viously described (Zufferey et al., 1998). Myc-Pol b wt and myc-Pol
b R83/152K were cloned into pRLL vector by substituting GFP
gene. IRES fused to the blasticidin resistance gene has been intro-
duced into SalI site immediately downstream of Pol b gene. Control
vector contains the IRES/blasticidin resistance gene insert instead
of the GFP gene. The envelope plasmid pMD.G and the packaging
plasmid pCMV DR8.91 have been previously described (Zufferey
et al., 1997).
The 73-mer and the corresponding 17-mer primer substrates for
DNA polymerase and EMSA were from Microsynth (Switzerland).
The sequences are the following: 73-mer, 50-GATCGGGAGGGTAG
GAATATTGAGGATGAAAGGGTTGAGTTGAGTGGAGATAGTGGAG
GGTAGTATGGTGGATA-30; and 17-mer, 50-TATCCACCATACTAC
CC-30.
Proteins
N-terminal 6His-tagged humanPol b full-length and amino acid point
mutants were expressed in E. coli TG1 strain and purified by fast
protein liquid chromatography (FPLC) on Ni-NTA HiTrap (Amersham
Biosciences) and Mono-SP HiTrap columns (Amersham Biosci-
ences). N-terminal 6His-tagged Fen1 was overexpressed in E. coli
BL21(DE3) pLysS strain and purified as mentioned above. GST fu-
sion proteins were expressed in E.coli TG1 strain. N-terminal 6His-
tagged PRMT4 and -6 were expressed in SF9 insect cells and puri-
fied on Ni-NTA ProBond Resin (Invitrogen). Calf thymus histones
(Type II-AS) were purchased from Sigma.
Antibodies
Pol b-specific antibody was purchased from Neo Markers. Mouse
IgG (sc-2025), anti-myc (sc-9E10), and anti-tubulin (sc-8035) anti-
bodies were obtained from Santa Cruz Biotechnology.
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Cells
Pol b2/2 mouse embryonic fibroblasts were described previously
(Sobol et al., 1996). The cells were grown in Dulbecco’s modified Ea-
gle’s medium supplemented with GlutaMAX, 10% fetal bovine se-
rum, 100 units/ml penicillin, 100 mg/ml streptomycin, and 80 mg/ml
hygromicin. 293T cells were cultivated in Dulbecco’s modified Ea-
gle’s medium supplemented with GlutaMAX, 10% fetal bovine se-
rum, 100 IU/ml penicillin, and 100 mg/ml streptomycin.
Lentivirus Production and Infection of Pol b Null Cells
Generation of viruses and transduction of cells were described pre-
viously (Zufferey et al., 1997). After several rounds of selection, ex-
pression of myc-tagged wild-type and mutant Pol b R83/152K was
screened by immunoblot analysis.
Growth Inhibition Assay
Cytotoxicity was determined by growth inhibition assays as de-
scribed previously (Sobol et al., 2000). Briefly, Pol b cells comple-
mented with control vector, wild-type, or R83/152K mutant of Pol
b were seeded at a density of 40,000 cells/well in 6-well dishes 36
hr prior to the treatment. Cells were exposed for 1 hr to a range of
concentrations of MMS. After 1 hr treatment, cells were washed
once with PBS, and then fresh medium was added. After 72 hr of re-
covery at 37ºC in a 5% CO2 atmosphere, cells were collected and
stained with 0.4% trypan blue stain. Viable cells were counted in
a Neubauer Hemocytometer according to the standard procedure.
Growth inhibition was expressed as the number of cells in drug-
treated wells relative to the number of cells in control wells (percent
of control growth).
Cell Cycle Analysis
The cell cycle distribution of stably complemented cell lines was an-
alyzed by FACS analysis. Harvested cells (2.53 105 cells) were fixed
with ice-cold 70% ethanol, treated with 200 mg/ml RNase A (Qiagen),
and subsequently stained with 20 mg/ml propidium iodide (Sigma) in
the presence of 0.1% Triton X-100. Cells were analyzed by using
Beckman Counter FC500/CXP.
COMET Assays
Pol b knockout cells complemented with control vector, wild-type,
or the R83/152Kmutant of Pol bwere seeded 12 hr before treatment.
Cells were exposed to 0.25 mMMMS for 1 hr, then washed with PBS
and either analyzed directly or replated in normal medium and incu-
bated for 24 hr or 48 hr. For the COMET assay, we applied the pro-
cedure described by Singh et al. (1988 and 1991). COMETs were vi-
sualized by ethidium bromide staining (20 mg/ml) and examined at
4003 magnification with a fluorescence microscope (Axiovert 200
M, Zeiss, Germany). More than 2500 DNA spots from each sample
were classified into five categories corresponding to the amount
of DNA in the tail, in accordance with Anderson et al. (1994). Results
were expressed as COMET TFs, calculated according to Ivancsits
et al. (2002). Statistical evaluation was done on the COMET stage
distributions (contingency tables and chi-square analyses) as well
as on the COMET TFs (Student’s t test; two tailed).
GST Pull-Down and Immunoprecipitation
GST-PRMT6 or GST alone bound to glutathione-Sepharose beads
were incubated with indicated proteins in 50 mM HEPES (pH 8.0),
90 mMNaCl, 0.1% (v/v) NP-40, 1 mMDTT, 1 mMPMSF, protease in-
hibitors (2 mg/ml leupeptin, 1 mg/ml pepstatin, 1 mg/ml bestatin) for 2
hr at 4ºC. The beads were washed three times with the same buffer
and heated at 95ºC for 5 min in SDS-PAGE sample buffer. Copreci-
pitated full-length Pol b or Pol b fragments were analyzed by immu-
noblot using anti-Pol b antibody.
For immunoprecipitation, cells were lysed in lysis buffer (50 mM
Tris-HCl [pH 8.0], 90mMNaCl, 1mMDTT, 0.1% [v/v] NP-40, and pro-
tease inhibitors [2 mg/ml leupeptin, 1 mg/ml pepstatin, 1 mg/ml besta-
tin]) for 20 min at 4ºC. Lysates were centrifuged at 13,000 rpm for 30
min at 4ºC, and supernatants were incubated with indicated anti-
bodies and protein G-Sepharose overnight at 4ºC. After extensive
washing, samples were incubated at 95ºC for 5 min in SDS-PAGE
sample buffer and used for further analysis.
Methylation Assays
Purified recombinant proteins were incubated with GST-PRMT6 in
30 ml methylation buffer (50 mM HEPES [pH 8.0], 0.01% [v/v] NP-
40, 10 mM NaCl, 1 mM DTT, 1 mM PMSF) supplemented with 25
nCi of S-adenosyl-L-(methyl-14C) methionine (14C-SAM) (Amersham
Biosciences) (radioactive methylation) or 20 nmol of S-adenosyl-L-
methionine sulfate p-toluenesulfonate (SAMe-PTS) (Sigma) for 1 hr
at 30ºC (cold methylation). Reactions were stopped either by adding
23 SDS-PAGE sample buffer followed by heating at 95ºC for 5 min,
or by adding 100 mM of NaCl and incubating at 4ºC for 10 min.
The in vivo methylation assay was performed by metabolic label-
ing of the cells with L-[methyl-3H]-methionine for 3.5 hr in the pres-
ence of cycloheximide and chloramphenicol as described by
Kzhyshkowska et al. (2001). Recombinant HA-Pol b and myc-
PRMT6 were immunoprecipitated from the cell lysates and analyzed
by SDS-PAGE followed by autoradiography.
BER Assay
BER assayswere performed essentially as described by Hasan et al.
(2002) except that the human XRCC1/LIG3 heterodimer was used in-
stead of the T4 DNA ligase. All BER proteins used were purified to
near homogeneity from E. coli according to standard procedures.
Purification included affinity chromatography facilitated by affinity
tags and ion exchange FPLC as follows: APE1, N-terminal 6His-
tag, purification over Ni2+-nitrilotriacetic acid (Ni-NTA)-agarose (Qia-
gen) and FPLC-UNO-S1 (Amersham Biosciences); XRCC1 C-termi-
nal 6His-tag, purification over Ni-NTA agarose and FPLC-HiTrapQ
HP (Amersham Biosciences); LIG3, N-terminal GST-tag, purification
over glutathione-Sepharose HP Amersham Biosciences) and FPLC-
HiTrapSP HP (Amersham Biosciences). Equimolar amounts of pu-
rified XRCC1 and LIG3 were allowed to form a stable complex at 4ºC
for 15 min prior to their use in the BER assay.
Mass Spectrometry
Pol b was methylated in vitro by GST-PRMT6 bound to glutathione-
Sepharose beads and subsequently treatedwith trypsin and chymo-
trypsin proteases. The peptide mixtures were purified using a C18
reversed-phase column (Millipore) and subjected to LC-MS/MS
analyses on LCQ Deca XP ion trap mass spectrometer (Thermo
Electron, San Jose, California).
DNA Polymerase Assays
DNA polymerase reaction was performed in a final volume of 10 ml
containing 50 mM Tris-HCl (pH 7.6), 0.25 mg/ml BSA, 1 mM DTT,
0.8 mM MnCl2, and 100 mM each of unlabeled dNTPs, [
32P]-50 end-
labeled primer annealed to the template, and the indicated amount
of purified Pol b. The reaction was incubated for 15 min at 37ºC un-
less otherwise stated. The processivity assay was performed in the
presence of a 100-fold molar excess of 17/73-mer DNA template as
a trap. Reaction was terminated by adding gel-loading buffer (95%
[v/v] formamide, 20 mM EDTA [pH 8.0]) and heating for 5 min at
95ºC. Reaction products were resolved on 10% polyacrylamide
and 7 M urea sequencing gel, dried, and exposed to an X-ray film.
EMSA
Purified Pol b or Pol b mutants were incubated with 10 fmol of la-
beled oligonucleotide template in buffer containing 50 mM Tris-
HCl (pH 8.0), 10 mM NaCl, 5 mM EDTA, 4% (v/v) ficol, and 50 mg/
ml BSA for 20 min at RT. Complexes were loaded on 5% polyacryl-
amide gels containing 0.53TBE, run at 100 V for 3 hr, and analyzed
by autoradiography.
Supplemental Data
Supplemental Data include one figure and can be found with this ar-
ticle online at http://www.molecule.org/cgi/content/full/22/1/51/
DC1/.
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